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Abstract 
 
Neutrophils are typically the first leukocytes to be recruited to inflamed sites 
to eliminate invading pathogens, and also play a prominent role in 
inflammatory processes. Although neutrophils are necessary for host 
defenses, paradoxically, they have also been involved in the pathology of 
chronic inflammatory conditions. Recent studies have found that at 
inflammatory sites characterised by low oxygen concentration, neutrophils 
are functionally regulated by the oxygen-sensitive hypoxia inducible factor 
(HIF) transcription factor, which in turn is modulated by a group of oxygen-
sensing hydroxylase enzymes, principally the prolyl hydroxylases (PHDs). 
More recently our group found that semaphorin3F, which was originally 
identified as an axon guidance molecule, is significantly induced in PHD3-
deficient neutrophils following hypoxic stimulation. I therefore proposed that 
semaphorin3F may play a role in neutrophil behaviour during inflammation. 
To investigate this, in vivo experiments were performed in the genetically 
tractable zebrafish, in parallel with in vitro experiments in human peripheral 
blood neutrophils. 
Hypoxia and inflammatory stimuli can modulate semaphorin3F expression. 
Semaphorin3F is significantly upregulated in response to inflammation at 
both mRNA and protein levels suggesting that semaphorin3F might be 
important in regulating neutrophil responses during inflammation. In vivo 
zebrafish experiments show that semaphorin3F plays a role in regulating 
neutrophil migration in inflammation. Semaphorin3F overexpression 
decreases neutrophil recruitment to the site of injury, and subsequently 
delays neutrophil reverse migration. In contrast, semaphorin3F knockdown 
accelerates the movement of neutrophils away from the site of inflammation, 
resulting in faster resolution of inflammation. Similar results were found with 
TALENs-generated semaphorin3F mutant fish. Notably, the phenotypes 
occur in neutrophils not macrophages, suggesting a specific role for 
semaphorin3F in neutrophil migration.  
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Neuropilin-2 and plexin A3 have been identified as expressed in neutrophils 
and potentially as receptors for semaphorin3F in these cells. Semaphorin3F 
inhibits neutrophil chemotaxis to chemoattractants, but did not appear to 
affect cell polarity as judged by the intracellular distribution of an Akt-GFP 
fusion protein that reports PI-3K activity. However, semaphorin3F does 
appear to be implicated in neutrophil shape change during migration. 
These results describe for the first time a role for semaphorin3F in regulating 
neutrophil migration, with consequences for inflammation initiation and 
particularly for resolution. This reveals a novel mechanism by which 
neutrophils are recruited to and maintained at sites of tissue injury. I propose 
therefore that semaphorin3F may be a potential therapeutic target in chronic 
inflammatory diseases caused by persistent neutrophilic inflammation. 
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Chapter 1: Introduction 
1.1 Semaphorins 
1.1.1 Semaphorin family 
Semaphorins are a family of genes encoding guidance molecules in the 
nervous system. The first semaphorin to be discovered was the grasshopper 
transmembrane protein semaphorin-1a (original name; Fasciclin IV) which 
was found in the developing grasshopper nervous system (Kolodkin et al., 
1992). The first semaphorin to be found as a secreted semaphorin was 
semaphorin3A (original name; Collapsin) which was identified from 
biochemically purified neuronal growth cone collapsing factor associated with 
chicken brain membranes (Luo et al., 1993). The name ‘semaphorin’ is 
derived from the word ‘semaphore’ meaning to convey information by a 
signalling system (Goodman et al., 1999). Semaphorins are now a large 
family of secreted and membrane-bound molecules characterised by the 
presence of a sema domain. This domain contains approximately 500 amino 
acids with the 5’ N-terminus being critical for semaphorin function. The sema 
domain forms in a seven-blade β-propeller fold having structural similarity to 
the extracellular domain of α-integrins (Koppel et al., 1997). Next to the C-
terminus of the sema domain, semaphorins contain the PSI (plexin-
semaphorin-integrin) domain which is rich in cysteines and referred to as a 
MET-related sequence (MRS) or a cysteine-rich domain (CRD) (Bork et al., 
1999). Semaphorins also contain other distinct protein domains including 
immunoglobulin-like domain, basic C-terminal domain and thrombospondin 
domain (Figure 1.1). Semaphorins are categorised into 8 classes, 1-7 and V: 
invertebrate semaphorins are grouped in classes 1, 2 and 5; classes 3-7 are 
vertebrate semaphorins; and class V contains virally encoded semaphorins. 
In vertebrates, class 3 semaphorins are secreted and are distinguished by a 
C-terminal conserved basic-charged domain. Class 4-7 semaphorins, cell-
membrane-anchored proteins, are characterised by unique structural 
elements, including thrombospondin repeats or a glycophosphatidylinositol 
(GPI) anchor (Capparuccia and Tamagnone, 2009).   
22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: The members of the semaphorin family and their structure. There are 8 
classes of semaphorins, of which class 1-2 and sema5C are invertebrate semaphorins, 
class 3-7 are vertebrate semaphorins (with the exception of sema5C). Semaphorins of 
classes 2, 3 and V are secreted, whereas the other classes are synthesized as 
transmembrane proteins. Class V semaphorins are found in DNA viruses. Semaphorins 
contain sema domains with additional domains, including PSI (Plexin, Semaphorin and 
Integrin) domains, Immunoglobulin (Ig)-like domains, thrombospondin repeats and GPI 
(Glycophosphatidylinositol) linkage. All proteins are shown with their N-termini to the top. 
This schematic was based on a diagram from Neufeld and Kessler (2008). 
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Semaphorins are expressed in both neuronal and non-neuronal tissues, and 
in many organ systems, including the gastrointestinal, cardiovascular, 
endocrine, hepatic, immune, musculoskeletal, renal, reproductive, and 
respiratory systems. The varied expression patterns of semaphorins suggest 
that they act in different roles in a variety of functions (Yazdani and Terman, 
2006).  
Semaphorins are best known for their roles in nervous system development, 
for instance, invertebrate class 1 semaphorins are required in Drosophila for 
embryonic motor and central nervous system axon guidance (Yu et al., 
1998). Invertebrate semaphorin2A functions as a selective target-derived 
signal inhibiting the formation of specific synaptic terminal arborisations in 
vivo in drosophila models (Matthes et al., 1995). Class 3 semaphorins are 
not involved in axonal guidance through repulsive gradient and induction of 
growth cone collapse, but are implicated in survival and apoptosis of 
neurons, such as semaphorin3C effects on survival and induction of 
neuritogenesis of rat cerebellar neurons in culture (Moreno-Flores et al., 
2003). Furthermore, semaphorin4D demonstrated neurotrophic effects by 
potentiating neurite outgrowth in the presence of nerve growth factor (Fujioka 
et al., 2003). Unlike other semaphorins, acting as repulsive guidance cues, 
semaphorin7A promotes central and peripheral axon growth and is 
necessary for axon tract formation during embryonic development 
(Pasterkamp et al., 2003). 
Accumulated evidence has shown that, besides their roles in the nervous 
system, semaphorins also function in a variety of other cell processes. Class 
3 semaphorins are the best example. Many studies of semaphorin3A have 
revealed that semaphorin3A is implicated in cell survival and proliferation, 
cell adhesion, cell migration, bone, heart and lung formation and 
cytoskeleton organisation (Yazdani and Terman, 2006). Semaphorin3A 
moreover can inhibit VEGF-induced cyclin D1 upregulation, with the 
abrogation of semaphorin3A expression responsible for VEGF-driven growth 
of tumour cells (Catalano et al., 2004). In the immune system, semaphorin3A 
expressed by tumour cells inhibited activation of cytotoxic activity in mixed 
lymphocyte culture with tumour cells, suggesting that semaphorin3A inhibited 
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primary T-cell activation and contributed to the T-cell dysfunction in the 
tumour microenvironment (Catalano et al., 2006). Interestingly, 
semaphorin3A has been reported to be involved in regulating the functional 
activity of macrophages (Casazza et al., 2013). 
Other studies have suggested that semaphorin3B acts as a tumour 
suppressor by inducing apoptosis in lung and breast cancer cells and by 
blocking the VEGF165 autocrine activity as a survival factor produced by 
tumour cells (Castro-Rivera et al., 2004). Semaphorin3B has been found to 
be expressed at high levels in invasive and metastatic human cancers. 
Silencing the expression of semaphorin3B in tumour cells results in defective 
IL-8 transcription, leading to reduction of tumour-associated macrophage 
recruitment and metastatic dissemination to the lung (Rolny et al., 2008). 
Some research has indicated that semaphorin3C can enhance glomerular 
endothelial cell proliferation, adhesion, directional migration, and tube 
formation in vitro by activating integrin phosphorylation and VEGF120 
secretion. These effects are opposite to semaphorin3A which controls 
vascular morphogenesis via integrin inhibition (Banu et al., 2006). 
Semaphorin3C is further required for normal cardiovascular patterning, and 
can promote crest cell migration into the proximal cardiac outflow tract using 
mouse models. Semaphorin3C mutant mice showed an early mortality from 
congenital cardiovascular defects caused by improper septation of the 
cardiac outflow tract (Feiner et al., 2001).  
In zebrafish models, knockdown of semaphorin3D mediated by morpholino 
injections inhibited the proliferation of hindbrain neuroepithelial cells, and 
decreased migratory neural crest cells (Berndt and Hoalloran, 2006). 
Furthermore, semaphorin3D is important for the normal patterning of 
pulmonary veins, with a defect of semaphorin3D signalling leading to total 
anomalous pulmonary venous connection disorder in mutant mice 
(Degenhardt et al., 2013). Sabag et al. reported that semaphorin3D and 
semaphorin3E inhibit the development of tumours from U87MG glioblastoma 
cells, and semaphorin3D plays a role as an inhibitor of angiogenesis (Sabag 
et al., 2012). 
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In contrast, a recent study has found that semaphorin3E enhances tumour 
cell survival by suppressing an apoptotic pathway. Blocking of semaphorin3E 
inhibited tumour growth and decreased metastasis in mouse models of 
breast cancer (Luchino et al., 2013). However, semaphorin3E has also been 
identified as a potent inhibitor of tumour-induced angiogenesis (Sakurai et 
al., 2010), and can regulate angiogenesis via a VEGF-induced feedback 
mechanism (Kim et al., 2011). 
Semaphorin3G has been identified as an attractive and repulsive regulator of 
angiogenesis. It functions further as a molecule of angiogenic endothelial 
cells controlling endothelial and smooth muscle cell functions in autocrine 
and paracrine effects (Kutschera et al., 2011). 
Interestingly, accumulated evidence has revealed that semaphorins play a 
crucial role in immune processes including immune cell differentiation into 
effector and helper cells, cell migration, clonal expansion and phagocytosis 
(Potiron et al., 2007). For instance, semaphorin4D expressed in leucocytes 
can increase macrophage recruitment to glomeruli during glomerular injury in 
experimental crescentic glomerulonephritis (Li et al., 2009). Semaphorin4A 
activates T-cell-mediated immunity by increasing proliferation and stimulation 
of interleukin and interferon production (Kumanogoh et al., 2002). Recent 
studies have demonstrated that endothelial semaphorin7A enhances 
neutrophil transmigration across endothelial cells during hypoxia (Morote-
Garcia et al., 2012). Moreover, viral semaphorinA39R expressed on 
neutrophils and dendritic cells inhibited phagocytosis of bacterial particles in 
vitro by inhibiting integrin-mediated adhesion. SemaphorinA89R disrupted 
the ability of CD8α+ DC to cross –prime CD8+ T-cells ex vivo (Walzer et al., 
2005). 
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1.1.2 Semaphorin3F 
Semaphorin 3F is a member of class 3 secreted semaphorins. The class 3 
semaphorin proteins are distinguished by a conserved, basic-charged 
domain at the C-terminus. Semaphorin3F, previously known as H SemaIV, 
was originally isolated from a 3p21.3 homozygous deletion in small cell lung 
cancer cell lines (Xiang et al., 1996). In lung, semaphorin3F is observed at 
the cytoplasmic membrane and in the cytoplasm (Brambilla et al., 2000), but 
there is currently no literature exploring localisation of semaphorin3F in 
neutrophil compartments. Although semaphorin3F was initially characterised 
as a mediator of growth cone repulsion (Luo et al., 1993), semaphorin3F has 
been shown to be involved in a variety of cellular processes including cell 
attachment, cell migration, cell proliferation, cytoskeleton organization, lung 
formation, synaptic transmission, neural connectivity, cell survival, apoptosis, 
tumour angiogenesis, tumour metastasis, tumour suppression and immune 
responses (Yazdani and Terman, 2006).  
In a breast cancer cell line, MCF7, semaphorin3F inhibited cell attachment 
and spreading by loss of lamellipodia extensions, cell-cell contacts (Nasarre 
et al., 2003). Semaphorin3F had a dual effect, chemoattractive and 
mitogenic, on embryoic oligodendrocyte precursor cells, the myelin-forming 
cells of the central nervous system, migrating from the site of emergence 
toward the final destination. Moreover, in the presence of semaphorin3F, the 
number of migrating oligodendrocyte precursor cells increased significantly 
(Spassky et al., 2002). In human U87MG glioma cells and human umbilical 
vein endothelial cells, semaphorin3F caused rapid cytoskeletal collapse by 
inactivation of a small GTPase and RhoA which is essential for cytoskeleton 
integrity (Shimizu et al., 2008). Semaphorin3F stimulated branching 
morphogenesis in the developing lung that was accompanied by an increase 
in the incorporation of bromodeoxyuridine into DNA in the epithelial cells 
(Kagoshima and Ito, 2001). Sahay et al. (2005) reported that recombinant 
semaphorin3F modulated fast excitatory synaptic transmission by increasing 
frequency and amplitude of miniature EPSC in granule cells of the dentate 
gyrus and pyramidal neurons in the adult hippocampus. Semaphorin3F was 
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identified as a ligand shown to be necessary for controlling the development 
of amygdaloid circuitry in the CNS (Sahay et al., 2003). 
Although semaphorin3F is widely expressed in most tissues, the expression 
of semaphorin3F is frequently downregulated in cancer cells, indicating that 
alterations of semaphorin3F are involved in tumourigenesis (Kusy et al., 
2005). Overexpression of semaphorin3F in tumourigenic human HEK293 
cells inhibited tumour-forming ability and cell development, and had a 
significantly lower concentration of tumour-associated blood vessels induced 
by VEGF165 (Kessler et al., 2004). Many recent studies have suggested that 
semaphorin3F might be a tumour-suppressor gene (Xiang et al., 1996). 
Experimental evidence indicated that semaphorin3F can inhibit cell migration 
of breast cancer cells (Nasarra et al., 2005), and induce apoptosis in ovarian 
cancer in vivo (Xiang et al., 2002). Some studies have suggested that 
Semaphorin3A and Semaphorin3F inhibit migration of endothelial cells by 
inhibiting activation of integrins and thereby disrupting tumour angiogenesis 
(Guttmann-Raviv et al., 2007). Semaphorin3F is expressed in many human 
tumour cell lines but is downregulated in highly metastatic tumour cells and 
in metastases in vivo (Bielenberg et al., 2004). Furthermore, overexpression 
of semaphorin3F inhibited cell growth of a lung cancer cell line in vitro and 
participated in p53 regulated tumour angiogenesis suppression. 
Semaphorin3F is also a direct transcriptional target of p53 (Futamura et al., 
2007).  
There is currently no literature exploring the role of semaphorin3F in 
regulating immune cell responses. The members of class 3 semaphorins 
which have been identified to be involved in the immune system are 
semaphorin3A and semaphorin3E. Semaphorin3A has been discovered to 
affect macrophage function involved in tumour growth and metastasis 
(Casazza et al., 2013). It was also found to inhibit human monocyte and T 
cell migration by inhibiting their responsiveness to chemokine gradients 
(Delaire et al., 2001). Furthermore, human recombinant semaphorin3A or 
semaphorin3A-transfected COS-7 cells can inhibit primary human T-cell 
proliferation and cytokine production, and inhibit the activation of the 
cytotoxic activity in mixed lymphocyte culture (Catalano et al., 2006). 
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Semaphorin3E and its receptor have been reported to be necessary in the 
development of thymocytes by regulating migration of maturing thymocytes 
into the medulla through chemokine gradients (Choi et al., 2008).  
 
1.1.3 Receptors 
Plexins and neuropilins are two groups of proteins which have been 
characterised as the primary semaphorin receptors. Several membrane-
bound semaphorins bind directly to plexins, whereas secreted class 3 
semaphorins further require neuropilins as obligate coreceptors (Takahashi 
et al., 1999). Therefore class 3 semaphorins signal through a specific 
holoreceptor complex consisting of a ligand-binding (neuropilins) and a 
signal-transducing subunit (plexins). 
Plexins are large, phylogentically conserved transmembrane proteins (~ 200 
kDa) containing a divergent extracellular semaphorin domain and a 
conserved cytoplasmic domain unique to plexins. Invertebrate plexins are 
grouped in two categories, plexin A and plexin B. In contrast, vertebrate 
plexins are divided into four categories, A to D. Similar to semaphorins, the 
extracellular domain of plexins contains a sema domain, followed by three 
plexin-semaphorin-integrin (PSI) domains and three immunoglobulin-like, 
plexin and transcription factors (IPT) domains (Bork et al., 1999). The PSI 
domain is rich in cysteines and referred to as a MET-related sequence 
(MRS) or a cysteine-rich domain (CRD), and is required for protein-protein 
interaction, whereas the IPT domain is essential for ligand binding. The 
intracellular domain of plexins is highly conserved between different classes, 
and contains a GTPase-binding domain and a segmented GTPase-activating 
protein (GAP) (Figure 1.2). The cytoplasmic tail of plexins is necessary for 
signal transduction upon ligand binding (Kruger et al., 2005). 
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Figure 1.2: The members of the plexin family and their structure. There are four classes 
of plexins in vertebrates. Plexins are chracterised by a sema domain and additional domains 
including three plexin-semaphorin-integrin (PSI) domains, three immunoglobulin-like, plexin 
and transcription factors (IPT) domains, a GTPase-binding domain, and a segmented 
GTPase-activating protein (GAP). Class B plexins contain additional a convertase-cleavage 
site, and a PDZ-binding site. All proteins are shown with their N-termini to the top. This 
schematic was based on a diagram from Neufeld and Kessler (2008). 
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Neuropilins, which are found only in vertebrates, are single-spanning 
transmembrane glycoproteins with molecular weights of 120-130 kDa. They 
were first identified as an antigen of a monoclonal antibody A5 generated 
against the optic nerve of Xenopus (Takagi et al., 1991). A5 was then 
renamed to neuropilin based on its expression in neuropils in a specific 
region of the nervous system. Neuropilins are expressed on neurons, 
endothelial cells, epithelial cells, osteoblasts and tumour cells. Two 
neuropilins are classified, neuropilin-1 and neuropilin-2, that share 40% 
homology. The basic structure of neuropilins contains three sections; a large 
extracellular domain, a very short transmembrane domain, and a short 
cytoplasmic domain. The extracellular domain is divided into three parts; an 
A domain containing two repeats of CUB (complement factor C1r and C1s, 
Uegf (Tolloid protein) and bmp1 (Bone Morphogenetic Protein 1)) domain 
(a1/a2), a B domain consisting of two repeats of coagulation factors FV/VIII 
domain (b1/b2), and a C domain containing a MAM (Meprin, A5, μ-
phosphatase) domain. The A and B extracellular domains are binding sites 
for neuropilin ligands. The cytoplasmic tail does not have a kinase motif, but 
a PDZ (PSD-95/Dlg/ZO-l) binding motif. This PDZ domain is a common 
protein-protein recognition module in the nervous system (Nakamura and 
Goshima, 2002) (Figure 1.3). Most of the class 3 semaphorins bind to one or 
to both of the neuropilin family. Although neuropilin was firstly identified as a 
direct binding receptor for class 3 semaphorins (Kolodkin et al., 1997), they 
alone have no ability to transduce the signals of class 3 semaphorins 
because of their non-kinase motif at the cytoplasmic tail. Neuropilins need 
therefore to form complexes with plexins (Takahashi et al., 1999). In addition, 
neuropilins were characterised as co-receptor for member of the vascular 
endothelial growth factor (VEGF) family (Soker et al., 1998), and can form 
complexes with other cell-surface receptors such as β1-integrin (Fukasawa 
et al., 2007) and transforming growth factor- β1 (TGF- β1) (Glinka et al., 
2008). 
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Figure 1.3: The neuropilin structure. Neuropilins consist of three extracellular domains 
(a1/a2, b1/b1, and c), a very short transmembrane domain, and a short cytoplasmic domain. 
Neuropil-1 and neuropilin-2A contain additional a PDZ-binding site at the cytoplasmic tail. All 
proteins are shown with their N-termini to the top. This schematic was based on a diagram 
from Neufeld and Kessler (2008). 
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Accumulated evidence has indicated that neuropilin-2 and class A plexins 
form a complex for semaphorin3F signalling. Chen et al. has reported that 
neuropilin-1 binds semaphorin3A with higher affinity than semaphorin3F, but 
neuropilin-2 binds semaphorin3F only, and the affinity of semaphorin3F for 
neuropilin-2 is ten times greater than for neuropilin-1 (Chen et al., 1997). 
Furthermore, semaphorin3F is the ligand for neuropilin-2-mediated axon 
guidance in vivo that plays a critical role in limbic and peripheral nervous 
system circuitry (Sahay et al., 2003). Experiments in metastatic human 
melanoma demonstrated that semaphorin3F expressed by tumour cells 
generated chemorepulsion of vascular and lymphatic endothelial cells 
expressing neuropilin-2 in a manner similar to semaphorin-induced axon 
repulsion. This repulsion was inhibited by neuropilin-2 RNA interference 
(Bielenberg et al., 2004). Studies of tumour angiogenesis showed that 
semaphorin3F signals through neuropilin-2 to inhibit VEGF165-induced 
proliferation of human umbilical vein endothelial cells, as well as VEGF-
induced phosphorylation of extracellular signal which led to inhibition of 
tumour angiogenesis (Kessler et al., 2004). Moreover, loss of neuropilin-2 
expression in tumour cells inhibited semaphorin3F-dependent activities 
including inactivation of RhoA, depolymerisation of F-actin and inhibition of 
tumour and endothelial cells (Coma et al., 2011). Furthermore, it has been 
shown that, besides neuropilin-2, different members of class A plexins 
function as co-receptors for semaphorin3F. Takahashi et al. used a COS-7 
cell contraction assay demonstrating that semaphorin3F was unable to 
induce the contraction of neuropilin-1/plexin A1- or neuropilin-1/plexin A2-
expressing COS-7 cells, but could generate the contraction of neuropilin-
2/plexin A1- or neuropilin-2/plexin A2-expressing COS-7 cells ((Takahashi 
and Strittmatter, 2001) Other observations revealed that semaphorin3F 
signals repulsion primarily through the action of plexin A3 (Yaron et al., 
2005). Nervous cell migration such as oligodendrocyte precursor cell 
migration mediated by semaphorin3F decreased significantly in the absence 
of neuropilin-2 and plexin A3 (Xiang et al., 2012). In ovarian cancer cell lines, 
the expression of semaphorin3F and plexin A3 was markedly decreased, 
whereas plexin A1 expression was not altered when compared to normal 
human ovarian epithelial cells (Joseph et al., 2010). 
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1.1.4 Signalling 
Whilst plexins are the most prominent semaphorin receptors, semaphorin 
signalling requires co-receptors forming as holoreceptor complexes with 
plexins. These co-receptors can act as ligand-binding subunits such as 
neuropilins, or modulatory subunits such as Immunoglobulin superfamily cell 
adhesion molecules (IgCAMs) (Tran et al., 2007), and receptor tyrosine 
kinases (RTKs) e.g. VEGFR2 (Toyofuku et al., 2004).  
Recent studies have shown that class 3 semaphorins serve as a key 
regulator of cellular processes including cell motility and migration of 
endothelial and tumour cells, tumour growth and angiogenesis, cell survival, 
proliferation and apoptosis. Class 3 semaphorins mediate their activities 
through plexin A1-A4 and neuropilins, with the exception of semaphorin3E, 
which binds directly to plexin D1 without the requirement for neuropilins 
(Gaur et al., 2009). In addition, some class 3 semaphorin signalling needs 
other molecules as co-receptors, for instance, semaphorin3A binds to 
neuropilin-1 which assembles plexin A1 as a neuropilin-1/plexin A1 receptor 
complex. This complex further requires a neuron cell adhesion molecule L1 
(L1CAM) for specific repulsion or attraction of the axon guidance actions 
(Castellani et al., 2000). One of the best known intracellular signalling events 
downstream of class 3 semaphorins is inhibition of integrin activity by 
semaphorin3A. Semaphorin3A mediates the axonal repulsion via direct 
binding of plexin A1 and FERM domain-containing guanine nucleotide 
exchange factor (GEF) FARP2. Once semaphorin3A binds to neuropilin-1, 
FARP2 dissociates from plexin A1 resulting in activation of Rac1 activity and 
recruitment of Rnd1 to plexin A1 (Toyofuku et al., 2005). Active Rac1 leads 
to regulation of actin dynamics, enhancing axon repulsion. Rnd1/plexin A1 
interaction stimulates plexin A1/RasGAP (GTPase-activating protein) activity 
resulting in inactivation of R-Ras and PI3K signalling. Thus, integrin ligand-
binding activity is inhibited (Zhou et al., 2008) (Figure 1.4). 
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Figure 1.4: Integrin inhibition by semaphorin3A signaling. Semaphorin3A binds 
neuropilin-1 to assemble a neuropilin-1-plexin A1receptor complex. This binding stimulates 
FERM domain-containing guanine nucleotide exchange factor (GEF) (FARP2) dissociation 
from the plexin A1. Dissociated FARP2 activates Rac1 and recruitment of Rnd1 to plexin A1. 
Active Rac1 leads to regulation of actin dynamics enhancing axon repulsion. Rnd1/plexin A1 
interaction stimulates plexin A1/RasGAP (GTPase-activating protein) activity resulting in 
inactivation of R-Ras and PI3K signalling. Thus, integrin ligand-binding activity is inhibited. 
This schematic was based on a diagram from Toyofuku et al. (2005) and Zhou et al. (2008). 
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As previously mentioned, class A plexins form a complex with neuropilin-2 to 
generate a functional semaphorin3F receptor in which neuropilin-2 acts as 
semaphorin3F binding element, and plexin A as signal transducer. It has 
been proposed that semaphorin3F functions as a tumour suppressor 
because of its downregulation of expression in tumours (Bielenberg et al., 
2004). Semaphorin3F can cause loss of activated α5β3-integrin Brambilla et 
al., 2000), downregulation of integrin-linked kinase activity (ILK), and 
reduction of cell adhesion to extracellular matrix (ECM) ((Kusy et al., 2005, 
Potiron et al., 2007). Potiron et al. reported that semaphorin3F inhibited ILK 
activity in H157 lung cancer cells leading to decreased extracellular signal-
regulated protein kinase 1 and 2 (ERK1/2) signalling. In parallel, 
semaphorin3F decreased protein kinase B or AKT and signal transducer and 
activator of transcription 3 (STAT3) phosphorylation in H157 cells 
independent from ILK-ERK1/2 signalling. As a consequence, semaphorin3F 
inhibited tumour growth and formation (Potiron et al., 2007). Consistently, 
studies of growth cone collapse in sympathetic neurons showed that 
semaphorin3F suppressed neurotrophin nerve growth factor (NGF)-induced 
activity resulting in inhibition of PI3K-AKT and mitogen-activated protein 
kinase kinase (MEK)-ERK pathway (Atwal et al., 2003) (Figure 1.5A).  
Accumulated evidence has indicated that semaphorin3F can inhibit tumour 
cell migration. One mechanism by which semaphorin3F inhibits cell migration 
is through inactivation of RhoA. Semaphorin3F forms a complex with 
neuropilin-2 and plexin A1 leading to recruitment of ABL2 tyrosine kinase (v-
Abl Abelson murine leukemia viral oncogene homolog 2) and p190RhoGAP 
to the cytoplasmic tail of plexin A1. ABL2 phosphorylates then the 
p190RhoGAP which inactivates RhoA, followed by inactivation of Rho 
kinase. As a result, cofilin, an actin depolymerisation factor, remains active, 
and promotes F-actin cytoskeleton depolymerisation. The migration and 
contractility of this cell are consequently inhibited. Moreover, semaphorin3F 
inactivates the small GTPase Rac1, a regulator of lamellipodia formation at 
the leading edge during migration, suggesting that semaphorin3F contributes 
to the regulation of cell migration (Shimizu et al., 2008) (Figure 1.5B). 
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Figure 1.5: Semaphorin3F signaling. (A) Signaling pathways involved in semaphorin3F 
signaling. Semaphorin3F can inhibit (Integrin-linked kinase) ILK activity leading to decreased 
extracellular signal-regulated protein kinase 1 and 2 (ERK1/2) signalling. In parallel, 
semaphorin3F decreases protein kinase B or AKT and signal transducer and activator of 
transcription3 (STAT3) phosphorylation. As a consequence, semaphorin3F inhibits tumour 
progression. Consistently, studies of growth cone collapse in sympathetic neurons showed 
that semaphorin3F suppresses neurotrophin nerve growth factor (NGF)-induced activity 
resulting in inhibition of PI3K-AKT and mitogen-activated protein kinase kinase (MEK)-ERK 
pathway. This schematic was based on a diagram from  Atwal et al. (2003) and Potiron et 
al. (2007). (B) Cell migration inhibition by semaphorin3F signalling. Semaphorin3F forms a 
complex with neuropilin-2 and plexin A1 leading to recruitment of ABL2 tyrosine kinase (v-
Abl Abelson murine leukemia viral oncogene homolog 2) and p190RhoGAP to the 
cytoplasmic tail of plexin A1. ABL2 phosphorylates then the p190RhoGAP which inactivates 
RhoA, followed by inactivation of Rho kinase. As a result, cofilin, an actin depolymerisation 
factor, remains active, and promotes F-actin cytoskeleton depolymerisation. The migration of 
this cell is consequently inhibited. Moreover, semaphorin3F inactivates small GTPase Rac1, 
a regulator of lamellipodia formation at the leading edge during migration. This schematic 
was based on a diagram from Shimizu et al. (2008). 
A 
B 
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A further mechanism through which semaphorin3F inhibits tumour 
angiogenesis is by antagonising VEGF-mediated signalling. Both 
semaphorin3F and VEGF have same ligands. However, many studies have 
indicated that in contrast to semaphorin3A, which competes with VEGF165 for 
binding to neuropilin-1, semaphorin3F does not compete with VEGF165 for 
binding to neuropilin-2 (Kessler et al., 2004). Neuropilin-2 is the co-receptor 
for both semaphorin3F and the VEGF family of angiogenesis factors 
including VEGF-A (145 and 165 isoforms) VEFG-C (Gluzman-Poltorak et al., 
2000, Xu et al., 2010). In principle, VEGF family members mediate their 
downstream effects by binding to neuropilins and forming complexes with 
VEGF receptors (VEGFR) analogous to the class 3 semaphorin-neuropilin-
plexin complex (Soker et al., 1998). Semaphorin3F has a higher binding 
affinity to neuropilin-2, which functions as a splice variant specific VEGF 
receptor that binds VEGF165, and therefore can signal though the 
neuropilin-2 to inhibit VEGF165 in angiogenesis (Serini et al., 2009).  Kessler 
et al. reported that semaphorin3F inhibited VEGF165 and basic fibroblast 
growth factor (bFGF)-induced phosphorylation of ERK1/2 signaling, 
indicating that semaphorin3F acts as an inhibitor of angiogenesis (Kessler et 
al., 2004). 
Nowadays, semaphorin3F has emerging roles in tumour progression and cell 
migration. It is interesting to consider whether semaphorin3F has other 
functions in cells in the immune system. In this study, the role of 
semaphorin3F in neutrophil function in inflammation was investigated. 
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1.2 Neutrophils 
1.2.1 Overview of neutrophils 
Polymorphonuclear neutrophils (PMNs) are a subdivision of myeloid derived 
granulocytes, representing the most abundant (50 to 70 percent of the total) 
circulating leukocytes and 95 percent of granulocytes in mammals. 
Neutrophils form an important part of the innate immune system, and are 
terminally differentiated cells rich in cytoplasmic granules which contain 
various enzyme components, including myeloperoxidase, serine proteases, 
neutrophil elastase, cathepsin and gelatinase, and antimicrobial proteins, 
including bactericidal/permeability increasing protein (BPI), defensins, 
lactoferrin and cathelicidin. Neutrophils release their granule contents during 
phagocytosis creating a highly toxic microenvironment (Schmidt et al., 1989).  
In the circulation, neutrophils normally have a very short half-life between of 
8 to 20 hours. This increases several fold once neutrophils arrive at inflamed 
or infected tissues where oxygen is typically rare (Edwards, 1994). 
Neutrophils are the first defensive cell type to be recruited to sites of 
inflammation, where they remove pathogens through phagocytosis. They 
migrate through the blood vessels, then through interstitial tissue, following 
chemical signals in a process called chemotaxis. Neutrophils and cells in the 
inflamed area express and release cytokines, which in turn have effects on 
neutrophil recruitment and function in inflammatory reactions. For instance, 
IL-1β is involved in the local recruitment of neutrophils to inflamed sites. 
TNF-α further promotes neutrophil migration and plays an important role in 
microbial defence and neutrophil apoptosis (Butterfield et al., 2006).  
Although neutrophils play a crucial role in host defence against infectious 
agents such as bacteria, fungi, protozoa, viruses, virally infected cells and 
tumour cells (Ratcliffe et al., 1988), paradoxically, they also contribute to the 
pathogenesis of a number of human diseases (John, 1944). In these 
conditions, host tissue damage occurs through neutrophil-released tissue-
damaging molecules such as protease during the killing of microbes.   
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1.2.2 Neutrophil priming  
Neutrophil priming was described by McPhail as the ability of a primary 
agonist, typically at a substimulatory concentration, to enhance superoxide 
production triggered by a second stimulus (McPhail et al., 1984). Resting 
neutrophils can become primed by cytokines, chemokines, growth factors 
and bacterial products, resulting in ‘primed’ or ‘activated’ neutrophils, which 
recruit towards the site of infection or inflammation (Hallett and Lloyds, 
1995). Priming occurs via two separate mechanisms. Priming agents can 
cause priming as a consequence of rapid mobilisation of secretory vesicles 
and secretion of cytokines, or by the activation of transcription factors that 
trigger the expression of cytokines or plasma membrane receptors, which 
then in turn regulate neutrophil function and lifespan (Wright et al., 2010). 
 
1.2.3 Neutrophil recruitment 
The recruitment of activated neutrophils from the circulation to the site of 
inflammation, via diapedesis, is regulated by selectins, integrin and adhesion 
molecules, cytokines, chemokines and products of invading microorganisms. 
Neutrophil rolling in blood vessels is mediated by selectins. In this, L-selectin 
expressed on the surface of neutrophils binds to ligands expressed on the 
surface of endothelial cells; E- and P-selectin, to facilitate a loose interaction, 
known as tethering, between neutrophils and endothelial cells leading to 
neutrophil rolling along the endothelium, followed by rolling arrest. This step 
is mediated by binding of neutrophil receptors to chemoattractants such as 
IL-8 or N-formylated peptides from bacteria (Kobayashi et al., 2005), and by 
adhesion molecules such as β1 (VLA-4; very late antigen-4) - and β2-
integrins (LFA-1; Lymphocyte function antigen, or Mac-1; macrophage 
antigen-1) (Ley, 2002). Once high-affinity adhesion to the endothelium 
occurs, neutrophils migrate into the tissue through the junctions between 
neighbouring endothelial cells, a process known as paracellular migration, 
using surface ligands including platelet endothelial cell adhesion molecule-
1(PECAM-1), intracellular adhesion molecule-1 (ICAM-1) and proteins of the 
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junctional adhesion molecule (JAM) family (Woodfin et al., 2009). They 
migrate then towards inflamed tissue along a chemotactic gradient. 
Neutrophils are directed by number of different chemoattractants, including 
N-formylmethionyl-leucyl-phenylalanine (fMLP), IL-8, and complement 
component 5a (C5a). These chemoattractants induce cellular polarisation 
and formation of actin-rich pseudopodia at the leading edge of the cells 
allowing neutrophils to migrate to their destination (Servant et al., 2000). 
 
1.2.4 Neutrophil phagocytosis and respiratory burst 
At the site of infection or inflammation, neutrophils bind and eliminate 
invading microorganisms by the process known as phagocytosis. Neutrophils 
can recognise pathogen-derived molecules including lipopolysaccharide 
(LPS), peptidoglycan or lipoporteins through their cell surface receptors such 
as Toll-like receptors (TLRs) and CD14 (Akira and Takeda, 2004). 
Phagocytosis is facilitated by specific opsonin (immunoglobulin G (IgG)) and 
non-specific opsonin (complement components). These opsonins bind then 
to receptors on neutrophils through Fc fragment of IgG, and complement 
C3b fragment receptors (Gomez et al., 1994). This binding triggers the 
formation of phagosomes, and release of lysis products depending on 
cytoplasmic granule types.  Primary or azurophilic granules contain 
myeloperoxidase, bacterial permeability-increasing protein (BPI), α-
defensins, elastase and cathepsin G. Scondary or specific granules contain 
alkaline phosphatase, lysozyme, NADH oxidase, lactoferrin and cathelicidin, 
whereas tertiary granules have cathepsin and gelatinase (Borregaard and 
Cowland, 1997). As a result, pathogens are killed at the site of infection or 
inflammation. 
During phagocytosis, neutrophils undergo an increase in glucose and oxygen 
consumption known as the respiratory burst. Neutrophils begin to produce 
large quantities of superoxide (O2
-), which is then catalysed by NADPH 
oxidase. NADPH oxidase transfers electrons from cytosolic NADPH across 
the plasma membrane to oxygen leading to formation of hydrogen peroxide 
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(H2O2) and reactive oxygen species (ROS), including hypochlorous acid 
(HOCl), singlet oxygen (1O2) and hydroxyl radical (OH
-). Superoxide and its 
secondary products accumulate within the phagosome, or in the extracellular 
environment when NADPH oxidase has been recruited to the neutrophil 
plasma membrane, followed by destructing of pathogens (Clark, 1999). 
However, the products of this process can also cause host tissue damage. 
 
1.2.5 Neutrophil apoptosis 
Once the pathogens are destroyed, neutrophils are thought to undergo 
apoptosis. Apoptosis, or programmed cell death, is essential to maintain the 
balance of cellular homeostasis under physiological conditions (Cartwright et 
al., 1964). Normally, aged neutrophils in the circulation without activation die 
by constitutive or spontaneous apoptosis after 8-20 hours (Cartwright et al., 
1964), whereas neutrophils at the site of inflammation can be influenced by 
survival or death signals from the inflammatory environment. Here, 
neutrophils’ life span is prolonged by pro-inflammatory mediators, including 
granulocyte macrophage colony-stimulating factor (GM-CSF), IL-1β, IL-6 and 
IL-8, or bacterial-derived products such as LPS. Conversely, pro-apoptotic 
stimuli, including Tumour Necrosis Factor-α (TNF-α), TNF-related apoptosis-
inducing ligand (TRAIL) and Fas ligand, shorten their life span (Lee et al., 
1993) (Renshaw et al., 2003).   Apoptosis renders neutrophils unresponsive 
to extracellular stimuli and leads to external “eat-me” signals, so that 
neutrophils can be recognised and removed by macrophages through 
phagocytosis (Savill et al., 1989). However, macrophages can promote 
neutrophil apoptosis at the inflamed site by releasing Fas ligand and 
triggering Fas-mediated neutrophil apoptosis (Brown et al., 1999). 
Furthermore, macrophages induce apoptosis of neighbouring neutrophils 
through cell-cell contact-dependent mechanism involving integrin-ligand 
binding (Meszaros et al., 2000). Many studies suggest that enhanced 
neutrophil survival occurs during the early stage of inflammation promoting 
the clearance of invading organisms, followed by downregulation of pro-
inflammatory capacity towards resolution of inflammation (Kobayashi et al., 
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2003). Since neutrophils are the most abundant type of leukocyte with potent 
cytotoxic components, appropriate neutrophil apoptosis provides a balance 
between neutrophil defense functions and their clearance. Loynes et al. 
demonstrated that pharmacological compounds, such as pyocyanin and 
roscovitine, which accelerate neutrophil apoptosis, reduced neutrophil 
numbers at the site of injury in zebrafish models. This led to acceleration of 
inflammation resolution (Loynes et al., 2010). Thus, the regulation of 
neutrophil apoptosis is important for prevention of tissue damage and trauma 
associated with inflammatory disease, and plays a crucial role in the 
resolution of inflammation. 
 
1.2.6 Neutrophil reverse migration 
Recent evidence has indicated that, in addition to neutrophil apoptosis, 
movement of neutrophils away from the site of inflammation, defined as 
reverse migration, is an alternative mechanism in inflammation resolution. In 
vivo a zebrafish model was the first demonstration that neutrophil reverse 
migration was largely responsible for clearance of neutrophils from inflamed 
sites. Mathias et al. had previously shown that neutrophils undergo 
retrograde chemotaxis back toward the vasculature after rapid chemotaxis to 
the wound site during inflammation (Mathias et al., 2006). More recently, 
work from Elks et al. has revealed that hypoxia-inducible factor-1α (HIF-1α) 
delays inflammation resolution by reducing neutrophil reverse migration in 
zebrafish (Elks et al., 2011). Molecules with pro-resolution activity such as 
Tanshinone IIA can also promote reverse migration of neutrophils resulting in 
facilitation of inflammation resolution (Robertson et al., 2014). Notably, a 
similar observation was recently made in a mammalian system. Woodfin et 
al. showed that mice with junctional adhesion molecule C (JAM-C)-deficient 
endothelial cells displayed an increase in reverse transendothelial migration 
of neutrophils compared to WT in intrascrotal inflammation induced by 
ischemia-reperfusion injury. However, this neutrophil population was also 
found in the lungs, suggesting that these transendothelial migrating 
neutrophils might enhance inflammation at sites distant from the actual injury 
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(Woodfin et al., 2011). Moreover, studies of rheumatoid arthritis showed that 
in patients with rheumatoid arthritis, 1-2% of their peripheral blood 
neutrophils were reverse-transmigrating neutrophils which were more 
resistant to apoptosis (Buckley et al., 2006). 
Thus neutrophil reverse migration may function as an alternative mechanism 
removing activated neutrophils from the site of inflammation. This can 
promote inflammation resolution, and may prevent the tissue damage from 
cytotoxic molecules secreted by activated neutrophils at the site of 
inflammation. However, it is possible that reverse migration of neutrophils 
back to the circulation might disseminate inflammation into other organs, 
retrieve antigen from extravascular tissue, and influence the adaptive 
immune response.  
 
1.2.7 Neutrophil-mediated inflammatory diseases 
Although neutrophil recruitment to the site of infection or inflammation is 
essential for host defense, neutrophil recruitment and inflammatory 
responses may be detrimental. As mentioned previously, primed or activated 
neutrophils release cytotoxic molecules such as proteinases, and reactive 
oxygen species (ROS), to kill invading organisms. Uncontrolled or impaired 
neutrophil activation can thus lead to persisting tissue damage from these 
cytotoxic molecules. In addition, activated neutrophils synthesise and secrete 
immune cell-stimulating agents including cytokines and chemokines such as 
TNF-α, IL-1β, IL-8, MIP-1α and IP-10, which can activate other neutrophils 
and other cells of the immune system, and prolong inflammation (Helen et 
al., 2010). Thus, the termination of inflammation is crucial and must be 
strictly regulated to prevent excessive inflammatory responses towards 
chronicity. Unresolved neutrophilic inflammation caused by neutrophil 
persistence has been associated with a wide variety of inflammatory 
diseases, including chronic obstructive pulmonary disease (COPD) (Quint 
and Wedzicha, 2007), inflammatory bowel disease (IBD) (Taylor and Colgan, 
2007), rheumatoid arthritis (Hallett et al., 2008) and cystic fibrosis (Elizur et 
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al., 2008) (Figure 1.6). As observed in rheumatoid arthritis, neutrophils are 
present in high numbers in the synovial tissues and tend to persist in 
synovial fluid (Cascao et al., 2009). Chakravati et al. also reported that under 
inflammatory conditions, neutrophils have the potential of persistence for 
more than 72 hours, in contrast to the short circulating half-life of neutrophils 
(Chakravati et al., 2008).  
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Figure 1.6: Neutrophilic inflammation. A diagram showing the phases of neutrophilic 
inflammation.  After an injurious stimulus, neutrophils are recruited to the site of injury and 
perform their destructive capacity to kill invading pathogens. Moreover, activated neutrophils 
release cytokines and chemokines modulating inflammation and other immune cells.  In the 
top picture, the acute inflammatory response is resolved by neutrophil clearance mostly by 
phagocytosis of apoptotic neutrophils by macrophages, followed by the restoration of normal 
tissue homeostasis.  In the bottom picture, dysregulation of inflammation resolution caused 
by persistence of neutrophils at the site of injury leads to chronic inflammation. This 
schematic was based on a diagram from Serhan et al. (2007).  
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1.3 Hypoxia 
1.3.1 Hypoxia and its regulation 
The microenvironment of inflamed tissue and tumours is characterised by 
low levels of oxygen, described as hypoxia (Frede et al., 2007). Oxygen 
delivery is absolutely critical for the survival of mammalian cells. Insufficient 
oxygen availability in tissue mediated by pathogenic conditions can lead to 
an imbalance of oxygen homeostasis, followed by cellular dysfunction. 
Therefore, mammals have developed sophisticated mechanisms to sense 
oxygen levels and execute an appropriate response such as adaptive 
changes in gene expression that either enhance oxygen delivery or promote 
survival in a hypoxic environment. A pathway mediated by oxygen-
dependent posttranslational hydroxylation of HIF plays a crucial role in this 
process (Schofield and Ratcliffe, 2004). 
HIF (Hypoxia Inducible Factor) is a heterodimeric transcription factor, a 
heterodimer of bHLH-PAS proteins, and consists of two basic helix-loop-helix 
proteins, namely the HIFα-subunit and HIFβ-subunit. This HIFα/β dimer 
binds DNA at a core DNA motif (G/ACGTG) located in hypoxia response 
elements (HREs) (Figure 1.7). There are three closely related forms of HIFα 
proteins (HIF-1α, HIF-2α, HIF-3α) in higher organisms, but only HIF-1α and 
HIF-2α show a similar regulatory manner and have been most extensively 
researched (Hogenesch et al., 1997). HIF plays a central role in the 
transcriptional response to changes in oxygen availability. Due to HIF-
directed transcriptional activation, a series of target genes involved in 
systemic responses to hypoxic environment and in cellular responses is 
transcribed. HIFα is an unstable subunit highly induced by hypoxia; by 
contrast, HIFβ is a stable, constitutively expressed nuclear protein (Kaelin 
and Ratcliffe, 2008). 
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Figure 1.7: The domain structure of HIF-1α and HIF-1β. A schematic showing of the 
structures of HIF-1α and HIF-1β subunits. HIF-1α subunit is composed of a bHLH (basic 
helix-loop-helix) domain, PAS (period-ARNT-sim) domain, NODDD (the amino-terminal 
oxygen-dependent degradation domain), carboxy-terminal oxygen-dependent degradation 
domain (CODDD), and CAD (the carboxy-terminal activation domain). The prolyl 
hydroxylase (PHD) enzymes can hydroxylate prolyl (Pro) residues, whereas factor inhibiting-
HIF (FIH) hydroxylates asparaginyl (Asn) on HIF-1α. HIF-1β subunit contains a bHLH (basic 
helix-loop-helix) domain and a PAS (period-ARNT-sim) domain. This schematic was based 
on a diagram from Schofield and Ratcliffe (2004).  
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Members of the prolyl hydroxylase domain (PHD) family play a pivotal role in 
regulation of HIFα stability. Under normoxic conditions, HIFα are 
hydroxylated at two highly conserved prolyl residues (Pro-402 and Pro-564) 
in the amino-terminal oxygen-dependent degradation domain (NODDD) and 
the carboxy-terminal oxygen-dependent degradation domain (CODDD) by 
PHD. As a result, the specific prolyl hydroxylation creates a binding site for 
the von Hippel-Lindau tumour suppressor protein (pVHL) which is the 
recognition component of an ubiquitin ligase complex. Due to this post-
translational modification, HIFα becomes polyubiquitylated and terminated by 
proteasomal degradation. In hypoxia, in contrast, the prolyl hydroxylation is 
inhibited. Thus, the HIFα subunit is not degraded by pVHL-mediated 
destruction which enables HIFα to accumulate and dimerize with a HIFβ 
subunit. This heterodimer can therefore transcriptionally activate several 
hundred target genes involved in adaptation to low oxygen conditions (Kaelin 
and Ratcliffe, 2008). 
Four PHD proteins, known as prolyl hydroxylase domain, (PHD1, PHD2, 
PHD3 and P4H-TM) have been identified to date. PHDs belong to the Fe(II) 
and 2-oxoglutarate-dependent oxygenase superfamily with the ability to 
catalyse HIF prolyl hydroxylation which is strongly dependent on oxygen 
because of an absolute requirement for molecular oxygen as a co-substrate 
(Koivunen et al., 2007). Whilst all PHDs have closely related domains, only 
PHD2 has been suggested to be the primary HIF prolyl hydroxylase for 
normoxic HIF-1α levels. Experimental evidence has shown that specific 
silencing of PHD2 is sufficient to stabilize HIF-1α steady-state levels in 
normoxia in all the human cells, fully protect HIF-1α degradation upon re-
oxygenation of hypoxia-stressed cells, and trigger HIF-1α nuclear 
accumulation and HIF-dependent transcriptional activation in normoxia 
(Berra et al., 2003). Interestingly, many studies have shown that the PHD 
enzymes, especially PHD2 and PHD3, but not PHD1, are induced to a high 
level in response to inflammatory stimuli and hypoxia in vivo and in vitro, 
providing an HIF-dependent auto-regulatory mechanism driven by the 
oxygen tension (Bruick and McKnight, 2001). 
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In addition to the prolyl hydroxylation, the HIFα subunit is also hydroxylated 
at a specific conserved asparaginyl residue. This asparagine is hydroxylated 
by factor inhibiting HIF (FIH); an Fe(II)- and 2-oxoglutarate-dependent 
dioxygenase (like the PHD family members). Asparaginyl hydroxylation 
blocks the protein-protein interaction between HIFα and the transcriptional 
coactivator p300 leading to inactivation of HIF transcriptional activity. 
Therefore, asparaginyl hydroxylation provides a second oxygen-regulated 
mechanism by inhibition of the activity of HIFα proteins that escape the prolyl 
hydroxylation/degradation pathway (Schofield and Ratcliffe, 2004). 
The association of angiogenesis with chronic inflammation is becoming 
clearer. An inflammatory state can promote angiogenesis, and angiogenesis 
can facilitate chronic inflammation. At sites of inflammation where oxygen is 
typically scarce, VEGF is a part of the hypoxic response. VEGF is an 
endothelial cell-specific growth factor; a multifunctional cytokine; that plays a 
key role in vasculogenesis and angiogenesis. Due to its effect on stimulating 
vessel hyperpermeability and endothelial cell proliferation is VEGF involved 
in both physiological and pathological angiogenesis. VEGF contains the 
conserved consensus sequence for the hypoxic response element (HRE) 
within its promoter. This highly conserved HRE is recognized by hypoxia 
inducible factor (HIF), which has been identified as a key regulator of VEGF 
expression. Thus, HIF accumulation causes an increase in VEGF that is 
postulated to drive angiogenesis resulting in raised oxygen delivery to the 
inflamed sites. Moreover, new blood vessels can maintain the chronic 
inflammatory state by transporting inflammatory cells to the site of 
inflammation (Forsythe et al., 1996). 
The VEGF family possesses several members, consisting VEGF-A, -B, -C, -
D, and placental growth factor (PIGF-1, -2), with VEGF-A often simply 
referred to as VEGF. VEGF-A has four relatively abundant isoforms (206, 
189, 165 and 121 amino acids in human) resulting from alternative splicing. 
VEGF165 is the predominant isoform and is soluble. VEGF can bind multiple 
receptors. There are three major receptors, namely VEGFR1, -R2 and –R3, 
which are characterized by protein-tyrosine kinase activity. As previously 
described, VEGF also binds to the same receptors for the class 3 
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semaphorin, neuropilins (NRP) 1 and 2. NRP1 interacts only with VEGF165, 
whereas NRP2 binds VEGF165 and VEGF145. To induce intracellular 
signalling, VEGF and its receptor necessarily complex with VEGF receptor 
and/or plexins that contain a kinase domain (Ferrara and Davis-Smyth, 
1997). 
Inflammatory cells, such as neutrophils, also contribute to angiogenesis. 
Neutrophils recently have been shown to express VEGF, and are a potential 
cell source of VEGF (Scapini et al, 1999). Interestingly, using a model of 
corneal angiogenesis demonstrated that neutrophil depletion significantly 
suppressed corneal angiogenesis resulting in reduction of microvessel 
density and neovascularisation. Neutrophils can also causally promote 
inflammatory angiogenesis via release of preformed VEGF in vivo (Gong and 
Koh, 2010).   
 
1.3.2 Hypoxia and neutrophilic inflammation 
The crucially important cellular events of the innate immune response during 
inflammation are leukocyte extravasation to sites of infection by means of 
chemoattractants, cell adhesion molecules, and especially, oxygen gradient. 
An oxygen gradient is a low oxygen signal for neutrophils to increase their 
extravasation through endothelial cells to sites of inflammation characterized 
by hypoxia. The hypoxic microenvironments also signal neutrophils to adhere 
to endothelial cells, and increase the adhesive properties of endothelial cells 
for neutrophils so that neutrophils effectively infiltrate into the injured tissues 
(Figure 1.8) (Ginis et al., 1993) (Borroni et al., 2009). 
At inflammatory sites characterised by low levels of oxygen and glucose, 
neutrophils have adapted to provide their antimicrobicidal function. Hypoxia, 
in turn, prolongs neutrophil life span through delaying apoptosis (Walmsley et 
al., 2005). This evidence is consistent with some observations that hypoxia 
can cause a dramatic decrease in neutrophil apoptosis in vitro (Hannah et 
al., 1995). Additionally, hypoxia can regulate neutrophil apoptosis in vivo in 
rheumatoid synovial fluid (Cross et al., 2006). As a result, neutrophils have 
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an ability to survive in hypoxia and become rescued from the constitutive 
apoptotic pathway. 
In particular, HIF-1α has been identified as a critical regulator of neutrophil 
survial under hypoxic condition at sites of inflammation. Walmsley et al. 
reported that in human and murine neutrophils, hypoxia caused an inhibition 
of neutrophil apoptosis mediated by HIF-1α –dependent NF-ϰB activity 
(Walmsley et al., 2005). Similarly, in a zebrafish inflammation model, 
activation of HIF-1α decreased neutrophil apoptosis (Elks et al., 2011). 
Besides HIF-1α, Thompson et al. revealed that HIF-2α overexpression also 
reduced neutrophil apoptosis both in humans, and in a zebrafish model 
(Thompson et al., 2013). 
Furthermore, accumulated evidence has shown that hypoxia plays a role in 
key neutrophil functions at the site of infection or inflammation.  Murine HIF-
1α knockout in myeloid cells can lead to impairment of neutrophil 
aggregation, bacterial killing, invasion and motility in the inflammatory 
microenvironment (Cramer et al., 2003). However, hypoxia selectively 
inhibits respriratory burst activity and killing of Staphylococcus aureus in 
human neutrophils, without affecting expression of the NADPH oxidase 
subunits (McGovern et al., 2011). Elks et al. revealed that activation of HIF-
1α further decreased neutrophil reverse migration, resulting in delay of 
inflammation resolution using a zebrafish model (Elks et al., 2011). Similarly, 
overexpression of HIF-2α in zebrafish resulted in delayed resolution of 
inflammation, accompanied with increased collagen deposition at the site of 
injury (Thompson et al., 2013). 
Work from our group has further shown that PHD3, a component of HIF 
hydroxylase pathway, also functions as a critical regulator of neutrophil 
apoptosis in inflammation. PHD3-deficient neutrophils result in a loss of 
hypoxic survival. In vivo, using an acute lung injury model, PHD3-/- mice 
showed increased levels of neutrophil apoptosis. PHD3 also prolongs 
neutrophil survival during hypoxia (Walmsley et al., 2011). 
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Figure 1.8: Neutrophil behavior in inflammation. Once an infection or injury occurs, 
neutrophils are recruited from the circulation to the site of injury by alarm signal from hypoxia 
and pro-inflammatory cytokines. At the wound site characterized by hypoxic 
microenvironment, neutrophils kill invading organisms by releasing cytotoxic molecules or 
phagocytosis. The inflammation is then resolved through apoptotic neutrophils which are 
removed by macrophages. An alternative mechanism promoting inflammation resolution is 
neutrophil reverse migration from the site of injury to circulation. 
 
 
 
53 
 
1.3.3 Hypoxia and semaphorins 
Recent accumulated evidence has indicated that hypoxia is mostly 
associated with semaphorins in the context of the tumour microenvironments 
and hypoxia. Sun et al. reported that semaphorin4D in head and neck 
squamous cell carcinoma (HNSCC) cells is strongly induced by hypoxia in a 
HIF-1-dependent manner. Semaphorin4D knockdown decreases endothelial 
cell migration, growth and vascularity of HNSCC expressing a degradation 
resistant HIF-1α subunit in vitro. They also suggested that semaphorin4D 
may be involved in hypoxia adaptive response (Sun et al., 2009). 
Consistently, Zhou et al. demonstrated that semaphorin4D expression 
regulated by the HIF-1 transcription factor works together with VEGF to 
promote tumour growth and angiogenesis in oral squamous cell carcinoma 
(Zhou et al., 2012). 
Recently, study of anti-angiogenic treatment in cancer using a small-
molecule tyrosine kinase inhibitor; sunitinib, has shown that semaphorin3A 
expression counteracts sunitinib-induced HIF-1α activation, and also reduces 
sunitinib-elicited cancer hypoxia, so that this may lead to anti-angiogenic 
treatment of tumours (Maione et al., 2012). Moreover, 
semaphorin3A/neuropilin-1 signalling blockade inhibits tumour growth and 
angiogenesis through inhibition of macrophage recruitment to hypoxic 
tumour areas (Casazza et al., 2013). Conversely, another class 3 
semaphorin such as semaphorin3E is upregulated in hypoxia resulting in 
enhanced postnatal angiogenesis. Moriya et al. suggested that inhibition of 
semaphorin3E may also be a strategy for therapeutic angiogenesis (Moriya 
et al., 2010). 
Some studies have demonstrated the correlation between hypoxia and 
semaphorin3F expression in tumours. Semaphorin3F expression causes 
loss of HIF-1α and VEGF mRNA levels in the lung cancer cell line H157 by 
reduction of AKT and of signal transducer and activator of transcription 3 
(STAT3) phosphorylation. This leads to decreased microvessel density and 
tumour growth (Potiron et al., 2007). Notably, hypoxia can inhibit 
semaphorin3F-dependent activities through direct repression of neuropilin-2 
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expression by HIF-1α. Loss of neuropilin-2 expression in tumour cells causes 
an increase in VEGF protein which then promotes tumour and endothelial 
cell migration (Coma et al., 2011). 
With regard to neutrophilic inflammation, semaphorin7A has been identified 
to function in association with hypoxia. During hypoxia, HIF-1α induces 
semaphorin7A expression in endothelial cells. This upregulated endothelial 
semaphorin7A promotes transmigration process of neutrophils through 
endothelia during hypoxia (Morote-Garcia et al., 2012). Interestingly, our 
group has recently found that in addition to the function of PHD3, a 
component of HIF hydroxylase pathway, as a regulator of neutrophil life span 
in inflammation, hypoxia also influences semaphorin3F expression in 
neutrophils. Results of gene array experiment profiling of hypoxic PHD3-/- 
neutrophils compared with WT controls have shown that loss of PHD3 
results in increased levels of semaphorin3F (Walmsley et al., 2011). 
However, the mechanism behind this increase is still incompletely described 
and remains to be elucidated.  
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1.4 Thesis aims 
There is a general acceptance that neutrophilic inflammation is closely 
associated with chronic inflammatory diseases. Once the processes that 
initiate neutrophil recruitment are completed, mechanisms of neutrophil 
removal, driving inflammation resolution, need to take place. During 
inflammation characterised by a hypoxic microenvironment, neutrophils 
utilise a wide range of signalling pathways for their activities. In this regard, 
semaphorin3F, which has been shown to be regulated in response to 
hypoxia, may have a critical functional role in regulating neutrophil 
recruitment and persistence.  I sought to provide understanding of the role of 
semaphorin3F in regulating neutrophilic inflammation. More specially, I 
proposed to 
- Characterise semaphorin3F expression in human and mouse 
neutrophils in response to hypoxia and pro-inflammatory mediators in 
vitro using human neutrophils, and in local inflammation in vivo using 
a murine acute inflammation model, 
- Investigate  the role of semaphorin3F in neutrophil behaviour in 
inflammation in vivo using a zebrafish model that can reveal the 
effects of semaphorin3F on neutrophilic recruitment and resolution of 
neutrophilic inflammation, 
- Identify the phenotype of neutrophil migration in semaphorin3F whole 
fish mutation using the Transcription Activator-Like Effector Nucleases 
(TALENs) technique that can better define the action of semaphorin3F 
on neutrophil migratory behaviour, 
- Investigate the mechanism by which semaphorin3F regulates 
neutrophilic inflammation, its dependence on co-receptors, the role of 
semaphorin3F in human neutrophil chemotactic response in vitro, and 
the association between semaphorin3F and Phosphoinositide 3-
Kinase (PI-3K) activity during inflammation in vivo using a zebrafish 
model. 
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Chapter 2: Materials and Methods 
2.1 Materials 
The following reagents were purchased from Abcam® (Cambridge, UK), anti-
semaphorin3F; anti-neuropilin1; anti-neuropilin2; anti-plexin A1; anti-plexin 
A2; anti-plexin A3; anti-plexin D1. 
The following reagents were purchased from Invitrogen Gibco Life 
Technologies (Paisley, Scotland, UK), RPMI 1640 media; culture 
supplements penicillin (50 U/ml), streptomycin (50 U/ml); Hanks Balanced 
salt solution; foetal bovine serum (FBS); phosphate buffered saline (PBS); 
Top10 competent cells; SOC media; mMessage mMachine® High Yield 
Capped RNA Transcription kit. 
The following reagents were obtained from R+D Systems Europe Ltd (Oxon 
UK), recombinant Human TNF-alpha; recombinant Human IL-1beta. 
The following reagents were obtained from New England Biolabs (NEB) ( 
Herts, UK), restriction enzymes PmeI; NotI; NheI; BamHI; Esp3I; MwoI; BslI; 
XbaI; T4 ligase, BSA; appropriate buffers; 10-beta competent cells. 
The following reagent was obtained from Cell signalling Technology 
(Danvers, USA), anti-p38 MAPK. 
The following reagents were obtained from QIAGEN (Manchester, UK), mini-
prep kit; midi-prep kit. 
The following reagents were obtained from Dako UK Ltd. (Cambridge, UK), 
anti-rabbit Immunoglobulina/HRP; anti-mouse Immunoglobulina/HRP. 
The following reagent was purchased from Bio-Rad Laboratories Ltd 
(Hertfordshire, UK), rainbow marker. 
The following reagent was purchased from Martindale Pharmaceuticals 
(Essex, UK), Sodium citrate. 
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The following reagent was obtained from Axis-Shield (Huntingdon, UK), 
OptiPrepTM . 
All other reagents were purchased from Sigma Chemical Company (Poole, 
Dorset, UK). 
96-well ‘Flexiwell’ plates were obtained from BD Falcon (Oxford, UK or 
Costar, High Wycombe, UK). Falcon 96 well polyvinyl chloride flexiplates and 
lids were purchased from Fred Baker Scientific (Reading, UK).  Incubator 
was purchased from Sanyo Electric Co Ltd. (Japan). Invivo2 400 hypoxic 
work station was purchased from Ruskinn (Bridgend, UK). Blood gas 
analyser (Model ABL5) was obtained from Radiometer (Copenhagen, 
Denmark). Mini PROTEAN®II electrophoresis cell system was purchased 
from Bio-Rad laboratories (Hemel Hempstead, UK). PVDF Immobilon-P 
transfer membranes were purchased from Millipore (Bedford, USA). 
Enhanced Chemi-LuminescentTM (ECL) system was obtained from EZ-ECL, 
Geneflow Ltd. (Fradley, UK). X-ray films were obtained from Amersham 
HyperfilmTM. Petri dishes were purchased from Scientific Laboratory Supplies 
Ltd. (SLS), (Coatbridge, UK). Non-filament glass capillary needles were 
obtained from Kwik-FilTM Borosilicate Glass Capillaries, World Precision 
Instruments (WPI) (Herts, UK). Flaming Brown micropipette puller was 
obtained from Sutter Instrument Co. (Novato, USA). Fluorescent dissecting 
stereomicroscope was purchased from Leica Microsystems GmbH (Wetzlar, 
Germany). Volocity® sorfware was purchased from Improvision, Perkin 
Elmer Inc. (Massachusetts, USA). Nikon Eclipse TE2000-U Inverted 
Compound Fluorescence Microscope was purchased from Nikon (Tokyo, 
Japan). NanodropTM 1000 spectrophotometer was obtained from Thermo 
Scientific (Hemel Hempstead, UK). Gel documentation was purchased from 
Syngene (Cambridge, UK). 
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2.2 Methods 
2.2.1 Human neutrophil assays 
2.2.1.1 Human neutrophil preparation 
Human neutrophils were isolated from the peripheral blood of healthy 
volunteers under the approval of the Sheffield Research Ethics Committee. 
Initially, 3.8% sodium citrate (Martindale Pharmaceuticals, Essex, UK) was 
added at one tenth of total blood volume to avoid coagulation. Falcon tubes 
were gently mixed and spun at 1200 rpm at 20οC for 20 minutes (MSE 
centrifuge, Sanyo, Loughborough, UK). The upper phase was aspirated into 
clean tubes and centrifuged at 2000 rpm at 20οC for 20 minutes to form 
platelet-poor plasma (PPP). The lower blood cell phase from the first spin 
was made up to 50 ml by adding 6 ml of 6% dextran (Sigma-Aldrich 
Company Ltd.,Gillingham, UK) and 0.9% sterile saline, following by gently 
inverting the tubes. Air bubbles were removed and the contents were allowed 
to sediment at 37οC for 20-30 minutes to separate the red blood cells from 
the white blood cells. Then, the upper layer was transferred to clean tubes 
and centrifuged at 1000 rpm at 20οC for 6 minutes. After this spin, 
neutrophils were isolated from other white blood cells using either OptiprepTM 
or Percoll® method (according to the department’s agreement on cost). 
OptiprepTM was used for the experiments in expression of semaphorin3F and 
VEGF (Figures 3.1, 3.2, 3.3, 3.4); Percoll® was used for the experiments in 
expression of neuropilins and plexins (Figures 6.1, 6.2, 6.3). Both methods 
yield similar purity of neutrophils with identical functional properties. 
OptiprepTM Method 
Following 100 rpm centrifigution, the white blood cell pellet was re-
suspended in a solution of 8 ml Hank’s balanced salt solution (HBSS) without 
Ca2+/Mg2+ (Invitrogen) with 20% PPP, then 4 ml OptiPrepTM (Axis-Shield, 
Huntingdon, UK) was added. The 1080 layer (10.435 ml HBSS with 20% 
PPP and 3 ml OptiPrepTM) was first gently pipetted over the contents, 
followed by the 1095 layer (8.036 ml HBSS with 20% PPP and 3 ml 
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OptiPrepTM). Another 10 ml of HBSS with 20% PPP was added. The 
contents were spun at 10000 rpm at 20οC for 30 minutes. Three separate 
cell layers were produced; erythrocytes at the bottom, a neutrophil band 
between 1095 and 1080 layer, and an upper band of peripheral blood 
mononuclear cells (PBMCs) above the 1080 layer. The PBMCs and 
neutrophils were carefully transferred into separate clean tubes and counted 
using a haemocytometer. Neutrophils were centrifuged at 1500 rpm at 20οC 
for 6 minutes, then, re-suspended to give 5x106 neutrophils per ml in RPMI 
1640 media (Gibco®, Invitrogen Ltd., Paisley, UK) containing 1% penicillin 
and streptomycin (Life Technologies,Paisley, UK) and 10% foetal bovine 
serum (FBS) (Invitrogen) (Figure 2.1). 
Percoll® Method 
90% Percoll® was prepared with 10% saline. Discontinuous plasma-Percoll 
gradients were prepared; a lower layer consisting of 0.98 ml 90% Percoll® 
and 1.02 ml PPP and an upper layer consisting of 0.84 ml 90% Percoll® and 
1.16 ml PPP. The white blood cell pellet was re-suspended in 2 ml PPP and 
layered on top of the upper layer of the plasma-Percoll gradient, and then 
spun at 11000 rpm at 20οC for 11 minutes. This resulted in three separate 
cell layers, with erythrocytes at the bottom, a layer of neutrophils and 
eosinophils above this between two plasma-Percoll layers, and an upper 
layer of PBMCs. The PBMCs and neutrophils were carefully transferred into 
separate clean tubes and counted using a haemocytometer. Neutrophils 
were centrifuged at 1500 rpm at 20οC for 6 minutes, then, re-suspended to 
give 5x106 neutrophils per ml in RPMI 1640 media (Gibco®, Invitrogen Ltd., 
Paisley, UK) containing 1% penicillin and streptomycin (Life 
Technologies,Paisley, UK) and 10% foetal bovine serum (FBS) (Invitrogen) 
(Figure 2.1). 
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Figure 2.1: Human neutrophil isolation. Neutrophils were isolated from human peripheral 
blood as previously described (2.2.1.1). Freshly isolated human neutrophils on a 
cytocentrifugation slide were imaged. Magnification x1000. 
 
2.2.1.2 Human neutrophil culture 
Human neutrophils were cultured in RPMI 1640 media (Gibco®, Invitrogen 
Ltd., Paisley, UK) containing 1% penicillin and streptomycin (Life 
Technologies,Paisley, UK) and 10% foetal bovine serum (FBS) (Invitrogen) 
at a concentration of 5x106/ml in 96-well ‘Flexiwell’ plates (BD Falcon, 
Oxford, UK or Costar, High Wycombe, UK). Neutrophils were incubated in 
normoxic conditions (19 kPa O2) at 37
οC in a humidified incubator with 5% 
supplemental CO2 (Sanyo Electric Co Ltd., Japan). For hypoxic culture, cells 
were re-suspended in media pre-equilibrated in 1% O2, 5% CO2 at 37
οC 
(Walmsley et al., 2011), using an Invivo2 400 hypoxic work station (Ruskinn, 
Bridgend, UK). The O2 and CO2 tension, pH and pCO2 of the hypoxic culture 
media were analysed using a blood gas analyser (Model ABL5, Radiometer, 
Copenhagen, Denmark) and mean values from experiments remained 
constant throughout (Table 2.1). 
Conditions pH PO2 (kPa) PCO2 (kPa) 
Normoxia (n=6) 7.35 +/- 0.02 19.01 +/- 0.14 4.67+/- 0.14 
Hypoxia (n=6) 7.34 +/- 0.01 3.55 +/- 0.15 4.53 +/- 0.09 
Table 2.1: The standardised O2 tension, pCO2 and pH for culture conditions.  Following 
4 hours culture in normoxic and hypoxic incubators, neutrophil culture media were analysed 
by an automated blood gas machine (Radiometer). Mean gas tension and corresponding pH 
values are shown for n=6 separate experiments +/- SEM. 
10 μm 
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2.2.1.3 Western blotting of human neutrophil lysates 
Preparation of human neutrophil lysates 
10x106 neutrophils per condition were gently harvested from 96-well culture 
plates and centrifuged at 2000 rpm at 4οC for 2 minutes. Cells were washed 
in ice cold phosphate buffered saline (PBS) (Gibco®, Invitrogen Ltd., Paisley, 
UK), followed by centrifugation at 2000 rpm at 4οC for 2 minutes. Cell pellets 
were suspended in 1 ml of hypotonic sonication lysis buffer (Appendix 2). 
Supernatant was discarded and cell pellets were re-suspended in 100 μl 
sonication lysis buffer and incubated on ice for 10 minutes. Cells were 
sonicated in a BioruptorTM (Diagenode Europe SA, Liege, Belgium) using 30 
second on-off high power cycles for 10 minutes. Whole cell fractions were 
collected and spun at 12000 g at 4οC for 10 minutes. Supernatant was 
transferred into clean 1.5 ml tubes and 100 μl of 2x SDS lysis buffer 
(Appendix 2) was added. Lysates were boiled at 95οC for 5 minutes, then 
either run immediately on SDS gels or stored at -80οC. 
Protein separation 
Proteins were separated by sodium dodecyl sulphate polyacrylamide 
electrophoresis (SDS-PAGE) using the Bio-Rad mini PROTEAN®II 
electrophoresis cell system (Bio-Rad laboratories, Hemel Hempstead, UK) 
on appropriate percentage of SDS gels (resolving and stacking gel) 
(Appendix 2). Gels were immersed with running buffer (Appendix 2). 
Neutrophil lysates were loaded into lanes with one lane of 5 μl rainbow 
marker (Bio-Rad laboratories). Gels were run at 120 volts (PowerPac 300, 
Bio-Rad Laboratories) until samples reached the resolving gel, then at 150 
volts until samples reached the bottom of the gel. 
Protein transfer 
The stacking gel was removed and the resolving gel was soaked in transfer 
buffer (Appendix 2). PVDF Immobilon-P transfer membranes (Millipore, 
Bedford, USA) were soaked in methanol for 2 minutes to activate, then in 
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transfer buffer. Gels were then transferred to PVDF membranes with a 
constant voltage of 100 volts for 70 minutes in ice-cold transfer buffer. 
Immunoblotting and detection 
Membranes were blocked in blocking buffer (Appendix 2) for 1 hour on an 
orbital shaker. Primary antibody was prepared in 4 ml blocking buffer at the 
appropriate concentration required in 50 ml falcon tubes. Membranes were 
transferred to the tubes and incubated at 4οC overnight on a rolling platform. 
The following day, membranes were washed in Tris-buffered saline + 0.1% 
tween 20 (TBS-Tween) (Appendix 2) and incubated at room temperature for 
1 hour with the appropriate horseradish peroxidase (HRP)-conjugated 
secondary antibody diluted in 4 ml blocking buffer. Membranes were then 
washed in TBS Tween. Proteins were detected using the Enhanced Chemi-
LuminescentTM (ECL) system (EZ-ECL, Geneflow Ltd., Fradley, UK) and 
exposed to X-ray film (Amersham HyperfilmTM) in a dark room.  
Membranes were stripped and re-probed using the following method: 
membranes were washed in distilled water for 7 minutes on an orbital 
shaker, then washed in 0.2 M Sodium hydroxide (NaOH) for 15 minutes. 
Membranes were washed again in distilled water, followed by blocking in 
blocking buffer for 1 hour and then incubation with another primary antibody 
at 4οC overnight on a rolling platform.  
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2.2.2 General zebrafish techniques and assays  
2.2.2.1 Zebrafish husbandry 
Zebrafish were maintained according to standard protocols (Nusslein-
Volhard, 2002), in a closed aquarium system at 28οC with a light cycle of 14 
light hours and 10 dark hours, in UK Home Office approved facilities in the 
MRC Centre for Developmental and Biomedical Genetics aquaria at the 
University of Sheffield. Zebrafish larvae at 5 days post fertilisation (dpf) were 
fed Tetra A-Z powdered fish feed. Zebrafish older than 13 dpf were fed live 
artemia twice daily. 
Fertilised, healthy embryos were collected and maintained in E3 medium 
(Appendix 2) in Petri dishes (Scientific Laboratory Supplies Ltd. (SLS), 
Coatbridge, UK), and incubated at 28οC. After the end of each experiment 
and prior to 5.2 dpf, embryos were culled by immersion in bleach according 
to UK Home Office legislation, which permits use of zebrafish embryos up to 
5.2 dpf outside of the Animals Act (Scientific Procedures).  
 
2.2.2.2 Microinjection of zebrafish embryos 
Ribonucleic acid (RNA) or morpholino was diluted with sterile water, and 
10% phenol red to allow visualisation, at the appropriate concentration 
required. RNA or morpholino was injected into the one-cell stage embryos 
using non-filament glass capillary needles (Kwik-FilTM Borosilicate Glass 
Capillaries, World Precision Instruments (WPI), Herts, UK) pulled by a 
Flaming Brown micropipette puller (Sutter Instrument Co., Novato, USA). 
Following injection, embryos were incubated in E3 medium at 28οC.  
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2.2.2.3 Inflammation assay 
To investigate the inflammatory responses of neutrophils, zebrafish embryos 
of the neutrophil or macrophage specific fluorescent lines Tg(mpx:GFP)i114 
or Tg(fms: GAL4;UNM) respectively (Appendix 3) were injured by tail fin 
transection as previously described (Renshaw et al., 2006) (Figure 2.2). 
Embryos were anesthetized at 2 dpf by immersion in 0.168 mg/ml Tricaine 
(Sigma-Aldrich, Poole, UK) and transection of the tail was performed with a 
micro-scalpel (WPI) to initiate an inflammatory response. At 6 hours after 
injury (hpi) and 24 hpi, neutrophils were counted at the site of injury by eye 
using a fluorescent dissecting stereomicroscope (Leica Microsystems GmbH, 
Wetzlar, Germany). Counting was performed blind to experimental 
conditions. 
 
 
 
 
 
 
Figure 2.2: Tail fin transection. Image shows a 2 dpf Tg(mpx:GFP)i114 zebrafish embryo. 
Injury was performed within the region with pigment disruption (as illustrated by the red line) 
using a micro-scalpel. 
 
2.2.2.4 Neutrophil tracking during recruitment to the site of 
injury 
To examine the speed and meandering index of neutrophil migration towards 
the site of tail injury by in vivo tracking, 2 dpf mpx:GFP embryos were 
anaesthetised in tricaine then injured. Embryos were mounted in a 1% 
solution of low melting point (LMP) agarose dissolved in sterile water 
containing 0.017% tricaine. Neutrophils were tracked over 1 hour during the 
initial recruitment phase using a 1394 ORCA-ERA camera on an Eclipse 
TE2000-U inverted compound fluorescence microscope. Tracking analysis 
65 
 
was performed using Volocity® software (Improvision, Perkin Elmer Inc.), 
which detected the intensity of fluorescence to examine individual GFP-
labelled neutrophils with various parameters for each track (Figure 2.3). 
 
 
 
 
 
Figure 2.3: Tracking experiment. A typical tracking experiment with arrows indicating the 
path of individual neutrophils’ movements over 1 hour during the initial recruitment phase of 
inflammation. Speed and meandering index (direction) were calculated by Volocity® 
software. 
 
2.2.2.5 Reverse migration assay 
To investigate the migration of neutrophils away from the site of injury, a 
reverse migration assay was performed. Tg(mpx:Gal4:Kaede)i222 or 
mpx:Kaede (Appendix 2) transgenic fish have embryos expressing Kaede, a 
photoconvertible protein that fluoresces red in neutrophils, and can be 
converted from green to red fluorescence in individual cells. 2 dpf 
mpx:Kaede were anaesthetised and tailfin transection was performed. At 6 
hpi, embryos were mounted in a chamber slide in a 1% solution of low 
melting point (LMP) agarose dissolved in sterile water containing 0.017% 
tricaine. Kaede-labelled neutrophils present at the site of injury were 
photoconverted at 10x magnification using a PerkinElmer UltraVIEW 
PhotoKinesisTM device (PerkinElmer Life and Analytical Sciences) on an 
UltraVIEWVoX spinning disk confocal microscope using 120 pulses of the 
405 nm laser at 40% laser energy (Dixon et al., 2012). Embryos were then 
transferred to Nikon Eclipse TE2000-U Inverted Compound Fluorescence 
Microscope (Nikon, Tokyo, Japan) and a time-lapse series was captured. 
Neutrophils fluorescing in the red channel were tracked over 3.5 hour. 
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Reverse migration analysis was performed using Volocity® sorfware 
(Improvision, Perkin Elmer Inc.). 
 
 
2.2.2.6 Apoptosis assay 
To examine the amount of neutrophil apoptosis at the site of injury, 2 dpf 
embryos were anaesthetised and injured at tailfin. At 12 hpi, embryos were 
then fixed in 4% paraformaldehyde (PFA) (Fisher Scientific, Loughborough, 
UK) overnight at 4οC. The next day, embryos were washed in phosphate 
buffered saline (PBS). Tyramide Signal Amplification (TSA) staining was 
performed using the TSATM-Plus Fluorescein System Kit (PerkinElmer Life 
and Analytical Sciences). Before staining, embryos were washed in amp 
diluent, then incubated in 1:50 FITC TSA;amp diluent in the dark for 10 
minutes at 28οC. Background staining was removed by washing in PBS. 
Embryos were then fixed in 4%PFA at 4οC overnight. This TSA staining 
labels myeloperoxidase in neutrophils with green fluorescence. 
The following day, embryos were washed in PBS + 0.1% tween 20 (PBT), 
digested with proteinaseK at 10 µg/ml at room temperature for 90 minutes, 
then washed in PBT. Embryos were fixed in 4% PFA at room temperature for 
20 minutes, washed in PBT, followed by immersion in 1:2 acetone:ethanol at 
-20οC for 7 minutes, then washed in PBT. The ApopTag® Red In situ 
Apoptosis Detection Kit (Millipore Corporation, Herts, UK) was used for 
terminal deoxynucleotidyl transferase (TdT) dUTP nick end labelling 
(TUNEL). Embryos were incubated in 50 μl equilibration buffer from the kit at 
room temperature for 45 minutes. Liquid was removed, 30 μl reaction buffer 
and 16 μl TdT enzyme were then added to the embryos, and incubated at 
37οC for 90 minutes. Liquid was removed and embryos were incubated with 
200 μl stop buffer at 37οC for 3 hours, and washed in PBT. Embryos were 
then incubated with 62 μl anti-dig-rhodamine and 68 μl blocking solution with 
gentle shaking at 4οC overnight. The following day, embryos were washed in 
PBT, fixed in 4% PFA at room temperature for 30 minutes, and mounted in 
80% glycerol at 4οC until imaging. 
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Neutrophils at the site of injury were imaged using the UltraVIEWVoX 
spinning disk confocal imaging system (PerkinElmer Life and Analytical 
Sciences). The neutrophil apoptosis was assessed by counting the number 
of apoptotic neutrophils at the site of injury (cells labelled with both TSA 
(green) and TUNEL (red)) divided by the total neutrophil number at the site of 
injury (cells labelled with TSA (green)).  
 
2.2.3 General molecular biology techniques 
2.2.3.1 Extraction of DNA from filter paper 
The filter paper containing plasmid was cut out and placed in a 1.5 ml 
eppendorf tube. 50 μl of 10 mM TE-buffer (Endotoxin-free) (QIAGEN, 
Manchester, UK) was added to the tube, followed by vortex for 1 minute. The 
contents were incubated at room temperature for at least 5 minutes before 
transformation. 
 
2.2.3.2 Transformation 
1-2 μl DNA of plasmid indicated was added to 25 μl of Top10 competent 
cells (Invitrogen, Paisley, UK) without mixing and incubated on ice for 30 
minutes. The mixture was then heat-shocked at 42οC for 45 seconds before 
returning to ice for 2 minutes. 250 μl of SOC media (Invitrogen) was added to 
the mixture, and the cells were then incubated at 37οC with vigorous shaking 
at 200-250 rpm for 1 hour. The cells were spread onto dry selection plates 
(autoclaved LB agar containing 50 μl/ml appropriate antibiotic) and incubated 
at 37οC overnight. 
The following day, individual colonies were picked and grown overnight in 
100 ml of autoclaved LB broth containing 50 μl/ml of appropriate antibiotic at 
37οC with vigorous shaking at 200-250 rpm. 
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2.2.3.3 DNA purification 
Following transformation, DNA was purified using a HiSpeed Plasmid Midi kit 
(QIAGEN, Manchester, UK), as directed by the manufacturer. The DNA 
concentration was quantified using a NanodropTM 1000 spectrophotometer 
(Thermo Scientific, Hemel Hempstead, UK). 
DNA was identified by diagnostic digest using the following method: 2 μl 
DNA, 1 μl restriction enzyme, 1 μl appropriate 10x buffer (and 0.1 μl Bovine 
Serum Albumin) were added to an eppendorf tube. The contents were made 
up to 10 μl by adding sterile water and incubated at 37οC for 2 hours. The 
samples were then run on 0.8% agarose gel (Bioline) containing 0.03% 
Ethidium bromide (Severn Biotech Ltd., Kidderminster, UK) at 100 volts for 
45 minutes, and visualised by gel documentation (Syngene, Cambridge, UK). 
 
2.2.3.4 RNA synthesis 
Following DNA purification, RNA synthesis was performed using the 
mMessage mMachine® High Yield Capped RNA Transcription kit 
(Invitrogen), as per the manufacturer’s instructions. 6 μl of DNA was 
incubated with 2 μl SP6 enzyme mix, 10 μl 2x NTP/CAP and 10 μl 10x 
reaction buffer at 37οC for 2 hours. After this incubation, 1 μl of TURBO 
DNAse was mixed to the sample, followed by incubation at 37οC for 30 
minutes. This reaction was stopped by adding 115 μl nuclease free water 
and 15 μl ammonium acetate stop solution. RNA was extracted by addition of 
150 μl phenol:chloroform and spin at 14000 rpm at 4οC for 15 minutes. The 
upper phase was then transferred to a new tube prior to adding an equal 
volume of isopropanol. The sample was centrifuged at 14000 rpm at 4οC for 
15 minutes. The pellet was then re-suspended in 20 μl sterile RNAse free 
water and stored at -80οC. The RNA concentration was quantified using a 
NanodropTM 1000 spectrophotometer (Thermo Scientific, Hemel Hempstead, 
UK). 
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2.2.3.5 Whole mount in situ Hybridisation probe synthesis 
Following transformation and DNA purification of plasmid vectors containing 
the zebrafish semaphorin3Fa or semaphorin3Fb coding sequence (Yu and 
Moens, 2005), the vectors were linearised by restriction digest with PmeI or 
NotI, respectively (New England Biolabs (NEB), Herts, UK) using the 
following method: 20 μg of vector DNA, 1 μl of Not1 and 20 μl of Not1 buffer 
were added to an eppendorf tube, made up to 200 μl by adding sterile water 
and incubated at 37οC for 2 hours. To extract the linearised DNA, 200 μl of 
phenol:chloroform was added. The mixtures were vortexed then spun at 
14000 rpm at 4οC for 7 minutes.  The upper phase was transferred to a new 
tube, followed by adding an equal volume of chloroform. The samples were 
vortexed, then centrifuged at 14000 rpm at 4οC for 5 minutes. The upper 
phase was again transferred to a new tube, followed by adding one tenth of 
this volume of 3 M sodium acetate and an equal volume of isopropanol. The 
samples were stored at -20οC for 20 minutes and spun at 14000 rpm at 4οC 
for 20 minutes. The pellet was washed in 70% ethanol, then spun 14000 rpm 
at 4οC for 5 minutes. The ethanol was removed and the pellet air-dried 
before re-suspension in 20 μl of sterile water. The DNA concentration was 
quantified using a NanodropTM 1000 spectrophotometer (Thermo Scientific, 
Hemel Hempstead, UK). 
Transcription of RNA probe was performed using an SP6 RNA digoxigenin-
labelling kit (Roche). 1 μg of linearised DNA was incubated with 2 μl NTP-
DIG-RNA labelling mix, 2 μl SP6 polymerase, 1 μl RNAse inhibitor and 2 μl 
transcription buffer in a final volume of 20 μl with RNAse free water at 37οC 
for 2 hours, followed by adding 4 μl DNAse and incubating at 37οC for 30 
minutes. For precipitation, 1 μl of 0.5 M EDTA pH8, 2.5 μl of 4 M LiCl and 75 
μl of 100% ethanol were added to the sample, then stored at -80οC for 1 
hour. The sample was centrifuged at 14000 at 4οC for 10 minutes. The pellet 
was air-dried before re-suspension in 20 μl of sterile water. After addition of 
80 μl of formamide, the RNA probe was stored at -80οC. 
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2.2.3.6 Whole mount in situ Hybridisation 
To determine the expression of semaphorin3Fa and semaphorin3Fb in 
zebrafish embryos, 20-somite and 3 dpf zebrafish embryos were fixed in 4% 
paraformaldehyde (PFA) (Fisher Scientific, Loughborough, UK) at 4οC 
overnight. Embryos were immersed in a methanol series (25%, 50% and 
75%) and stored in 100% methanol at -20οC. Embryos were then re-hydrated 
though a reverse methanol series and washed in phosphate buffered saline+ 
0.1% tween 20 (PBT), followed by digestion with proteinaseK at 10 μg/ml for 
30 minutes (for 20-somite) or 70 minutes (for 3dpf embryos). After re-
washing in PBT, embryos were then fixed in 4% PFA at room temperature 
for 20 minutes and re-washed in PBT. Pre-hybridisation was performed by 
incubating embryos with PreHyb buffer (Appendix 2) horizontally at 70οC for 
3 hours. The PreHyb was removed and ProbeHyb (Appendix 2) was added 
to embryos. Embryos were then incubated horizontally at 70οC overnight. 
The next day, the ProbHyb was replaced with a series of HybWash/2x SSC 
(75%, 50% and 25%), then another wash in 2x SSC at 70οC. Embryos were 
washed in a series of 0.2x SSC/PBT (75%, 50% and 25%) and then PBT at 
room temperature. To minimise non-specific binding, embryos were 
incubated with blocking solution (Appendix 2) at room temperature for 1 hour 
with gentle rocking. Embryos were then incubated with an anti-DIG-AP 
antibody (Roche, Herts, UK) at a 1:5000 dilution in blocking solution at 4οC 
overnight with gentle rocking. The following day, embryos were washed in 
PBT, then in staining wash (Appendix 2). Staining solution (Appendix 2) was 
added to embryos. This was incubated at room temperature with gentle 
rocking until staining developed. The reaction was stopped by adding 1 mM 
EDTA. Embryos were washed in PBT, fixed in 4% PFA at room temperature 
for 20 minutes then stored in methanol at -20οC until imaging. 
Before imaging, embryos were re-hydrated in a reverse methanol series 
(75%, 50% and 25%) then in 80% glycerol. Imaging was performed by 
fluorescent dissecting microscope with a Leica DFC310 camera and Leica 
Application Suite software. 
 
71 
 
2.2.3.7 Semaphorin3F whole fish overexpression  
Semaphorin3Fa or semaphorin3Fb whole fish overexpression and 
knockdown were carried out using RNA and morpholino oligonucleotide 
(Appendix 1) microinjections into one-cell stage embryos of 
Tg(mpx:GFP)i114, respectively. Injections were performed into the yolk. 
Following injection, embryos were incubated in E3 media at 28οC. 3 dpf 
embryos were then tested using whole mount in situ hybridisation for 
semphorin3F whole fish overexpression or by RT-PRC for semaphorin3F 
whole fish knockdown. 
Semaphorin3Fa or semaphorin3Fb whole fish overexpression 
3 dpf embryos injected with semaphorin3Fa or semaphorin3fb RNA (50ng/μl) 
were collected and fixed in 4% PFA overnight at 4οC, then followed by whole 
mount in situ hybridisation method as described above. The embryos were 
imaged using a fluorescent dissecting microscope (Figure 2.4). Non-injected 
embryos were used as controls. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Semaphorin3Fa or semphorin3Fb whole fish overexpression by RNA 
injection. The whole fish overexpression of zebrafish semaphorin3Fa and b was identified 
by whole mount in situ hybridization. 3dpf embryos were stained with sema3Fa (A-B), 
sema3Fb (C-D) and sense probes, respectively. RNA-injected embryos showed stronger 
blue stain than in non-injected embryos providing the overexpression of semaphorin3Fa or b 
in the RNA-injected embryos. 
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2.2.3.8 Semaphorin3F whole fish knockdown 
Additionally, the efficacy of semaphorin3F morpholinos to generate the whole 
fish knockdown in zebrafish embryos was confirmed by Reverse 
Transcription polymerase chain reaction (RT-PCR). Two antisense 
morpholino oligonucleotides were designed to target the translation start 
sites of semaphorin3Fa (Yu and Moens, 2005) and semaphorin3Fb (Tanaka 
et al., 2007). To enable proofing by molecular methods, another antisense 
morpholino oligonucleotide of semaphorin3Fb which targets an exon-intron 
boundary between exon 3 and exon 5 and interrupts pre-mRNA splicing, was 
designed by Dr.Stephen Renshaw (University of Sheffield).  
Embryos were injected with semaphorin3Fb splice blocking morpholino. A 
single 3 dpf injected embryo was transferred to a 96-well plate. For the 
genomic DNA extraction, the single embryos were incubated with 100 μl of 
50 mM NaOH at 95οC for 20 minutes, followed by adding of 10 μl of 1 M Tris-
HCl pH 8.0 and mixing. After centrifugation at 14000 rpm at 4οC for 30 
minutes, 2 μl of supernatant was applied to separate 96-well plate with 10 μl 
ReddyMix PCR master mix (Thermo Scientific), 1 μl of 10 μM of each 
forward and reverse primer (Appendix 1) and 6 μl of dH2O, mixed gently and 
run using this cycle: 
 98οC  30 seconds 
 98οC 10 seconds 
 65οC 30 seconds        34x 
 72οC 30 seconds 
 72οC 10 minutes 
 10οC forever 
Samples were run in parallel with primer for zebrafish ef1α (Appendix 1) as 
control. The PCR products were then run on 2.5% agarose gel (Bioline) 
(Figure 2.5). 
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Figure 2.5: Semaphorin3Fa or semphorin3Fb whole fish knockdown by 
semaphorin3Fb splice blocker morpholino injection. Semaphorin3Fb morpholino 
inhibited splicing. The gel represents genomic DNA from morpholino-injected fish subject 
to PCR analysis targeting the translation start site of semaphorin3Fa or b. Semaphorin3Fb 
splice blocking morpholino (0.25 mM – 1 mM) was injected into 1-cell stage zebrafish 
mpx:GFP embryos. In addition, 1 mM mismatch morpholino which has no effect on zebrafish 
development, was used as a control. The upper band provided the WT band, in contrast, the 
lower band showed misspliced bands with exon4 deletion. A loading control was quantified 
by EF1α. 
 
The semaphorin3Fb splice blocking morpholino showed mis-splicing with 
exon 4 deletion resulting in a shorter band compared to WT in a dose-
dependent manner. This confirmed whole fish knockdown of semaphorin3Fb. 
The effect of all three morpholinos was then compared by inflammation 
assay as described previously. Neutrophil numbers at the injury site at 6hpi 
and 24 hpi were counted. Semaphorin3Fa translation blocking, 
semaphorin3Fb translation blocking and semaphorin3Fb splice blocking 
morpholino showed no significant difference in neutrophil numbers at the site 
of injury both at recruitment and resolution phase (Figure 2.6). Therefore, all 
three morpholinos had the equivalent effects on inflammatory responses of 
neutrophils by generating whole fish semaphorin3F knockdown. I also 
selected semaphorin3Fa translation blocking morpholino and 
semaphorin3Fb translation blocking morpholino for all experiments in chapter 
4. 
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Figure 2.6: All three antisense morpholino oligonucleotides showed no significant 
difference in neutrophil numbers at the site of injury both at recruitment and 
resolution phase. Each morpholino (1 nl of 0.5mM) was injected into 1-cell stage zebrafish 
mpx:GFP embryos. Tailfin transection was performed at 2dpf, and neutrophils counted at 6 
and 24 hpi. (A) 6 hpi timepoint neutrophil counts (recruitment). (B) 24 hpi timepoint 
neutrophil counts (resolution). Data shown are mean + SEM. n= 30 performed as 3 
independent experiments, P values were calculated using one-way ANOVA ***P<0.001. 
 
2.2.3.9 Transcription activator-like effector nuclease (TALEN) 
To generate site-specific DNA double-strand breaks resulting in mutations of 
semaphorin3Fa and semaphorin3Fb gene, transcription activator-like effector 
nuclease (TALEN) was performed according to previously described 
protocols (Cermark et al., 2011) (Zu et al., 2013). A heterodimer with a left 
and a right subunit containing a C-terminal Fok1 nucleases domain and an 
N-terminal site specific DNA binding domain, at a target site was first 
designed by website http://tale-nt.cac.cornell.edu/node/add/talen-old. The 
target genomic sequence should have a wide spanning restriction enzyme 
that cuts well in reddymix to allow saving on time and cost for screening 
process. The DNA binding domain should be comprised of between 15-21 
repeat variable domain (RVD) units and have a space between two subunits 
about 15 bp. All plasmids were provided by Golden Gate TALEN kit 
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(Addgene, Cambridge, UK) and obtained as a kind gift from Dr. Stone 
Elworthy (University of Sheffield).  
Preparing TALEN constructs 
In assembly stage 1, part A and part B of each subunit were assembled. The 
part A was assembled into pFusA plasmid with the first ten RVD plasmids. 
The part B was assembled into pFusB plasmid with the rest of RVD 
plasmids. Each of four reactions was transferred to 0.2 ml PCR tubes on ice. 
Following this, 2 μl of T4 ligase (NEB), 2 μl of T4 ligase buffer (NEB) and 1 μl 
of BsaI (NEB) were added to each tube. The contents were made up to a 
total volume of 20 μl by adding dH2O and mixed gently. All reactions were 
run using the program ‘TALEN’ with not hot-lid option. 
                   10x (37οC/5 min + 16οC/10 min) + 50οC/5 min + 80οC/5 min   
After this cycle, the reactions were incubated with 0.3 μl of 25 mM ATP and 1 
μl of plasmid safe nuclease at 37οC for 1 hour to eliminate all unligated linear 
dsDNA fragments including incomplete ligation products. Each reaction was 
transformed into 12.5 μl of 10-Beta competent cells (NEB), as directed by the 
NEB manufacturer, and then spread on spectinomycin (50 μg/ml) Xgal 
(1:1000) LB agar plate using flat toothpicks, followed by incubation at 37οC 
overnight. The next day, three white colonies of each reaction were picked 
then incubated separately in 6 ml of autoclaved LB broth containing 50 μl/ml 
spectinomycin at 37οC with vigorous shaking at 200-250 rpm overnight. 
In assembly stage 2, the heterodimer (a left and a right subunit) were 
combined together. For this, DNA of the previous overnight cultures above 
were purified using a Mini kit (QIAGEN, Manchester, UK), as per the 
manufacturer’s instructions. The DNA was then eluted into 50 μl dH2O and 
checked by restriction digest with NheI + XbaI (NEB) using the following 
method: 4 μl of mini prep DNA, 0.5 μl of NheI, 0.5 μl of XbaI, 0.1 μl of 
10mg/ml BSA and 1 μl of 10x NEB2 buffer were added to an eppendorf tube, 
made up to 10 μl by adding sterile water and incubated at 37οC for 1 hour. 
The samples were then run on 1.1% agarose gel (Bioline). The expected 
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band sizes were 266 bp, 2132 bp and 500-1100 bp (depending on RVD 
number). 
The correct clones of each part A and part B were transferred to 0.2 ml PCR 
tubes on ice. Following this, 4 μl of part A mini prep DNA, 4 μl of part B mini 
prep DNA, 1 μl of 150 ng/μl the appropriate final RVD plasmid, 1 μl of 75 
ng/μl pCAGT7TALEN plasmid, 2 μl of T4 ligase (NEB), 2 μl of T4 ligase 
buffer (NEB), 1 μl of Esp3I (NEB) and 5 μl of dH2O were added to each tube. 
The contents were made up to a total volume of 20 μl by adding dH2O and 
mixed gently. All reactions were run using program ‘TALEN’ with not hot-lid 
option. 
                   10x (37οC/5 min + 16οC/10 min) + 50οC/5 min + 80οC/5 min   
Each reaction was transformed into 12.5 μl of 10-Beta competent cells 
(NEB), as directed by the NEB manufacturer, and then spread on 
carbenecillin (50 μg/ml) Xgal (1:1000) LB agar plate using flat toothpicks, 
followed by incubation at 37οC overnight. The next day, one white colony of 
each reaction was picked, then incubated separately in 100 ml of autoclaved 
LB broth containing 50 μl/ml carbenecillin at 37οC with vigorous shaking at 
200-250 rpm overnight. The following day, DNA of the previous overnight 
cultures above were purified using a nucleobond Midi kit (QIAGEN, 
Manchester, UK), as per the manufacturer’s instructions. The DNA was then 
eluted into 120 μl dH2O and the DNA concentration was quantified by a 
spectrophotometer using a wavelength A260. The clone DNA was checked 
by sequencing using TAL_R2 and SeqTALEN_5-1 primers and by restriction 
digest with BamHI + XbaI (NEB) using the following method: 1.5 μl of 100 
ng/μl DNA, 0.5 μl of BamHI, 0.5 μl of XbaI, 0.1 μl of 10mg/ml BSA and 1 μl of 
10x NEB3 buffer were added to an eppendorf tube, made up to 10 μl by 
adding sterile water and incubated at 37οC for 1 hour. The samples were 
then run on 1.1% agarose gel (Bioline). The expected band sizes were 4346 
bp and 3669 bp (depending on RVD number). 
To linearization the constructs, the DNA of correct clones was digested with 
NotI using this method: 6 μg of left construct DNA, 6 μg of right construct 
DNA, 30 μl of 10x NEB3 buffer, 3 μl of 10mg/ml BSA and 10 μl of NotI (NEB) 
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were added to an eppendorf tube, made up to 300 μl by adding sterile water, 
mixed gently and incubated at 37οC for 1 hour. The linearized DNA was then 
purified by PCR clean up columns (QIAGEN, Manchester, UK), as directed 
by the manufacturer, and eluted into 30 μl dH2O. 
Preparing mRNA for injecting 
RNA from the NotI linearized DNA was performed using Epicenter 
messageMaxTM T7 ARCA-Capped Message Transcription kit (Cambio Ltd., 
Cambridge, UK). For this, 5.5 μl of 400 ng/μl DNA, 2 μl of 10x buffer, 8 μl of 
NTP CAP mix, 2 μl of 100 mM DTT, 0.5 μl of scriptguard and 2 μl of enzyme 
mix were added to a 0.2 ml PCR tube, mixed gently and incubated in PCR 
machine at 37οC for 30 minutes. Following this, 1 μl of DNAase was added, 
mixed gently and incubated 37οC for 15 minutes. For RNA purification, the 
RNA was applied to RNA minelute column (QIAGEN, Manchester, UK) 
following instruction and eluted into 14 μl RNAase free water. The RNA was 
stored immediately at -80οC. 
Microinjection 
3.5 μl of RNA was added with 0.5 μl phenol red to allow visualisation, and 
injected into the one-cell stage mpx:GFP embryos using non-filament glass 
capillary needles (Kwik-FilTM Borosilicate Glass Capillaries, World Precision 
Instruments (WPI), Herts, UK). Following injection, embryos were incubated 
in E3 medium at 28οC.  
Mutation analysis 
A single 3 dpf injected embryo was transferred to a 96-well plate. For the 
genomic DNA extraction, the single embryos were incubated with 100 μl of 
50 mM NaOH at 95οC for 20 minutes, followed by adding of 10 μl of 1 M Tris-
HCl pH 8.0 and mixing. After centrifugation at 14000 rpm at 4οC for 30 
minutes, 2 μl of supernatant was applied to another 96-well plate with 10 μl 
ReddyMix PCR master mix (Thermo Scientific), 1 μl of 10 μM forward primer 
(Sema3Fa MwoI (F) or Sema3Fb BslI (F)), 1 μl of 10 μM reverse primer 
(Sema3Fa MwoI (R) or Sema3Fb BslI (R)) and 6 μl of dH2O, mixed gently 
and run using this cycle: 
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 94οC  2 minutes 
 94οC 20 seconds 
 55οC 20 seconds        34x 
 72οC 45 seconds 
 72οC 3 minutes 
 10οC forever 
The PCR products were analysed by restriction digest with 0.5 μl MwoI (for 
semaphorin3Fa) or BslI (for semaphorin3Fb) at appropriate temperature for 1 
hour prior to run on 2.5% agarose gel (Bioline). The rest of the mutated 
embryos were allowed to grow in the aquarium system. 
Screening potential founder fish 
Once the mutated fish were about 2-3 months old, these fish were crossed 
with mpx:GFP, and put into individual tanks. Their progeny embryos were 
tested using the previous described mutation analysis method above. From 
each potential founder, three 3 dpf embryos were transferred to each of eight 
wells in a 96-well plate. The positive digestion results were then accurately 
analysed by sequencing using the same primers for PCR. The embryos of 
potential founder with frameshift mutation were allowed to grow in the 
aquarium system. 
Screening F1 carriers 
Once the offspring of the potential founder were 2-3 months old, the 
screening of these F1 fish was performed by fin clipping and mutation 
analysis. Fish were anaesthetised by immersion in 4.2% tricaine until gill 
movement was slowed. A small amount of fin from the end of the tail was 
clipped with the scissors and transferred to a 96-well plate. The genomic 
DNA was extracted and tested using the previous described mutation 
analysis method. The positive digestion results were then analysed by 
sequencing using the same primers for PCR. Fish with the same mutation as 
the founder were maintained in aquarium system for further experiments. 
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2.2.3.10 Analysis of PI-3K activity 
To examine PI-3K activation during neutrophil recruitment in vivo, the 
zebrafish transgenic line Tg(lyz:PHAkt-EGFP), subsequently referred to as 
lyz/PHAkt, were injured at the tail fin as described above at 3 dpf. Embryos 
were then mounted in a 1% solution of low melting point (LMP) agarose 
dissolved in sterile water containing 0.017% tricaine, and imaged on an 
UltraVIEWVoX spinning disk confocal imaging system (PerkinElmer Life and 
Analytical Sciences) with an inverted Olympus IX81 microscope at 60x 
magnification with oil immersion objective (Hamburg, Germany). Neutrophils 
in the region between the site of injury and the posterior blood island were 
individually imaged using the 488 nm laser line with 20 Z slices. Single slices 
in which a leading edge and trailing edge of each cell could be defined were 
exported as .tif files and analysed using ImageJ. In this, using the straight-
line tool, a transecting line was drawn through each cell from the trailing 
edge towards the leading edge. A plot profile was generated to measure the 
fluorescence intensity per pixel along the length of the line. The values were 
then inserted into a Microsoft® Excel worksheet. Using Microsoft Excel, the 
mean intensity values for each parameter, as illustrated in Figure 2.7, were 
entered into the equation to calculate the polarity index: 
 
                       Polarity index = (log10 a / b) x [(a + b) / c] 
             where a = trailing edge of cell; b = leading edge of cell; c = whole cell 
 
 
 
00000000000 
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Figure 2.7: A neutrophil with straight-line tool and fluorescence intensity plot profile 
of a migrating neutrophil. A representative recruited neutrophil with straight-line tool as 
illustrated in yellow line is matched to a representative plot profile generated in imageJ by 
drawing a straight line through a migrating neutrophil from the trailing edge towards the 
leading edge. The fluorescence intensities per pixel were imported into Excel, a threshold 
was applied and the appropriate pixels were selected to define the trailing edge (a), the 
leading edge (b) and the whole cell (c). 
Subsequently, neutrophil roundness was measured using the ‘analyse’ 
function of imageJ (Yoo et al., 2012). In this, using the freehand selections 
tool, a freehand line was drawn around each cell, and the roundness of each 
neutrophil was quantified by ‘measure’ of the analyse function (Figure 2.8). 
To measure roundness,  
 
                               
                                  Roundness = 4 x [Area] /   x [Major axis] 2 
 
 The value is between 0 and 1, which 0 is a line segment, and 1 is actually a circle. 
  
was calculated. 
 
Wound 
a 
b 
c 
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Figure 2.8: A neutrophil with freehand selections tool. A representative recruited 
neutrophil with freehand line as illustrated in yellow line was analysed using measure of the 
analyse function of imageJ to calculate the neutrophil roundness.  
 
2.2.4 Murine experiments 
2.2.4.1 Murine neutrophil RNA extraction   
Murine peripheral blood or bone marrow neutrophil RNA was extracted using 
the mirVana™ total RNA isolation protocol (Ambion, Austin, USA).  Cells 
(1x106 per condition) were lysed in 300 µl of mirVana lysis/binding buffer and 
stored at -80 ˚C if not being extracted immediately.  To extract the RNA, 
miRNA homogenate (1/10th of the lysate volume) was added to the lysate to 
stabilise the RNA and inactivate RNases.  Samples were vortexed (Vortex 
Genie®2, Scientific Industries, Bohemia, USA) to mix and incubated on ice 
for 10 minutes. A volume of Acid-Phenol:Chloroform  equivalent to that of the 
initial lysate was added, mixed well using a vortex mixer and spun at 13400 
rpm (Eppendorf Mini Spin Hamburg, Germany) for 5 minutes at room 
temperature.  The upper aqueous layer was carefully removed and 
transferred to a clean RNase-free 1.5 ml eppendorf tube.  The volume 
removed was noted to enable 1.25 volumes of ethanol to be added. Samples 
were vortexed  and a maximum of 700 μl of this aqueous layer/ethanol 
mixture was transferred onto a filter cartridge within a labelled mirVana kit 
collection tube. These tubes were spun for 15 seconds at room temperature 
at 10000 rpm. The flow through was discarded and any remaining 
aqueous/ethanol mixture was added to the filter cartridge.  Once all the 
aqueous/ethanol mixture had been spun over the cartridge, 700 μl miRNA 
wash-solution 1 was added to the filter cartridge.  Tubes were again spun for 
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15 seconds at 10000 rpm, the flow through was discarded and washing of 
the filter cartridge was repeated a further two times using 500 μl miRNA 
wash-solution 2/3, discarding the flow through after each wash. After the final 
wash, the tubes were spun for a further 60 seconds to dry the filter cartridge.  
Cartridges were then placed into a clean labelled collection tube and 30 μl of 
RNase free water pre-heated to 95 °C was added to the filter cartridge.  
Tubes were spun again for 20-30 seconds at 13400 rpm.  The flow through 
containing the RNA was then analysed using a NanoDrop™ 1000 
spectrophotometer (Fisher Scientific UK Ltd.). cDNA synthesis was 
performed but due to the low numbers of murine neutrophils and low yield of 
RNA, 500 ng of RNA were used to make each cDNA sample. 
 
2.2.4.2 Acute lung injury models 
Intratracheal instillation of lipopolysaccharide (LPS) 
Mice were anaesthetised with ketamine (100 mg/kg i.p; Willows Francis 
Veterinary, Crawley, U.K.) and acepromazine (5 mg/kg i.p.; C-Vet Veterinary 
Products, Lancashire, UK) before fur was shaved from their necks.  A small 
(<1 cm) midline incision was made and the trachea exposed through gentle 
blunt dissection until it could be cannulated under direct vision with a 24G 
cannula (Jelco® radiopaque cannula, Smiths Medical International Ltd. 
Rossendale, UK). LPS from Salmonella minnesota R595 (TLRgrade™, Enzo 
Life Sciences, Exeter, UK) was directly instilled (0.3 µg in 20 µl) via the 
cannula and the animals recovered for 6 hours in a warmed cage in room air 
(Rowe et al., 2002).  
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2.2.5 Statistical analyses 
GraphPad Prism® software was used for all Statistical analyses. To compare 
between two groups, an unpaired two-tailed- t-test was used, and the 
variances were analysed by an F test. For simultaneous comparisons 
between multiple groups, a one-way or two-way ANOVA was used with 
Bonferroni’s multiple comparison post-test, and the equal variances were 
analysed by Bartlett’s test. For reverse migration assays, results were 
analysed by using either linear regression to compare the difference between 
slopes or non-linear regression to compare the difference between curves, 
depending on data. On all figures, where * p<0.05, where ** p<0.01 and 
where *** p<0.001. 
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Chapter 3: Characterisation of Semaphorin3F 
expression in human and mouse neutrophils 
 
3.1 Introduction 
Neutrophils as key host defence cells are required to migrate to and function 
at sites of infection or inflammation. In the circulation, resting neutrophils can 
become activated by bacterial products, cytokines or chemokines such as 
TNF-α, IL-1β, IL-8, GM-CSF and IFN-γ (Hallett and Lloyds, 1995). Once 
activated neutrophils leave the circulation and transmigrate through the 
endothelium towards the inflamed tissue where oxygen is typically scarce 
(hypoxia), along a chemotactic gradient (Servant et al., 2000). 
Recently, the oxygen- sensitive hypoxia inducible factor (HIF) has been 
identified as a critical regulator of neutrophil survival (Walmsley et al. 2005), 
and also of important neutrophil functions such as chemotaxis and bacterial 
killing (Cramer et al. 2003, Peyssonnaux et al. 2005, Peyssonnaux et al. 
2007). The oxygen-sensitive hypoxia inducible factor (HIF) transcription 
factor is modulated by a group of oxygen-sensing hydroxylase enzymes, 
principally the prolyl hydroxylases (PHDs) (Kaelin and Ratcliffe 2008). 
Interestingly, our group examined transcript abundance between WT mouse 
neutrophils and PHD3 (one of the prolyl hydroxylase enzymes)-deficient 
mouse neutrophils using a whole mouse genome Affymetrix array. While 
confirming PHD3 was essential for hypoxic regulation of neutrophilic 
inflammation, we also found that semaphorin3F, which was originally 
identified as an axon guidance molecule (Dickson, 2002), was the most 
significantly induced gene in PHD3-deficient neutrophils following hypoxic 
stimulation (Walmsley et al., 2011). On the basis of these findings, we 
hypothesised that semaphorin3F may have a role in neutrophil function in 
response to hypoxia or to inflammation. 
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Semaphorin3F has also been crucially implicated in the cross talk between 
tumour cells and the surrounding micro-environment and in the negative 
feedback on Vascular Endothelial Growth Factor (VEGF)-mediated signals, 
which are themselves in part HIF-regulated (Capparuccia and Tamagnone 
2009). Accumulating evidence has indicated that semaphorin3F antagonises 
VEGF effects in the context of hypoxic conditions. For example, 
semaphorin3F negatively affects integrin-linked kinase (ILK)-phosphor-
extracellular signal-regulated kinase 1/2 (ERK 1/2) and AKT-signal 
transducer and activator of transcription 3 (STAT3) signalling, which extend 
downstream to hypoxia-inducible factor-1α (HIF-1α) protein and VEGF 
mRNA levels. As a consequence, both HIF-1α and VEGF were reduced in 
semaphorin3F-transfected lung cancer cell lines (Potiron et al., 2007). In 
breast cancer cell lines, semaphorin3F and VEGF had opposing effects on 
cell attachment and spreading (Nasarreet al., 2003). Guo et al. has reported 
that VEGF and semaphorin3F have opposing roles in regulating neuropilin-2 
vascular function in angiogenesis. Thereby, VEGF functions as a potent pro-
angiogenic cytokine, whereas semaphorin3F is a potent endogenous 
angiogenesis inhibitor (Guo et al., 2013). Semaphorin3F is also able to inhibit 
human endothelial cell survival and migration induced by VEGF (Favier et 
al., 2006). Antagonism between semaphorin3F and VEFG is also seen to 
control cell migration and gangliogenesis in the nervous system (Shwarz et 
al., 2008). 
In this chapter, I therefore sought to characterise the expression of 
semaphorin3F and VEGF in parallel in human neutrophils in response to 
hypoxia and pro-inflammatory mediators (TNF-α and IL-1β), using human 
neutrophils isolated from healthy volunteers. Furthermore, semaphorin3F 
expression in neutrophils recruited to the lung in acute models of neutrophilic 
inflammation in mouse lung section and semaphorin3F mRNA in murine 
bronchoalveolar lavage (BAL) neutrophils were investigated. 
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Aims and hypotheses 
Our initial aim is to characterise neutrophil expression of semaphorin 3F in 
response to culture under physiologically relevant hypoxia and in the 
presence of pro-inflammatory mediators in vitro using human neutrophils. In 
addition, semaphorin3F expression in inflammatory neutrophils was 
determined in vivo using mouse models as acute models of neutrophilic 
inflammation. 
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3.2 Results 
3.2.1 Human neutrophils constitutively express 
semaphorin3F and this is downregulated in response to 
hypoxia.  
First, to investigate whether human neutrophils express semaphorin3F, and 
how hypoxia regulates semaphorin3F expression, freshly isolated peripheral 
blood neutrophils from healthy volunteers were cultured in normoxic (21% 
O2, 5% CO2 at 37
οC)  and hypoxic (1% O2, 5% CO2 at 37
οC) conditions for 4 
hours. Cells were lysed using hypotonic sonication lysis buffer, the lysates 
were then separated by SDA-PAGE with 8% resolving gels. In parallel, 
breast cancer cell line lysates (MCF7) were run as positive control, and p38-
MAPK was used as a loading control. 
Figure 3.1A shows a full length blot of semaphorin3F in human neutrophils. 
Semaphorin3F has an approximate molecular weight of 88 kDa which was 
apparent in the MCF7 positive control. Although neutrophil-derived 
semaphorin3F represents slightly different molecular weight from the positive 
control, it thought to be the correct band regarding the different cell types. 
Other bands lower in the gel could be non-specific bands from a serum 
contamination. Figure 3.1 showed that human neutrophils constitutively 
expressed semaphorin3F protein. This expression was greatest in freshly 
isolated neutrophils without culture (T0), and was significantly downregulated 
in neutrophils aged in hypoxia compared to normoxia (densitometry 
performed relative to p38, *P<0.05, n=5 performed as 5 independent 
experiments) (Figure 3.1). 
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Figure 3.1: Human neutrophils expressed semaphorin3F constitutively and this was 
downregulated in response to hypoxia. (A) A full length blot of semaphorin3F in human 
neutrophils (PMNs). Neutrophils were lysed at time 0 or following 4 and 8 hours, and 
cultured in normoxia (N) or hypoxia (H) (B) Representative blot of semaphorin3F protein in 
human neutrophils. Human peripheral blood neutrophils (PMNs) and breast cancer cell line 
(MCF7) cells were sonication lysed in hypotonic lysis buffer at time 0 or following 4 hours for 
PMNs, and 24 hours for MCF7, cultured in normoxia (N) or hypoxia (H), with p38-MAPK 
used as a loading control. (B) Densitometry performed relative to p38 in normoxia and 
hypoxia (n=5), P values were calculated using one-way ANOVA, *P<0.05, **P<0.01. 
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3.2.2 The expression of VEGF in human neutrophils is 
increased in aged hypoxic neutrophils. 
Since semaphorin3F and VEGF are known to be antagonistic in other 
circumstances, I considered that VEGF expression might be regulated 
differently to semaphorin3F in response to hypoxia. Although VEGF is the 
downstream target of the hypoxia-inducible factor-1α (HIF-1α), the 
expression of VEGF in human neutrophils under hypoxic conditions has not 
been previously investigated. To further understand the previous finding of 
semaphorin3F expression, I therefore sought to determine VEGF expression 
in human neutrophils in response to hypoxia. Neutrophils were harvested 
and lysed using hypotonic sonication lysis buffer, the lysates were then 
separated by SDA-PAGE with 8% resolving gels. MCF7 cells were used as 
positive controls, and antibody to p38-MAPK was applied as a loading 
control. Initially, isolated neutrophils were incubated in normoxia and hypoxia 
for 4 hours, but I was unable to detect a difference in the intensity of the 46 
kDa VEGF band between normoxic and hypoxic conditions. I considered the 
possibility that VEGF regulation might be delayed compared to 
semaphorin3F. I therefore incubated neutrophils in both conditions longer for 
8 and 20 hours, allowing sufficient time for HIF itself to be induced and to 
enhance the transcription of its downstream target genes including VEGF.  
As a result, hypoxic neutrophils exhibited considerable expression of VEGF 
and this was significantly upregulated after 20 hours compared to normoxia 
(densitometry performed relative to p38, *P<0.05, n=3 performed as 3 
independent experiments) (Figure 3.2). Moreover, VEGF expression 
declined in aged normoxic neutrophils.   
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Figure 3.2: Human neutrophils expressed VEGF and this was significantly 
upregulated in response to hypoxia after 20 hours compared to normoxia. (A) Western 
blot analysis of sema3F protein in human neutrophils. Human peripheral blood neutrophils 
(PMNs) and breast cancer cell line (MCF7) cells were sonication lysed in hypotonic lysis 
buffer at time 0 or following 4, 8 and 20 hours for PMNs, and 24 hours for MCF7, cultured in 
normoxia (N) or hypoxia (H), with p38-MAPK used as a loading control. (B) Densitometry 
performed relative to p38 in normoxia and hypoxia (n=3), P values were calculated using 
one-way ANOVA *P<0.05. 
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3.2.3 Pro-inflammatory cytokines (TNF-α, IL-1β) overcome 
hypoxic suppression of semaphorin3F expression. 
In this section, I focused on semaphorin3F expression in response to 
inflammatory conditions including hypoxia and the presence of pro-
inflammatory mediators. Since neutrophil function in inflammation is a highly 
regulated process requiring pro-inflammatory cytokines, this led me to 
question how pro-inflammatory cytokines such as TNF-α and IL-1β, which 
are required for local recruitment of neutrophils to the site of inflammation 
(Blond et al., 2002) (Vieira et al., 20009), modulate the expression of 
semaphorin3F in hypoxia. I decided to choose TNF-α and IL-1β for this 
experiment as neutrophil migration during inflammation was particularly 
investigated. To address this question, normoxic or hypoxic aged human 
neutrophils were incubated in the presence or absence of TNF-α and IL-1β 
for 4 hours. Western blot was carried out to analyse the expression of 
semaphorin3F protein.  
Hypoxic suppression of semaphorin3F expression was partially rescued by 
co-incubation of neutrophils with TNF-α and IL-1β (densitometry performed 
relative to p38, **P<0.01, *P<0.05, n=4 performed as 4 independent 
experiments) (Figure 3.3). 
 
 
 
 
 
 
 
 
 
92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Pro-inflammatory cytokines (TNF-α, IL-1β) overcome hypoxic suppression 
of semaphorin3F expression. (A) Western blot analysis of sema3F protein in human 
neutrophils. Human peripheral blood neutrophils (PMNs) were lysed at time 0 or following 4 
hours +/- TNF-α or IL-1β PMNs culture in normoxia (N) or hypoxia (H), with p38-MAPK used 
as a loading control. (B) Densitometry performed relative to p38 of sema3F at time 0 or 
following 4 hours in normoxia and hypoxia (n=4), P values were calculated using one-way 
ANOVA *P<0.05, **P<0.01. 
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3.2.4 Proinflammatory cytokines (TNF-α, IL-1β) enhance 
VEGF expression in hypoxia. 
To determine the expression of VEGF, which might be affected by pro-
inflammatory cytokines, freshly isolated human neutrophils were cultured in 
the presence and absence of TNF-α and IL-1β for 4 hours in normoxic or 
hypoxic conditions. Western blot was performed to assess the expression of 
VEGF protein.  
TNF-α and IL-1β similarly enhanced VEGF expression in hypoxia. VEGF 
expression in the presence of TNF-α and IL-1β was significantly induced in 
hypoxia compared to normoxia with the same stimulation or compared to 
unstimulated neutrophils (densitometry performed relative to p38, *P<0.05, 
n=3 performed as 3 independent experiments) (Figure 3.4).  
These findings indicated that pro-inflammatory cytokines TNF-α and IL-1β 
could modulate the expression of semphorin3F as well as VEGF under 
hypoxic conditions. 
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Figure 3.4: Pro-inflammatory cytokines (TNF-α, IL-1β) enhance VEGF expression in 
hypoxia. (A) Western blot analysis of VEGF protein in human neutrophils. Human 
peripheral blood neutrophils (PMNs) were sonication lysed in hypotonic lysis buffer at time 0 
or following 4 hours +/- TNF-α (10 ng/ml)  or IL-1β (10 ng/ml)  PMNs culture in normoxia (N) 
or hypoxia (H), with p38-MAPK used as a loading control. (B) Densitometry performed 
relative to p38 of VEGF at time 0 or following 4 hours in normoxia and hypoxia (n=3), P 
values were calculated using one-way ANOVA *P<0.05. 
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3.2.5 Semaphorin3F expression in acute models of 
neutrophilic inflammation 
To explore the expression of semaphorin3F in neutrophilic inflammation in 
vivo, an acute model of lung injury in mice was performed. LPS was directly 
instilled via the intratracheal route, inducing acute lung injury. Six hours after 
LPS instillation, mice were recovered in environmental normoxia or hypoxia. 
Mice were sacrificed at 24 hours, lung sections were stained for expression 
of the neutrophil marker myeloperoxidase (MPO) and semaphorin3F (data 
with permission from Dr.Sarah Walmsley). 
Semaphorin3F was co-localised to MPO positive cells (i.e. neutrophils) both 
in normoxia and hypoxia. Semaphorin3F expression was markedly induced 
in neutrophils in hypoxic conditions compared to normoxia (Figure 3.5). This 
finding indicated that semaphorin3F was upregulated in neutrophils recruited 
to the lung in acute models of neutrophilic inflammation (data with permission 
from Dr.Sarah Walmsley).     
 
 
 
 
 
 
 
 
 
 
 
 
96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Semaphorin3F expression was marked induced in neutrophils recruited to 
the lung in acute models of neutrophilic inflammation.  An acute lung injury was 
induced by intratracheal LPS installation. Six hours after LPS, mice were recovered in 
environmental normoxia or hypoxia. Mice were sacrificed at 24 hours. Lung sections were 
stained for expression of the neutrophil marker MPO and semaphorin3F (deep purple/black 
staining) (data with permission from Dr.Sarah Walmsley). 
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3.2.6 Semaphorin3F mRNA expression was upregulated in 
murine bronchoalveolar lavage (BAL) neutrophils. 
To further characterise the semaphorin3F expression in response to 
inflammation in vivo, semaphorin3F mRNA in murine bronchoalveolar lavage 
(BAL) neutrophils was quantified. Acute lung injury in mice was induced by 
intratracheal LPS installtion. Then, 6, 24 and 48 hours after LPS, mice were 
recovered in environmental hypoxia. Mice were sacrificed, BAL cell pellets 
were collected, and cDNA was then extracted. The cDNA samples of each 
condition were applied to TaqMan® gene expression assays. Beta-actin 
(ACTB) was selected as the endogenous control as it is highly expressed 
and expression is not altered by hypoxia (data with permission from Dr.Sarah 
Walmsley). 
The expression of semaphorin3F mRNA was significantly upregulated in BAL 
neutrophils at all time points (6, 24 and 48 hours) compared to peripheral 
blood neutrophils (PBT0) (data normalized to beta-actin expression, 
***P<0.001, n=4) (Figure 3.6). These results demonstrated that 
semaphorin3F was markedly induced in neutrophilic inflammation at mRNA 
level using a murine acute lung injury model (data with permission from 
Dr.Sarah Walmsley). 
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Figure 3.6: Semaphorin3F mRNA expression was upregulated in murine 
bronchoalveolar lavage (BAL) neutrophils. Fold change in expression of semaphorin3F 
following acute lung injury with LPS. Mice were recovered for 6, 24 and 48 hours in hypoxia. 
BAL cells were then collected, and cDNA was extracted. TaqMan analysis of cDNA was 
performed with data normalized to beta-actin (ACTB) expression. Data show mean and SEM 
of fold change compared to peripheral blood neutrophils (PBT0), n=4-6 (1 independent 
experiment), analysed by ANOVA, ***P<0.001 (data with permission from Dr.Sarah 
Walmsley). 
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3.3 Discussion 
Semaphorin3F is widely expressed in most tissues both in neuronal and non-
neuronal tissues (Luo et al., 1993), but no evidence for the expression of 
semaphorin3F in neutrophils has been identified.  In this chapter, I have 
characterised semaphorin3F expression in human and mouse neutrophils in 
response to hypoxic and to inflammatory conditions. In parallel, the 
expression of a well-known downstream target of HIF-1α, VEGF, in human 
neutrophils was determined.  
 
3.3.1 The expression of VEGF  
VEGF is a part of the hypoxic response that is upregulated by the HIF 
hydroxylase pathway (Shweiki et al., 1992). Recently, VEGF expression and 
secretion have been characterised in a variety of human cell types such as 
human vascular smooth muscle cells (HSMC) (Breier et al., 1992), 
mononuclear cells (Iijima et al., 1993), and neutrophils (Gaudry et al., 1997). 
Human neutrophils express mRNA for the two common VEGF splice 
variants, namely VEGF121 and VEGF165 ((Webb et al., 1998). The release of 
VEGF by human neutrophils under hypoxic conditions was investigated by 
other groups demonstrating that the incubation of human neutrophils in 
hypoxia for time period between 0.5 to 24 hours did not cause a significant 
increase in soluble VEGF in supernatants compared to normoxic conditions. 
Moreover, detection of mRNA expression of VEGF in neutrophils revealed no 
significant differences in VEGF mRNA after 8, 12 or 24 hours exposure to 
normoxia or hypoxia (Koehne et al., 2000). Here, I provide evidence that 
protein levels of VEGF in human neutrophils are unchanged between 
normoxia and hypoxia after 4 or 8 hours incubation, whereas VEGF 
expression is significantly induced in response to hypoxia after 20 hours. 
One possibility for the delayed upregulation of VEGF protein is that cells 
exposed to hypoxia require an increase of VEGF transcription rate mediated 
by binding of HIF-1 to a hypoxia responsive element located in the 5’-flanking 
region of the VEGF gene. Once the VEGF gene is transcribed, VEGF mRNA 
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is bound by RNA-binding proteins that inhibit its degradation under hypoxic 
conditions. Following an increase in the stability of VEGF mRNA, VEGF 
protein is then efficiently translated (Levy et al., 1998). Another possibility is 
the relationship between VEGF and semaphorin3F. Potiron et al. reported 
that in lung cancer cells, semaphorin3F expression reduces AKT and signal 
transducer and activator of transcription 3 (STAT3) phosphorylation, which 
changes downstream VEGF mRNA levels (Potiron et al., 2007). Here, after 
incubation of neutrophils under hypoxic conditions for 8 hours, semaphorin3F 
expression totally disappears suggesting that the inhibition of VEGF 
expression by semaphorin3F is abrogated after 8 hours. 
By contrast, VEGF expression in neutrophils cultured with TNF-α or IL-1β is 
significantly increased after 4 hours under hypoxic conditions compared to 
normoxic control suggesting that neutrophil-derived VEGF is modulated 
during inflammation. Likewise, other groups have shown association 
between activated neutrophils and VEGF expression in the acute 
inflammatory response. Isolated neutrophils incubated in the presence of 
TNF-α for 4 hours significantly produce VEGF compared with control (Webb 
et al., 1998). Taichman et al. demonstrated that neutrophils infiltrating 
inflamed tissues are a potential source of VEGF. VEGF release is 
significantly induced by neutrophils exposed to an inflammatory stimulus 
after 30 minutes, over 70% compared to unstimulated control (Taichman et 
al., 1997). Furthermore, neutrophil-derived VEGF is upregulated in numerous 
human inflammatory lesions such as mucosa in mucus extravasation 
phenomenon or mucocele (Taichman et al., 1997), synovial fluids and 
rheumatoid synovial tissue (Fava et al., 1994), healing wounds (Brown et al., 
1992), and in delayed hypersensitivity reactions (Brown et al., 1995).  
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3.3.2 The expression of semaphorin3F 
Whilst semaphorin3F has been reported to be expressed in a variety of cell 
types, there is currently little literature regarding semaphorin3F expression in 
neutrophils. Here, I reveal a series of semaphorin3F expression patterns in 
response to hypoxia, to pro-inflammatory mediators, and in an acute model 
of neutrophilic inflammation. I initially found that isolated peripheral blood 
neutrophils express semaphorin3F, which is significantly downregulated in 
response to hypoxia. However, this suppression of semaphorin3F is rescued 
by pro-inflammatory cytokines; TNF-α and IL-1β. These findings indicate that 
hypoxia can regulate neutrophil-derived semaphorin3F expression. 
Consistently, other cell types demonstrate a similar correlation between 
hypoxia and semaphorin3F expression. Human U87MG glioblastoma and 
A375SM melanoma cells cultured in hypoxic conditions show an inhibition of 
semaphorin3F-induced biological activity. In addition, when those cells are 
treated with an inhibitor of prolyl hydroxylation of HIF-1; DFO, semaphorin3F 
activity is also suppressed, suggesting that besides physical hypoxia, 
semaphorin3F is regulated by HIF-1 (Silvia et al., 2011). In turn, 
semaphorin3F shows an ability to modulate HIF-1 expression. Recent 
evidence has revealed that semaphorin3F expression caused loss of HIF-1α 
mRNA levels in lung cancer cell line H157 cells (Potiron et al., 2007). 
Furthermore, based on our previous observation in PHD3-deficient 
neutrophils following hypoxic stimulation, semaphorin3F transcript was the 
most upregulated in the context of inhibition of prolyl hydroxylation of HIF-1α. 
These findings also support the findings here that hypoxia and HIF regulate 
the expression of semaphorin3F in neutrophils. 
On the other hand, in the presence of TNF-α and IL-1β, the hypoxic 
suppression of semaphorin3F protein in human neutrophils was significantly 
inhibited. Semaphorin3F expression of mouse lung sections with acute 
neutrophilic inflammation was markedly induced in hypoxia compared to 
normoxia. This is consistent with the finding that semaphorin3F mRNA was 
significantly upregulated in bronchoalveolar lavage (BAL) mouse neutrophils 
compared to peripheral blood neutrophils. These findings indicate that 
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semaphorin3F expression is upregulated in response to inflammation both at 
mRNA and protein level. It has been seen that semaphorin3F is further 
regulated by the activity of additional factors released in the inflammatory 
microenvironment. Here, semaphorin3F might be inducible in neutrophils 
with the presence of pro-inflammatory cytokines or other inflammatory 
responses or signals rather than by hypoxia alone. For example, in multiple 
sclerosis, an inflammatory condition, increased semaphorin3F mRNA 
expression is seen in multiple sclerosis lesions. Semaphorin3F is also only 
detected around active inflammatory lesions suggesting that it is associated 
with inflammatory processes of plaque formation (Williams et al., 2007). 
Furthermore, kruppel-like factor 2 (KLF2), known as a regulator of 
endothelial pro-inflammatory activation, can potently induce semaphorin3F 
expression during inflammation (Dekker et al., 2006). Notably, semaphorin3F 
expression in response to hypoxia was markedly induced in neutrophils in 
incubation with TNF-α and IL-1β, which are required for local recruitment of 
neutrophils to the site of inflammation (Blond et al., 2002) (Vieira et al., 
20009), suggesting that semaphorin3F might be upregulated once 
neutrophils receive recruitment signals or once they reach the site of 
inflammation. 
This led me to question how semaphorin3F may regulate neutrophil function 
during inflammation, including neutrophil recruitment to the inflamed site, and 
the biological functions of recruited neutrophils at the site of inflammation or 
after during the resolution phase. Thus, in the next chapter, I determined the 
role of semaphorin3F in neutrophilic inflammation in vivo using zebrafish 
models. 
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3.3.3 Conclusions 
In conclusion, I have provided evidence that human neutrophils express 
semaphorin3F, which is modulated by hypoxia or inflammatory stimuli. 
Semaphorin3F is significantly upregulated in response to inflammation both 
at mRNA and protein levels. Isolated human neutrophils also express VEGF. 
Under hypoxic conditions, VEGF expression is the inverse of semaphorin3F. 
I hypothesised that the markedly regulatable semaphorin3F expression in 
inflammation might be instrumental in regulating neutrophil responses during 
inflammation. 
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Chapter 4: Investigation of the role of 
semaphorin3F in neutrophil behaviour in 
inflammation using the genetically tractable 
zebrafish  
 
4.1 Introduction 
In the previous chapter, assessment of semaphorin3F expression in human 
peripheral blood neutrophils suggested that semaphorin3F expression is 
modulated in response both to inflammatory mediators and by regional 
hypoxia. The marked induction of semaphorin3F in neutrophils recruited to 
the lung in acute models of neutrophilic inflammation led me to question 
whether semaphorin3F, acting either in an autocrine or paracrine fashion, 
may itself be regulating neutrophil recruitment to or persistence at sites of 
inflammation.  
Since the first semaphorin protein, semaphorin4D, was described to have 
immunoregulatory functions in B-cell/dendritic cell activation (Kumanogoh et 
al., 2000), emerging evidence indicates that several semaphorins are 
crucially involved in immune responses. For instance, semaphorin4A is 
produced by mature macrophages recruited at injury sites suggesting that it 
regulates macrophage functions during inflammation (Meda et al., 2012). 
Hypoxia-induced semaphorin3A acts as an attractant for tumour-associated 
macrophage recruitment to and retention in hypoxic environment (Casazza 
et al., 2013). Furthermore, semaphorin7A induction on endothelia through 
HIF-1α can promote neutrophil migration during hypoxia (Morote-Garcia et 
al., 2012). Taken together with my observation that semaphorin3F 
expression is modified in human neutrophils in the context of infection, I 
therefore questioned whether semaphorin3F may specifically have a role in 
neutrophil migration. 
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To directly investigate the effect of semaphorin3F on neutrophil recruitment 
to and resolution of an inflammatory response in vivo, I turned to the 
zebrafish. Zebrafish (Danio rerio) is a small tropical fresh-water fish that has 
recently emerged as an excellent non-mammalian vertebrate model 
organism to enable real-time study of the vertebrate immune system (Trede 
et al., 2004). It is a genetically tractable organism, possessing many similar 
cell types, including neutrophils, macrophages and eosinophils, and immune 
pathways to mammalian systems (Bennett et al., 2001). Moreover, zebrafish 
has advantages of large number of offspring, short generation time and 
transparency of embryos. 
Prior to study of zebrafish models of tissue injury and repair, I addressed 
whether semaphorin3F is conserved across species and more specifically 
whether zebrafish carry orthologs to human. Importantly, I identified that 
zebrafish do express semaphorin3F, but unlike humans and mice where one 
copy of semaphorin3F is described, and in keeping with the reported 
duplication of many other genes, zebrafish have two copies of 
semaphorin3F, namely semaphorin3Fa and semaphorin3Fb. Both copies are 
orthologs of human semaphorin3F and have 70% DNA sequence identity to 
human semaphorin3F, compared to 96% identity between murine and 
human semaphorin3F. In addition, zebrafish semaphorin3F is the most 
closely related to human semaphorin3F compared to other class 3 zebrafish 
semaphorins. Although semaphorin3G was also reported to be similar to 
human semaphorin3F, it maps to a region of the genome that is syntenic with 
a region of the human X chromosome that no longer contains semaphorin 
genes, suggesting that semaphorin3G orthologs have been lost during 
evolution (Yu and Moens, 2005) (ENSEMBL BLAST) (Figure 4.1). Although 
zebrafish semaphorin3F has less similarity to the human than mouse 
semaphorin3F, the zebrafish system provides the opportunity to study the 
inflammatory response of neutrophils in vivo using real time imaging to follow 
neutrophil migration to and from the site of injury (Renshaw et al., 2006). 
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Figure 4.1: The phylogenetic tree of zebafish semaphorin3F gene and other vertebrate 
semaphorin3 referred to ENSEMBL (http://www.ensembl.org). Zebrafish has two copies 
of semaphorin3F; semaphorin3Fa and semaphorin3Fb. These both copies are duplicated 
orthologs to human semaphorin3F and have similarities to human semaphorin3F 70 percent. 
Zebrafish semaphorin3F is the most closely related to mammalian semaphorin3F compared 
to other class 3 zebrafish semaphorins.  Mouse semaphorin3F has similarity to human 
semaphorin3F 96 percent. In all cases, the zebrafish semaphorin3F is more closely related 
to the semaphorin3F of other species than to other class 3 semaphorins of those species, 
and is also more closely related to those semaphorin3F than any of the other zebrafish class 
3 semaphorins (zebrafish semaphorin3G, the next most closely related, is included for 
comparison). 
 
To examine neutrophil behaviour during inflammation, an established 
transgenic zebrafish line Tg(mpx:GFP)i114, subsequently referred to as 
mpx:GFP, was used. The mpx:GFP zebrafish expresses green fluorescent 
protein (GFP) under the mpx promotor which allows the visualisation and 
quantitation of neutrophils (Renshaw et al., 2006). Due to the transparency of 
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zebrafish embryos, the inflammatory responses of neutrophils can be easily 
observed in vivo using such transgenically labelled neutrophil populations 
(Martin and Renshaw, 2009). The migratory behaviour of neutrophils during 
inflammation, including the number of neutrophils recruiting to the site of 
injury at the recruitment phase and the number of neutrophils persisting at 
the site of injury at the resolution phase, was assessed using the previously 
described injury model (Renshaw et al., 2006). 
After injury to the tail fin of zebrafish embryos, mpx:GFP labelled neutrophils 
can be imaged as they migrate to the injury site. The recruitment of 
neutrophils to the injury site occurs with the highest number of neutrophils 
present at the wound at 6 hours after injury, followed by spontaneous 
resolution by 24 hours after injury. The data can be quantified by counting of 
green fluorescent neutrophils at the site of injury. The time course of the 
zebrafish response followed in this way is comparable with mammalian 
models of neutrophilic inflammation (Renshaw et al., 2006). 
In addition, the mpx:GFP zebrafish provides a model in which individual 
labelled neutrophils can be identified and tracked in vivo to investigate their 
motility in real-time allowing quantification of the speed and direction of 
individual neutrophil migration (Elks et al., 2011). 
 
Aims and hypotheses 
My hypothesis is that semaphorin3F will affect neutrophil migration in vivo. 
My aim in this chapter is to test this in vivo by manipulating semaphorin3Fa 
and semaphorin3Fb expression (overexpression and knockdown) in 
zebrafish while following neutrophil migration to and from the injury site.  
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4.2 Results 
4.2.1 Identification of zebrafish semaphorin3Fa and 
semaphorin3Fb expression 
Unpublished microarray data from Professor Stephen Renshaw’s group, 
which profiled GFP sorted neutrophils from mpx:GFP fish, showed that 
zebrafish neutrophils express semaphorin3Fa and semaphorin3Fb at low 
levels. I subsequently performed whole mount in situ hybridisation to further 
quantify semaphorin3Fa and semaphorin3Fb expression at 20-somite stage 
and 3 day postfertilization (dpf) of mpx:GFP embryos.  
Embryos were collected and fixed at 20-somite stage and 3 dpf, then stained 
with semaphorin3Fa or semaphorin3Fb anti-sense probes. In addition, 
semaphorin3Fa or semaphorin3Fb sense probes were used as controls. 20-
somite stage embryos expressed both copies of semaphorin3F, but in 
different patterns (Figure 4.2). Semaphorin3Fa was expressed in the root of 
zona limitans intrathalamica, anterior dorsal portion in the midbrain and 
hindbrain, and pharyngeal arches. Semaphorin3Fb was observed in the 
anterior neural ridge, rhombomeres 3 and 5, and notochord. Meanwhile, in 3 
dpf embryos, both semaphorin3Fa and semaphorin3Fb were expressed in 
head and blood vessels, however, semaphorin3Fb is additionally observed in 
the spinal cord (Figure 4.3).  
These observations are in general agreement with previous studies (Yu and 
Moens, 2005). However, these did not address expression in neutrophils. 
Unfortunately, due to the inability to resolve in situ hybridisation labelling to 
the level of single cell expression, we were unable to confirm whether 
neutrophils expressed semaphorin3Fa and semaphorin3Fb in vivo by in situ 
hybridisation on intact whole embryos. 
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Figure 4.2: 20-somite stage embryos showed differential expression of 
semaphorin3Fa and semaphorin3Fb. Expression of zebrafish semaphorin3F was 
identified by in situ hybridisation. RNA Probes include 2 copies of zebrafish semaphorin3F 
(semaphorin3Fa and semaphorin3Fb). (A-B) 20somite stage embryos were stained with 
semaphorin3Fa. The expression of semaphorin3Fa was observed in the root of zona 
limitans intrathalamica (*), anterior dorsal portion (in the midbrain (*) and hindbrain (*)), and 
pharyngeal arches (*). (C-D) 20somite stage embryos were stained with semaphorin3Fb. 
Semaphorin3Fb was expressed in the anterior neural ridge (*), rhombomeres 3/5 (*) and 
notochord (*).   
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Figure 4.3: 3 days post fertilization (dpf) embryos showed differential expression of 
semaphorin3Fa and semaphorin3Fb. Expression of zebrafish semaphorin3F was 
identified by in situ hybridisation. RNA Probes include 2 copies of zebrafish semaphorin3F 
(semaphorin3Fa and semaphorin3Fb). (A-B) 3dpf embryos were stained with 
semaphorin3Fa and (C-D) semaphorin3Fb, respectively. Both semaphorin3Fa and 
semaphorin3Fb are expressed in head and blood vessels (*), however, semaphorin3Fb is 
additionally observed in the spinal cord (*). Note that by this time semaphorin3Fb expression 
in the notochord (*) has diminished. 
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Because we could not discern whether neutrophils expressed semaphorin3F 
in neutrophils in uninjured embryos, I hypothesised that if semaphorin3F was 
induced in embryos in parallel with inflammation, the expression of 
semaphorin3F from neutrophil cells might be visible after tissue injury. For 
this, mpx:GFP embryos were injured at 2 dpf. Then, embryos were fixed at 3, 
6 and 24 hours post injury (hpi), and stained with semaphorin3Fa or 
semaphorin3Fb RNA probe.  
Semaphorin3Fa expression in the injured embryos in general was similar to 
that found previously in uninjured embryos. Semaphorin3Fa was expressed 
in the head, blood vessels, muscles, tissues and epithelial cells through all 
time points. However, at 6 hpi and 24 hpi, semaphorin3Fa expression was 
also notably upregulated in the tissues adjacent to the site of tail transection 
(Figure 4.4).  
In the same manner, semaphorin3Fb expression was observed in the head, 
blood vessels, muscles, tissues, epithelial cells and spinal cord. Interestingly, 
injured embryos again showed marked upregulation adjacent to the upper 
region of the site of injury at 6 and, to a lesser extent, at 24 hpi (Figure 4.5). 
The strong expression adjacent to the site of tail transection at 6 hpi and 24 
hpi is clearly affecting a veriety of cell types, including most obviously 
notochord, but also possibly neural cells in the spinal cord. Whether this also 
includes neutrophils remains difficult to determine, particularly against the 
background of expression in these other tissues. However, it is clear that in 
the injured fish semaphorin3F expression is upregulated in inflamed tissues 
in vivo. These findings are consistent with the previous result of 
semaphorin3F expression in mouse lung sections of acute models of 
neutrophilic inflammation. Given our evidence of semaphorin3F expression 
in human neutrophils and the marked upregulation of semaphorin3F in 
inflamed tissues, I next tested the effect of manipulating semaphorin3F 
expression in vivo. 
 
 
112 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Semaphorin3Fa expression with tail fin injury. Tailfin transection was 
performed in 2dpf mpx:GFP embryos, then the embryos were fixed at 3 hpi (A-C), 6 hpi (D-
F) and 24 hpi (G-I). The expression of zebrafish semaphorin3Fa was identified by in situ 
hybridization. All embryos were stained with semaphorin3Fa probe. Semaphorin3Fa was 
expressed in the same pattern at each time point both in uninjured and injured embryos. 
Interestingly, at 6 hpi and 24 hpi semaphorin3Fa expression was additionally observed at 
the injury sites (arrows).  
3 hpi 
24 hpi 
6 hpi 
injured 
uninjured 
A 
B 
F 
D 
C 
E 
Semaphorin3Fa 
Expression 
uninjured 
uninjured 
injured 
injured 
Injured control 
F 
H 
I 
G 
Injured control 
Injured control 
113 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Semaphorin3Fb expression with tail fin injury. Tailfin transection was 
performed in 2dpf mpx:GFP embryos, then the embryos were fixed at 3 hpi (A-C), 6 hpi (D-
F) and 24 hpi (G-I). The expression of zebrafish semaphorin3Fb was identified by in situ 
hybridization. All embryos were stained with semaphorin3Fb probe. Semaphorin3Fb was 
expressed in the same pattern at each time point both in uninjured and injured embryos. 
Interestingly, at 6 hpi and, to a lesser extent at 24 hpi, semaphorin3Fa expression was 
additionally observed at the injury sites (arrows). 
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4.2.2 Semaphorin3F whole fish overexpression decreased 
neutrophil recruitment and delayed neutrophil resolution. 
I began by testing the effect of ubiquitous semaphorin3F overexpression on 
neutrophilic inflammation. Overexpression was achieved by microinjection of 
semaphorin3F RNA into one cell stage mpx:GFP embryos (methods chapter 
2 section 2.2.3.7). To determine inflammatory responses of neutrophils, tail 
transection was performed at 2 days after fertilization (dpf). The numbers of 
neutrophils at the injury site were assessed by counting green fluorescent 
cells at injured sites at 6 and 24 hours after injury (hpi). These times were 
chosen because neutrophils are recruited with the highest numbers at 6 hpi, 
followed by spontaneous resolution over 24 hpi (Renshaw et al., 2006). 
Embryos injected with mCherry (red fluorescent protein) RNA were used as 
controls, besides non-injected embryos, to ensure that RNA microinjections 
did not affect inflammatory responses of neutrophils.  
As shown in figures 4.6 and 4.7, during the recruitment phase (6 hpi), 
semaphorin3Fa as well as semaphorin3Fb whole fish overexpression caused 
a significant reduction in neutrophil numbers (semaphorin3Fa 
mean=19.4+0.60, semaphorin3Fb mean=18.7+0.66) at the injury site 
compared to mCherry injected (mean=26.4+0.61) and non-injected controls 
(mean=26.6+0.53) (P<0.001, n= 30 performed as 3 independent 
experiments). Co-injection of semaphorin3Fa and semaphorin3Fb together 
decreased neutrophil recruitment (mean= 19.2+0.54) only to the same extent 
as single injection of semaphorin3Fa or semaphorin3Fb RNA. At 24 hours 
after injury, semaphorin3Fa or semaphorin3Fb overexpression increased 
significantly the number of neutrophils (semaphorin3Fa mean=14.9+0.42, 
semaphorin3Fb mean=15.1+0.44) at the site of tail transection compared to 
controls (non-injected mean=10.7+0.34, mCherry mean=11.0+0.44) 
(P<0.001, n= 30 performed as 3 independent experiments). This had the 
same effects as co-injection of both semaphorin3Fa and semaphorin3Fb 
(mean=14.4+0.39). Thus, overexpression of semaphorin3F was sufficient to 
both decrease neutrophil recruitment to the site of injury, and delay 
neutrophil resolution away from the injury site (Figure 4.6, Figure 4.7). 
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Figure 4.6: Semaphorin3F whole fish overexpression in zebrafish significantly 
decreased neutrophil recruitment and delayed resolution. Semaphorin3Fa or 
semaphorin3Fb RNA (50ng/μl) was injected into 1-cell stage zebrafish mpx:GFP embryos. In 
addition, 50ng/μl mCherry RNA was used as control. Tailfin transection was performed at 
2dpf, and neutrophils counted at 6 and 24 hpi. (A-H) Overlaid fluorescence and brightfield 
photomicrographs of injured 2dpf embryos at 6hpi and 24 hpi, (A-B) non-injected, (C-D) 
mCherry RNA-injected, (E-F) semaphorin3Fa-injected,(G-H) semaphorin3Fb RNA-injected 
and (I-J) semaphorin3Fa+b RNA injected zebrafish embryos.   
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Figure 4.7: Semaphorin3F whole fish overexpression in zebrafish significantly 
decreased neutrophil recruitment and delayed resolution. Semaphorin3Fa or 
semaphorin3Fb RNA (50ng/μl) was injected into 1-cell stage zebrafish mpx:GFP embryos. In 
addition, 50ng/μl mCherry RNA was used as control. Tailfin transection was performed at 
2dpf, and neutrophils counted at 6 and 24 hpi. (A) 6 hpi time point neutrophil counts 
(recruitment). Data shown are mean + SEM. n= 30 performed as 3 independent 
experiments. (B) 24 hpi time point neutrophil counts (resolution). Data shown are mean + 
SEM. n= 30 performed as 3 independent experiments, P values were calculated using one-
way ANOVA and Bonferroni multiple comparison test, ***P<0.001. 
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4.2.3 Semaphorin3F whole fish knockdown accelerated 
resolution of inflammation 
To determine whether semaphorin3F expression is required for normal 
neutrophil migration, semaphorin3F whole fish knockdown was induced 
(methods chapter 2 section 2.2.3.8). mpx:GFP embryos were microinjected 
with morpholino-modified antisense oligonucleotide specific to 
semaphorin3Fa or semaphorin3Fb sequence to generate semaphorin3Fa or 
semaphorin3Fb whole fish knockdown. Morpholinos are synthetic molecules 
of about 25 bases with altered backbone linkages. A morpholino specifically 
binds to a target sequence to inhibit access of necessary components to that 
specific site. This enables it to block translation or splicing, and it also has 
effective targeted gene knockdown in zebrafish (Nasevicius and Ekker, 
2000). As described in the Methods, semaphorin3Fa translation blocking 
morpholino (Yu and Moens, 2005) as well as semaphorin3Fb translation 
blocking morpholino (Tanaka et al., 2007) were injected into mpx:GFP 
embryos to induce whole fish knockdown of semaphorin3F (Figure 2.4&2.5). 
A mismatch morpholino which has no effect on zebrafish development, was 
used as control. Neutrophils were counted at 6 hpi for the numbers present 
in the recruitment phase, and at 24 hpi for the numbers of neutrophils 
remaining at the site of injury. 
Semaphorin3Fa or semaphorin3Fb knockdown caused no significant 
changes in recruited neutrophil numbers (semaphorin3Fa mean=27.7+0.52, 
semaphorin3Fb mean=26.9+0.48) at the injury site compared to non-injected 
(mean=27.6+0.45) and control morpholino injected embryos 
(mean=27.9+0.45). Likewise, the double knockdown of semaphorin3Fa and 
semaphorin3Fb showed no effect on neutrophil recruitment at 6 hpi 
(mean=27.7+0.53). In contrast, at 24 hpi, semaphorin3Fa or semaphorin3Fb 
knockdown resulted in fewer neutrophil numbers (semaphorin3Fa 
mean=6.7+0.28, semaphorin3Fb mean=6.8+0.36) at the site of injury than 
the controls (non-injected mean=10.7+0.30, control morpholino 
mean=10.8+0.36) (P<0.001, n= 30 performed as 3 independent 
experiments). Thus, semaphorin3F knockdown by morpholino accelerated 
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significantly neutrophil resolution. Interestingly, the double semaphorin3F 
knockdown caused significantly faster neutrophil resolution from the injury 
site (mean=3.0+0.34) than knockdown of either semaphorin3F alone (Figure 
4.8 and Figure 4.9).  
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Figure 4.8: Knockdown of semaphorin3F by morpholino-injection showed a 
significant increased level of resolution of neutrophilic inflammation. Semaphorin3Fa 
or semaphorin3Fb morpholino ((1 nl of 0.5mM)) was injected into 1-cell stage zebrafish 
mpx:GFP embryos. In addition, 1 nl of 0.5mM of control morpholino was used as control. 
Tailfin transection was performed at 2dpf, and neutrophils counted at 6 and 24 hpi. (A-H) 
Overlaid fluorescence and brightfield photomicrographs of injured 2dpf embryos at 6hpi and 
24 hpi, (A-B) non-injected, (C-D) control MO injected, (E-F) semaphorin3Fa MO injected, (G-
H) semaphorin3Fb MO-injected and (I-J)semaphorin3Fa+b MO injected zebrafish embryos.   
A B 
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Figure 4.9: Knockdown of semaphorin3F by morpholino-injection showed a 
significant increased level of resolution of neutrophilic inflammation. Semaphorin3Fa 
or semaphorin3Fb morpholino ((1 nl of 0.5mM)) was injected into 1-cell stage zebrafish 
mpx:GFP embryos. In addition, 1 nl of 0.5mM of control morpholino was used as control. 
Tailfin transection was performed at 2dpf, and neutrophils counted at 6 and 24 hpi. (A) 6 hpi 
timepoint neutrophil counts (recruitment). Data shown are mean + SEM. n= 30 performed as 
3 independent experiments. (B) 24 hpi timepoint neutrophil counts (resolution). Data shown 
are mean + SEM. n= 30 performed as 3 independent experiments, P values were calculated 
using one-way ANOVA and Bonferroni multiple comparison test, ***P<0.001. 
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4.2.4 Microinjection of semaphorin3F RNA and morpholinos 
caused no changes in total neutrophil numbers. 
To determine whether the microinjection of semaphorin3F RNA and 
semaphorin3F morpholinos had any effects on whole body neutrophil 
numbers, mpx:GFP embryos were injected with semaphorin3F RNA or 
semaphorin3F morpholino. At 3 dpf, total neutrophils were counted. Neither 
semaphorin3F overexpression nor knockdown caused any significant 
changes in the whole body neutrophil population compared to the controls 
(Figure 4.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: The injection of semaphorin3F RNA as well as semaphorin3F 
morpholinos had no effect on the whole body neutrophil numbers. (A) Semaphorin3Fa 
or semaphorin3Fb RNA (50ng/μl) or (B) Semaphorin3Fa or semaphorin3Fb morpholino (1 nl 
of 0.5mM) was injected into 1-cell stage zebrafish mpx:GFP embryos. Whole body total 
neutrophil numbers were counted at 3dpf. n= 30 performed as 3 independent experiments, 
P values were calculated using one-way ANOVA and Bonferroni multiple comparison test. 
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4.2.5 Semaphorin3F whole fish overexpression reduced 
speed of neutrophil migration towards the site of injury. 
The initial findings demonstrated that semaphorin3F overexpression 
significantly inhibited neutrophil recruitment. Neutrophil counts were 
inadequate to evaluate the neutrophil migratory behaviour. To more 
thoroughly investigate the mechanism behind the neutrophil recruitment 
phenotype and to confirm the previous findings, neutrophil movements 
during the recruitment phase were tracked for one hour to analyse the speed 
and meandering index of each individual neutrophil cell.  
For this, 2 dpf mpx:GFP embryos injected with semaphorin3Fa or 
semaphorin3Fb RNA were injured and mounted in agarose for timelapse 
imaging on a fluorescence microscope. Between 1-2 hpi, each green 
fluorescent neutrophil was tracked during migration towards the injury site. 
The speed and meandering index were analysed using Volocity® software. 
Meandering index is a ratio of displacement of each cell from origin to track 
length giving an indication of cell movement direction. A meandering index of 
1 indicates that neutrophil moves in a straight line. 
Semaphorin3F overexpression significantly reduced neutrophil speed 
towards the site of injury (Figure 4.11 A), but this had no effect on 
meandering index (Figure 4.11 B). It seems that semaphorin3F 
overexpression inhibited neutrophil movement causing most neutrophils 
either to move more slowly to the site of injury or to remain stationary. 
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Figure 4.11: Semaphorin3F whole fish overexpression significantly decreased speed 
of neutrophil migration towards the site of injury, but had no effect on meandering 
index. Semaphorin3Fa or semaphorin3Fb RNA (50ng/μl) was injected into 1-cell stage 
zebrafish mpx:GFP embryos. In addition, 50ng/μl mCherry RNA was used as control. Tailfin 
transection was performed at 2dpf. Tracking of neutrophil movement over a 1 hour timelapse 
during the recruitment phase of inflammation (1-2hpi). Significant changes were observed in 
the speed of neutrophil migration (A), but there was no difference (B) in meandering index 
(displacement/path length). Data shown are mean ± SEM, n = 15 fish performed as 3 
independent experiments (each point represents a single neutrophil), P values were 
calculated using one-way ANOVA and Bonferroni multiple comparison test, ***P<0.001. 
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4.2.6 Semaphorin3F whole fish knockdown had no effect on 
speed and meandering index of neutrophil migration to the 
site of injury. 
The initial results showed that semaphorin3F knockdown did not affect the 
recruited neutrophil numbers at the transection site compared to controls. To 
confirm this finding, the speed and meandering index of each individual 
neutrophil was analysed as it migrated towards the site of injury. 
In the same way, semaphorin3Fa or semaphorin3Fb morpholino was 
injected to mpx:GFP 1 cell-stage embryos, tail fin transection was performed 
at 2 dpf embryos. Following injury, GFP-labelled neutrophils were tracked for 
1 hour between 1-2 hpi, the neutrophil speed and meandering index were 
then calculated using Volocity® software. Embryos injected with mismatch 
control morpholino were used as controls.   
As expected, no significant difference in the neutrophil speed was observed 
in semaphorin3F knockdown compared to control (Figure 4.12 A), and the 
meandering index was unchanged (Figure 4.12 B). This observation was 
consistent with the previous results confirming that semaphorin3F 
knockdown has no detectable effect on neutrophil migration during neutrophil 
recruitment to the site of injury. 
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Figure 4.12: Semaphorin3F whole fish knockdown had no effect on speed and 
meandering index of neutrophil migration towards the site of injury. Semaphorin3Fa or 
semaphorin3Fb morpholino ((1 nl of 0.5mM)) was injected into 1-cell stage zebrafish 
mpx:GFP embryos. In addition, 1 nl of 0.5mM of control morpholino was used as control. 
Tailfin transection was performed at 2dpf. Tracking of neutrophil movement over a 1-hour 
timelapse during the recruitment phase of inflammation (1-2hpi). No change was observed in 
the speed of neutrophil migration (A), or (B) meandering index (displacement/path length). 
Data shown are mean ± SEM, n = 15 fish performed as 3 independent experiments (each 
point represents a single neutrophil), P values were calculated using one-way ANOVA and 
Bonferroni multiple comparison test. 
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4.2.7 Neutrophil resolution was not caused by neutrophil 
apoptosis at the site of injury.  
The effects of semaphorin3F overexpression and knockdown on neutrophil 
resolution at 24hpi, together with effect of overexpression on migration to the 
injury site, are consistent with the idea that semaphorin3F upregulation slows 
neutrophil migration either to or from the site of injury. However, previous 
studies of neutrophil resolution have suggested that the mechanism by which 
neutrophil-mediated inflammation is resolved is by neutrophil apoptosis at 
the injury site. This mechanism is thought to support neutrophil clearance to 
prevent tissue damage (Haslett, 1999; Bratton and Henson, 2011). Thus, it is 
possible that semaphorin3F expression could alter the rates of neutrophil 
apoptosis at the injury site. 
I therefore investigated neutrophil apoptosis at the site of injury using dual 
TSA/TUNEL staining. TSA or Tyramide signal amplification is an enzyme-
mediated detection of endogenous neutrophil-specific myeloperoxidase 
activity staining neutrophils in green. TUNEL or Terminal deoxynucleotidyl 
transferase (TdT) dUTP Nick-End Labelling can detect double stranded DNA 
breaks of apoptotic cells in red colour. An apoptotic neutrophil will therefore 
be dual-labelled with green and red. Following injection of semaphorin3F 
RNA or morpholinos into 1-cell stage mpx:GFP embryos, tail transection was 
performed on 2 dpf  mpx:GFP embryos. At 24 hpi, embryos were fixed in 4% 
PFA, followed by TSA staining, then TUNEL staining. The total neutrophil 
number at the site of injury and number of dual-labelled apoptotic neutrophils 
was examined in each embryo to calculate the mean percentage of 
neutrophil apoptosis. 
Neither semaphorin3F overexpression (Figure 4.13) nor knockdown (Figure 
4.14) showed any significant difference of the percentage of neutrophil 
apoptosis at the injury site compared to controls. This lack of difference 
suggests that the neutrophil resolution phenotype affected by semaphorin3F 
was not caused by altered neutrophil apoptosis, but by another mechanism.  
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Figure 4.13: Semaphorin3F whole fish overexpression has no effect on neutrophil 
apoptosis at the site of injury. Semaphorin3Fa or semaphorin3Fb RNA (50ng/μl) was 
injected into 1-cell stage zebrafish mpx:GFP embryos. Tail transection was performed on 2 
dpf. Embryos were fixed in 4% PFA at 24 hpi and stained with TSA and TUNEL. (A) Injured 
tail. Represented apoptotic neutrophil is indicated by the white arrows. (B) TUNEL and TSA 
co-localisation shows the percentage of apoptotic neutrophils at the injury site. Data shown 
are mean ± SEM, n = 180 performed as 3 independent experiments. 
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Figure 4.14: Semaphorin3F whole fish knockdown has no effect on neutrophil 
apoptosis at the site of injury. Semaphorin3Fa or semaphorin3Fb morpholino (1 nl of 
0.5mM) was injected into 1-cell stage zebrafish mpx:GFP embryos. Tail transection was 
performed on 2 dpf. Embryos were fixed in 4% PFA at 24 hpi and stained with TSA and 
TUNEL. TUNEL and TSA co-localisation shows the percentage of apoptotic neutrophils at 
the injury site. Data shown are mean ± SEM, n = 180 performed as 3 independent 
experiments. 
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4.2.8 Semaphorin3F overexpression decreased neutrophil 
resolution by decreasing their reverse migration. 
The previous results suggested that altered neutrophil apoptosis did not 
affect the numbers of neutrophils remaining at the site of injury at resolution 
phase following modulation of semaphorin3F expression. Recent studies 
have suggested an alternative mechanism by which neutrophils might be 
removed from the injury site. Robertson et al. has shown that neutrophil 
clearance from the wound in vivo resulted from neutrophil apoptosis and an 
additional mechanism, neutrophil reverse migration (Robertson et al., 2014). 
Similarly, studies from other groups have demonstrated this phenomenon 
and its importance for inflammation resolution (Mathias et al., 2006) (Elks et 
al., 2011) (Starnes and Huttenlocher, 2012). 
To investigate whether semaphorin3F affects this mechanism, a reverse 
migration assay was performed by using double transgenic zebrafish line 
Tg(mpx:Gal4; UAS:Kaede)i222 or mpx:Kaede. Kaede, a photoactivatable 
fluorescent protein, was originally found in stony coral. Green fluorescent 
neutrophils of this line can express the kaede protein, which is 
photoconvertible from green to red fluorescence by certain wavelengths of 
light. Thereby the recruited green fluorescent neutrophils at the site of injury 
are converted to red fluorescence using 120 pulses of the 405 nm laser at 
40% laser power (Figure 4.16a&4.18a) (Elks et al., 2011). The resulting red 
fluorescent neutrophils were then tracked for 3.5 hours, and the numbers of 
red neutrophils reverse migrating from the site of injury into a defined distal 
region were quantified (Figure 4.16a&4.18a). In order to examine the effect 
of semaphorin3F overexpression on neutrophil reverse migration, 
mpx:Kaede embryos were injected with semaphorin3F RNA. Tail fin 
transection was performed at 2 dpf. At 6hpi, the neutrophils present at the 
transection site were photoconverted to red fluorescence, and the numbers 
of these red neutrophils were assessed.  
Semaphorin3Fa or semaphorin3Fb overexpressing fish had significantly 
fewer red neutrophils (semaphorin3Fa mean=4.8+0.18, semaphorin3Fb 
mean=4.5+0.15) moving away from the injury site than mChery injected 
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controls (mean=9.8+0.22). As with the previous assays, overexpression of 
semaphorin3Fa and b together did not enhance this effect (mean=5.0+0.14) 
(P<0.0001, n= 9 performed as 3 independent experiments).  
Linear regression analysis of three graphs combining displayed that single 
overexpression of semaphorin3Fa or semaphorin3Fb as well as the double 
overexpression had similar slopes (semaphorin3Fa slope=0.026+0.001, 
semaphorin3Fb slope=0.022+0.001, semaphorin3Fa and b 
slope=0.020+0.002), and showed significant difference from control 
(slope=0.031+0.002) (P<0.0001, n= 9 performed as 3 independent 
experiments) (Figure 4.15&4.16b). These results indicated that 
semaphorin3F whole fish overexpression decreased neutrophil resolution by 
decreasing the rate of reverse migration of neutrophils during inflammation 
resolution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
131 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15: Semaphorin3F wholefish overexpression decreased reverse migration of 
neutrophils during inflammation resolution. (A)Semaphorin3Fa,(B)semaphorin3Fb or (C) 
semaphorin3Fa+b RNA (50ng/μl) was injected into 1-cell stage zebrafish mpx:Kaede 
embryos. In addition, 50ng/μl mCherry RNA was used as control. Tailfin transection was 
performed at 2dpf, and kaede labelled neutrophils were photoconverted at 6hpi. The 
numbers of photoconverted red neutrophils leaving the area of transection over a time 
period of 3.5 hours were analysed. Data shown are mean ± SEM, n = 9 performed as 3 
independent experiments. 
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Figure 4.16: Semaphorin3F wholefish overexpression decreased reverse migration of 
neutrophils during inflammation resolution. Semaphorin3Fa, semaphorin3Fb or 
semaphorin3Fa+b RNA (50ng/μl) was injected into 1-cell stage zebrafish mpx:Kaede 
embryos. In addition, 50ng/μl mCherry RNA was used as control. Tailfin transection was 
performed at 2dpf. (A, above) Representative pictures of semaphorin3F overexpression. At 
6hpi the recruited green fluorescent neutrophils at the site of injury are photoconverted to 
red fluorescence using120 pulses of the 405 nm laser at 40% laser power (as illustrated). (A, 
below) The red fluorescent neutrophils were tracked for 3.5 hours, and the numbers of red 
neutrophils migrating reverse from the site of injury into a defined region as illustrated were 
quantified. (B) Combining of three graphs of semaphorin3F overexpression. Data shown are 
mean ± SEM, n = 9 performed as 3 independent experiments. 
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4.2.9 Semaphorin3F knockdown increased reverse migration 
of neutrophils during inflammation resolution. 
Neutrophil counts revealed that semaphorin3F whole fish knockdown 
significantly lowered neutrophil numbers at the transection site at 24 hpi. In 
order to investigate the migration behaviour of neutrophils during the 
resolution phase, the reverse migration assay was performed. 
Semaphorin3F morpholinos were injected into 1 cell-stage of mpx:Kaede 
embryos. Tailfin transection was performed at 2 dpf, and at 6 hpi the 
neutrophils at the site of injury were photoconverted to red fluorescence. The 
numbers of these red neutrophils leaving the area of transection over a time 
period of 3.5 hours were calculated. 
As expected, there were more photoconverted red neutrophils moving away 
from the site of injury in semaphorin3Fa knockdown (mean=15.4+0.35) than 
in mismatch morpholino injected negative control embryos (mean=9.5+0.20). 
Semaphorin3Fa knockdown had similar numbers of neutrophils leaving the 
injury site as semaphorin3Fb knockdown (mean=14.8+0.29). However, it 
was observed that the double knockdown of semaphorin3Fa and 
semaphorin3Fb (mean=16.9+0.27) caused much more neutrophil reverse 
migration away from the site of injury than the single knockdown (P<0.0001, 
n= 9 performed as 3 independent experiments). 
Linear regression analysis of three graphs combining displayed that single 
knockdown of semaphorin3Fa or semaphorin3Fb had similar slopes 
(semaphorin3Fa slope=0.050+0.002, semaphorin3Fb slope=0.043+0.002), 
and showed significant differences from control (slope=0.029+0.003). The 
double knockdown of semaphorin3Fa and semaphorin3Fb 
(slope=0.067+0.002) caused much faster neutrophil reverse migration 
(P<0.0001, n= 9 performed as 3 independent experiments) (Figure 
4.17&4.18b). 
In summary, semaphorin3F knockdown accelerated neutrophil clearance 
from sites of inflammation by increased reverse migration of neutrophils 
during the resolution phase. 
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Figure 4.17: Semaphorin3F wholefish knockdown accelerates neutrophilic 
inflammation resolution by increase in neutrophil reverse migration. 
(A)semaphorin3Fa, (B)semaphorin3Fb or (C)semaphorin3Fa+b morpholino (1 nl of 0.5mM) 
was injected into 1-cell stage zebrafish mpx:Kaede embryos. In addition, 1 nl of 0.5mM 
control morpholino was used as control. Tailfin transection was performed at 2dpf, and 
kaede labeled neutrophils were photoconverted at 6hpi. The numbers of photoconverted red 
neutrophils leaving the area of transection over a time period of 3.5 hours were analysed. 
Data shown are mean ± SEM, n = 9 performed as 3 independent experiments. 
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Figure 4.18: Semaphorin3F wholefish knockdown accelerates neutrophilic 
inflammation resolution by increase in neutrophil reverse migration. 
(A)semaphorin3Fa, (B)semaphorin3Fb or (C)semaphorin3Fa+b morpholino (1 nl of 0.5mM) 
was injected into 1-cell stage zebrafish mpx:Kaede embryos. In addition, 1 nl of 0.5mM 
control morpholino was used as control. Tailfin transection was performed at 2dpf. (A, 
above) Representative pictrures of semaphorin3F knockdown. At 6hpi the recruited green 
fluorescent neutrophils at the site of injury are photoconverted to red fluorescence using120 
pulses of the 405 nm laser at 40% laser power (as illustrated). (A, below) The red 
fluorescent neutrophils were tracked for 3.5 hours, and the numbers of red neutrophils 
migrating reverse from the site of injury into a defined region as illustrated were quantified. 
(B) Combining of three graphs of semaphorin3F overexpression. Data shown are mean ± 
SEM, n = 9 performed as 3 independent experiments. 
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4.2.10 Semaphorin3F phenotype is specific to the 
neutrophils. 
Since semaphorin3F affected the migration behaviour of neutrophils 
recruiting to the site of injury and leaving from the site of injury, it was 
interesting to examine the effect of semaphorin3F on other inflammatory 
cells. Besides neutrophils, macrophages play also an important role in the 
initiation, maintenance and resolution of inflammation. I therefore wished to 
investigate the effect of semaphorin3F on macrophage recruitment and 
resolution during the inflammation.  
To address this, a macrophage specific fluorescent zebrafish line 
Tg(fms:GAL4;UNM), which has mCherry labelled macrophages, 
subsequently referred to as fms:UNM, was used. Semaphorin3F RNA or 
morpholino was injected into 1 cell-stage of fms:UNM embryos. At 2 dpf, tail 
fin injury was performed. Macrophages tend to persist at the transection site 
beyond the time when neutrophilic inflammation has resolved, and the 
number of recruited macrophages at the site of injury approaches its peak at 
8 hpi (Loynes et al., 2010). However, in order to comply with the UK Home 
Office legislation, all procedures must end prior to 5.2 dpf and so the number 
of macrophages at the site of injury for the resolution phase was counted at 
72 hpi even though this is prior to complete resolution.  
At 8 hpi, semaphorin3Fa and semaphorin3Fb whole fish overexpression 
exhibited no significant change in macrophage numbers at the inflammation 
site compared to mCherry injected and non-injected controls. Co-injection of 
semaphorin3Fa and semaphorin3Fb also showed the similar effects (Figure 
4.19a). Furthermore, there was no significant difference in macrophage 
numbers at the site of injury at 72 hpi in all conditions (Figure 4.19b). 
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Figure 4.19: Semaphorin3F wholefish overexpression has no effect on macrophage 
recruitment and resolution. Semaphorin3Fa or semaphorin3Fb RNA (50 ng/μl) was 
injected into 1-cell stage zebrafish fms:UNM embryos. In addition, 50 ng/μl mCherry RNA 
was used as control. Tailfin transection was performed at 2dpf, and macrophages counted at 
8 hpi (A) and 72hpi (B). Data shown are mean + SEM. n= 30 performed as 3 independent 
experiments, P values were calculated using one-way ANOVA. 
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Similarly, single morpholino knockdown of semaphorin3Fa or 
semaphorin3Fb, as well as double knockdown caused no significant change 
in the number of macrophages recruiting to the injury site (Figure 4.20a) and 
leaving the injury site (Figure 4.20a) compared to control morpholino injected 
and non-injected controls. 
These experiments have shown that semaphorin3F did not affect the 
migratory behaviour of macrophages. The numbers of macrophages at the 
site of injury both in recruitment phase and defined resolution phase were 
unchanged compared to controls. These findings indicate that semaphorin3F 
specifically plays a role in neutrophil migration during inflammation and does 
not affect macrophage recruitment or resolution. 
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Figure 4.20: Semaphorin3F wholefish knockdown has no effect on macrophage 
recruitment and resolution. Semaphorin3Fa or semaphorin3Fb morpholino (1 nl of 0.5mM) 
was injected into 1-cell stage zebrafish fms:GAL4.UNM embryos. In addition, 1 nl of 0.5mM 
control morpholino was used as control. Tailfin transection was performed at 2dpf, and 
macrophages counted at 8 hpi (A) and 72hpi (B). Data shown are mean + SEM. n= 30 
performed as 3 independent experiments, P values were calculated using one-way ANOVA. 
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4.3 Discussion 
In this chapter, I have characterised the expression patterns of 
semaphorin3Fa and semaphorin3Fb in zebrafish embryos, and have 
investigated the role of semaphorin3F in neutrophil behaviour during 
inflammation using the genetically tractable zebrafish. Semaphorin3F 
overexpression delays neutrophil recruitment and reverse migration resulting 
in a persistent inflammatory response. On the other hand, semaphorin3F 
knockdown enhances resolution of inflammation by accelerating neutrophil 
reverse migration. These manipulations do not affect the behaviour of 
macrophages in the same injury model. This suggests that semaphorin3F 
acts as a critical and specific regulator of neutrophil persistence at the 
inflamed site.  
 
4.3.1 Zebrafish as in vivo model for neutrophilic inflammation 
One of the most important examples of directed cell movement is the 
inflammatory response. Inflammation occurs at the injury sites leading to the 
migration of immune cells to the site of inflammation to protect the host from 
infection. Neutrophils are the most abundant leukocytes recruiting rapidly to 
sites of inflammation. Recently, translucent zebrafish embryos have been 
used as in vivo model for inflammation assay allowing live imaging or 
visualisation of fluorescent proteins in cellular processes. Zebrafish immune 
system shares also a wide range of features of mammalian systems. Here, 
we utilise the zebrafish transgenic line Tg(mpx:GFP)i114 as an in vivo model 
for study of neutrophilic inflammation. The established Tg(mpx:GFP)i114, 
expresses the neutrophil-specific protein myeloid-specific peroxidase (mpx) 
which is homologue of the mammalian myeloperoxidase (mpo) (Lieschke et 
al., 2001). Following tail transection, inflammation is induced at the site of 
injury, and green fluorescent neutrophils are recruited to the wound site. This 
inflammation subsequently resolves and proceeds with kinetics similar to 
those in mammalian systems. Counting of neutrophil number at the tail fin 
wound enables us to assay the degree of inflammation. This established 
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inflammation model thus provides quantifiable neutrophil recruitment and 
resolution (Renshaw et al., 2006).  Moreover, we can use the model for in 
vivo tracking of neutrophils in real-time, so that neutrophil speed and 
direction can be explicitly observed. Importantly, numerous studies in 
mammalian models have reported that neutrophil reverse migration from the 
site of injury is an alternative mechanism by which neutrophils can be 
cleared from the injury site (Hughes et al., 1997) (Mathias et al., 2006) 
(Buckley et al., 2006). This phenomenon can be also determined using 
generated transgenic zebrafish line Tg(mpx:Gal4; UAS:Kaede)i222 with 
photoactivatable fluorescent protein. Study from several groups has defined 
the role of neutrophil reverse migration in inflammation resolution using this 
zebrafish transgenic line (Yoo and Huttenlocher, 2011) (Elks et al., 2011). 
The observation in zebrafish immunity has also many aspects with 
consequences for the important knowledge of mammalian immune function. 
 
4.3.2 Semaphorin3Fa and semaphorin3Fb expression in 
zebrafish embryos 
Due to a whole genome duplication through vertebrate evolution, 
semaphorin3F gene has two related members, namely semaphorin3Fa and 
semaphorin3Fb. As a first step toward understanding semaphorin3F role in 
vivo, I identified the expression pattern of both copies in 20-somite stage and 
3 dpf zebrafish embryos. Consistent with the finding of other groups, I found 
semaphorin3Fa and semaphorin3Fb are expressed mostly in cells of 
zebrafish nervous system (Yu and Moens, 2005) (Callander et al., 2007). 
With regard to the microarray data from Professor Stephen Renshaw’s group 
profiling zebrafish neutrophils, it was also difficult to determine whether 
zebrafish neutrophils expressed semaphorin3Fa or semaphorin3Fb. In 
addition, the whole mount in situ hybridisation technique was not sensitive 
enough to detect the expression of these both copies in neutrophils. 
However, human neutrophils demonstrate constitutive semaphorin3F 
expression, with the convincing evidence that semaphorin3F mRNA 
expression is markedly induced in BAL neutrophils in response to 
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inflammation. Moreover, zebrafish semaphorin3Fa and semaphorin3Fb 
expression is observed adjacent to the site of injury suggesting that 
expression of both genes is upregulated in the inflamed tissues. These 
results are also consistent with semaphorin3F expression in mouse lung 
sections of acute models of neutrophilic inflammation. Together, these 
findings persuade me of the role of semaphorin3F in inflammation. 
 
4.3.3 Role of semaphorin3F in migratory behaviour of 
neutrophils during inflammation  
Recent research has shown a role of zebrafish semaphorin3F in neural crest 
cell migration in vivo. Yu et al. reported that semaphorin3F is expressed in 
cranial neural crest-free zone in the head periphery of zebrafish embryos, 
whereas its receptors, nrp2a and nrp2b are expressed in the neural crest 
cells (NCCs) themselves, pluripotent migratory cells, which are important for 
the development of the peripheral nervous system. Repulsive semaphorin3F-
neuropilin2 signalling is involved in signalling processes of neural cells 
leading to guidance of cranial neural crest cell migration (Yu and Moens, 
2005). However, semaphorin3F has not previously been identified to be 
involved in regulating cell migration in the immune system.  
Neutrophils contribute to the pathogenesis of a number of human diseases 
caused by persistence of neutrophilic inflammation. Thus, regulation of 
neutrophil clearance is a critical prerequisite for successful inflammation 
resolution. In addition to neutrophil apoptosis followed by macrophage 
uptake, neutrophil clearance is accomplished by the retrograde migration of 
neutrophils from sites of inflammation (Mathias et al., 2006). Other 
semaphorin members have been identified to be a regulator of neutrophil 
migration. In vitro, semaphorin3B showed an ability to increase the basal 
migration of neutrophils with direct correlation with IL-8 levels in those cells 
(Rolny et al., 2008), in contrast, semaphorin3E acted as a potent inhibitor of 
neutrophil migration induced by chemoattractant stimuli, CXCL8/IL-8 (Saati, 
2013).     
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Here, we have found for the first time a role for semaphorin3F in regulating 
neutrophil migration during inflammation. Semaphorin3F overexpression 
decreases neutrophil recruitment to the site of injury by reducing speed of 
neutrophils. As a consequence, neutrophils stay persistently at the wound 
site accompanied by delayed inflammation resolution.  By contrast, 
semaphorin3F knockdown causes faster neutrophil reverse migration from 
the site of injury. This also accelerates resolution of neutrophilic 
inflammation. Interestingly, the double knockdown of semaphorin3F copies 
leads to much faster neutrophil migration away from the injury site than the 
single knockdown, whereas the double overexpression of both copies and 
the single overexpression reveal no significant difference in neutrophil 
recruitment as well as neutrophil resolution. These findings indicate that loss 
of function in duplicate affects the regulation of neutrophil migration more 
than gain of functions. This suggests that the role of semaphorin3Fa in 
regulating neutrophil movement is equivalent to that of semaphorin3Fb, and 
that there is some redundancy between the proteins. Notably, semaphorin3F 
knockdown has no effect on neutrophil recruitment to the site of injury. In 
light of the data on semaphorin3F expression in mouse lung lesions and in 
bronchoalveolar lavage (BAL) mouse neutrophils in the previous chapter, 
which demonstrates that semaphorin3F expression is upregulated by the 
additional factors released in the inflammatory microenvironment, this 
suggests that semaphorin3F expression may not be induced until neutrophils 
reach the inflamed site. This would explain why the knockdown of 
semaphorin3F at the beginning of inflammation shows no considerable 
influence on neutrophil migration. 
Having determined that semaphorin3F does not have significant effect on 
neutrophil apoptosis rate at the inflamed site compared to controls. This also 
suggests that semaphorin3F is unlikely to be involved in any of the pathways 
of programmed neutrophil death, including extrinsic, intrinsic, or endoplasmic 
reticulum stress pathways (El Kebir and Filep, 2010). Consistent with this, 
the number of macrophages at the site of injury is unaffected by either 
semaphorin3F overexpression or knockdown, suggesting that the rate of 
phagocytosis of apoptotic neutrophils by macrophages is not different to 
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controls. Thus, bearing in mind the effect of semaphorin3F on neutrophil 
reverse migration, it seems plausible that the levels of semaphorin3F 
expression may cause either neutrophil persistence at the site of 
inflammation or acceleration of inflammation resolution depending on the 
amount of expression that occurs during inflammation. 
Exactly how semaphorin3F affects neutrophil migration during inflammation 
is not clear. Recent studies have implicated semaphorin3F activity in 
migration of endothelial cells and tumour cells. Work by other groups has 
identified that semaphorin3F can inhibit migration of endothelial cells by 
inhibiting activation of integrins and thereby disrupting tumour angiogenesis 
(Guttmann-Raviv et al., 2007). Interestingly, numerous studies of 
tumourigenesis have demonstrated the ability of semaphorin3F to inhibit 
tumour cell migration. Semaphorin3F inactivates RhoA, a member of the Rho 
family of GTPases that stabilises the F-actin cytoskeleton (Shimizu et al., 
2008). Semaphorin3F also inactivates small GTPase Rac1, a regulator of 
lamellipodia formation at the leading edge during migration by inactivation of 
RhoA (Burridge and Wennerberg, 2004). As a result, the migration and 
contractility of the tumour cells are inhibited. Another approach to 
identification of the mechanism regulating neutrophil migration during 
inflammation is to study dynamic processes involving in neutrophil motility 
such as chemotaxis and neutrophil polarity via PI-3 kinase signalling. My 
investigations into this area are presented in Chapter 6. 
Another thing that remains unclear is whether semaphorin3F regulates 
neutrophil migration through autocrine or paracrine signalling. RNA- and 
morpholino-injections can generate only in the whole fish overexpression and 
knockdown, respectively. To specifically address in which cells 
semaphorin3F is required in vivo, will require the creation of zebrafish 
transgenic lines in which semaphorin3F expression is specifically modified in 
neutrophils. 
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4.3.4 Conclusions 
All findings in this chapter imply that semaphorin3F not only plays a role in 
endothelial cell or tumour cell migration (Bielenberg et al., 2004) (Guttmann-
Raviv et al., 2007) (Guttmann-Raviv et al., 2007) (Shimizu et al., 2008), but 
also triggers neutrophil migration in response to inflammation in vivo. I found 
that semaphorin3F overexpression decreases neutrophil recruitment to the 
site of injury, and delays subsequent neutrophil reverse migration. In 
contrast, semaphorin3F knockdown accelerates the retrograde movement of 
neutrophils away from the site of injury, without affecting recruitment, 
resulting in faster resolution of neutrophilic inflammation. Notably, these 
phenotypes occur specifically in neutrophils, not in macrophages, suggesting 
the specific role of semaphorin3F in neutrophil migration. 
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Chapter 5: Phenotype of neutrophil migration in 
semaphorin3F mutant in zebrafish using 
TALENs 
 
5.1 Introduction 
On the basis of our observation that semaphorin3F whole fish knockdown by 
morpholino injection accelerates neutrophil reverse migration during 
inflammation, I sought to confirm the phenotype of neutrophil migration by 
generating a semaphorin3F mutation zebrafish transgenic line. For this, I 
generated zebrafish semaphorin3F mutant using Transcription Activator-Like 
Effector Nucleases (TALENs) technique. 
Although morpholinos are easily delivered to cells and have high efficacy to 
specifically knockdown genes throughout zebrafish embryonic and larval 
development, they become progressively less effective as development 
proceeds due to spatiotemporal gene expression, dilution and degradation 
(Bedell et al., 2011). Morpholinos are normally injected into the yolk sacs of 
1-cell-stage zebrafish embryos. Most morpholino phenotypes are identified 
within the first 3 days of development, with effects rarely persisting after the 
first 5 days following injection (Bill et al., 2008). This is believed to be a 
consequence of the rapid increase in numbers of nuclei over this period of 
time, resulting in a significant decrease in intranuclear concentration. The 
use of higher dosages of morpholinos is precluded by their effects on 
embryonic development. Morpholinos may also act ‘off target’ in that they 
can have effects on the production of other gene products, thereby resulting 
in the observed phenotype being unrelated to the gene of interest (Eisen and 
Smith, 2008). Another reason for limited effectiveness of morpholinos is that 
they are ineffective when the cognate maternal protein is present (Kardash, 
2012), or when the maternal transmission of the gene under study 
suppresses the phenotype of interest (Nasevicius and Ekker, 2000). 
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Consequently, I sought to study the phenotype of neutrophil migration by 
generating a stable semaphorin3F mutant transgenic line. 
TALENs are a newly developed technology that can efficiently modify any 
sequence of interest in living cells or organisms. TALENs are artificial 
proteins containing a DNA binding domain and a non-specific FokI 
endonuclease domain. A novel DNA binding domain, Transcription Activator-
Like Effector (TALE) protein, is produced by a plant pathogen in the genus 
Xanthomonas (Xanthomonas bacteria) (Boch and Bonas, 2010). This 
domain is a customizable sequence-specific domain composed of multiple 
sets of highly conserved repeat domains of 34 identical or near identical 
tandem amino acids in tandems (Schornack et al., 2006). The individual 
TALE repeat recognises a specific single base of the target DNA sequence 
determined by the identity of a hyper variable pair of amino acids (the repeat 
variable diresidue (RVD)) typically found at position 12 and 13 of the repeat 
(Boch et al., 2009). Recently, four domains with the RVD NI, NG, HD and NN 
have been used for the recognition of A, T, C and G, respectively (Figure 
5.1). TALE binds specifically to the target sequence, which is cleaved by 
FokI endonuclease resulting in double-stand breaks into that specific DNA 
site. The double-stand breaks are then repaired by normal DNA repair 
mechanisms including non-homologous end-joining (NHEJ) or homologous 
recombination (HR) to enable target genome alternations at the cleavage site 
resulting in the creation of insertion or deletion mutations (Urnov et al., 2010) 
(Figure 5.1). 
Recently, TALENs have enabled alteration of target genes in a number of 
model organisms including zebrafish (Sander et al., 2011, Huang et al., 
2011, Bedell et al., 2012). The TALENs system can efficiently cause double-
stand breaks in target endogenous genes of interest in zebrafish following 
error-prone repair. As a result, the introduction of small insertions or 
deletions at cleavage sites frequently induces frameshift knockout mutations 
at the somatic cell level that pass through the germline to create mutant fish 
(Sander et al., 2011). Moreover, TALENs offer an easy and rapid method to 
edit and create potentially targeted mutations in a greater range of DNA 
sequences.  
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Figure 5.1: Overview of TALENs and TALE repeat. (A) Schematic diagram of a TALEN. 
DNA binding domain is composed of 34 amino acids TALE repeat modules with an N-
terminal domain and a C-terminal domain. TALE repeats are shown as coloured squares. 
Letters inside each repeat represent the two repeat variable diresidue (RVD) typically found 
at position 12 and 13 of the repeat. The amino acid sequence of a single TALE repeat is 
expanded below with the RVD highlighted in red and bold text. The non-specific nuclease 
domain from the FokI endonuclease is shown as a red figure. (B) TALE-derived DNA binding 
domain aligned with its target DNA sequence. The targeted nucleotides of each RVD are 
expanded below. NI, NG, HD and NN are used for the recognition of A, T, C and G, 
respectively. (C) TALENs bind to a half-site with dimeric FokI nuclease domains cleaving the 
targeted DNA site within the intervening spacer region. The nuclease-induced double-strand 
breaks are repaired by error-prone non-homologous end-joining (NHEJ) or homologous 
recombination (HR) resulting in the creation of insertion or deletion mutation. 
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In this chapter, I sought to determine whether semaphorin3F mutation using 
TALENs affected the migratory behaviour of neutrophils during inflammation, 
including the number of neutrophils recruiting to the site of injury during the 
recruitment phase and the number of neutrophils persisting at the site of 
injury at the resolution phase.  I also determined whether this semaphorin3F 
mutant zebrafish line demonstrated the same phenotypes as seen in 
semaphorin3F whole fish knockdown using morpholino-injections. For this, I 
created semaphorin3Fa mutant and semaphorin3Fb mutant lines. To 
examine neutrophil migration during inflammation, the previously described 
injury model was performed (Renshaw et al., 2006). 
 
Aims and hypotheses 
The aim of this chapter is to investigate the role of semaphorin3F in the 
migratory behaviour of neutrophils during inflammation in vivo using TALENs 
technology to create semaphorin3Fa and semaphorin3Fb mutant zebrafish 
lines. The findings of this chapter will let us further understand the role of 
semaphorin3F in neutrophilic inflammation. 
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5.2 Results 
5.2.1 Design of DNA binding domain 
A heterodimer with a left and a right subunit containing a C-terminal Fok1 
nuclease domain and an N-terminal site specific DNA binding domain, at a 
target site was first designed by using the website http://tale-
nt.cac.cornell.edu/node/add/talen-old. The target genomic sequence should 
have a wide spanning restriction enzyme that cuts well in Reddymix to allow 
saving on time and cost for screening process. The DNA binding domain 
should be comprised of between 15-21 repeat variable domain (RVD) units 
and have a space between two subunits about 15-18 bp. All plasmids were 
provided by Golden Gate TALEN kit (Addgene, Cambridge, UK) and 
obtained as a kind gift from Dr.Stone Elworthy (University of Sheffield).  
 
DNA binding domain of semaphorin3Fa 
I targeted semaphorin3Fa gene at exon 8 because of its position in the 
middle of the gene and its specific cleavage site recognised by MwoI 
restriction endonuclease. A left and a right subunit of semaphorin3Fa TALE 
repeat (Figure 5.2) were designed by using http://tale-
nt.cac.cornell.edu/node/add/talen-old recognising the targeted sequence in 
exon 8. The space between two subunits is the cleavage site of MwoI. 
Primers were then designed for genotype test by digest array. The PCR 
product size is 228 bp in length, which is digested by MwoI to give 
approximately 130 bp and 80 bp products (Figure 5.2). 
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tgtttcagacatggatgggctcattttgtcaagtttatctctctatctctccttatctcccttatgctcactctgttttggcagAT 
 
GGCCAGCTTTATGCCGGCGTCTACATCGATTTTATGGGAACAGACTCTGCCAT 
 
CTTTCGCACGTTGGGCAAACACACGGCAATGAGGACCGACCAGTATAACTCCC 
 
GCTGGCTCCACGgtatgcccaaaatgtttgaaccgtggcacactaccaagacaaatg 
 
 
Figure 5.2: TALEN design for inducing double-strand breaks at the endogenous 
zebrafish semaphorin3Fa gene at exon 8.  (A) A left and a right subunit of semaphorin3Fa 
TALE repeat aligned with its target DNA sequence in exon 8. The targeted nucleotides (as 
highlighted in yellow) of each RVD (as highlighted in blue) are expanded above or below. NI, 
NG, HD and NN are used for the recognition of A, T, C and G, respectively. The specific 
cleavage site of MwoI restriction endonuclease is highlighted in red.  (B) The targeted DNA 
sequence of exon 8 with designed primers. A left and a right TALE repeat of DNA binding 
domain are highlighted in yellow. The specific cleavage site of MwoI restriction 
endonuclease is highlighted in red. A left and a right primer are highlighted in green. PCR 
product sizes (as illustrated in red arrow) after MwoI digestion are 130 bp and 80 bp. 
Uppercase = exon; lowercase = intron.  
 
 
 
GGGAACAGACTCTGCCATCTTTCGCACGTTGGGCAAACACACGGCAATGAGGA 
CCCTTGTCTGAGACGGTAGAAAGCGTGCAACCCGTTTGTGTGCCGTTACTCCT 
Left subunit 
Right subunit 
Exon 8 
A 
B 
130 bp 
80 bp 
NN NN NN NI  NI  HD NI NN NI HD NG HD NG NN HD NN HD HD NI NG HD NG  
 
NG NN NG NN NG NN HD HD NN NG NG NI HD NG HD HD 
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DNA binding domain of semaphorin3Fb 
Likewise, I targeted semaphorin3Fb gene at exon 8 because of its position in 
the middle of the gene and its specific cleavage site recognised by BslI 
restriction endonuclease. A left and a right subunit of semaphorin3Fa TALE 
repeat (Figure 5.3) were designed by using http://tale-
nt.cac.cornell.edu/node/add/talen-old recognising the targeted sequence in 
exon 8. The space between two subunits is the cleavage site of BslI.  
Primers were then designed for genotype test by digest array. The PCR 
product size is 252 bp length, which digested by BslI gives approximately 
125 bp and 110 bp products (Figure 5.3). 
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atgtttctccctgcattgtcttgccctaatatgaaaagtgtgattataaattgtccaaaatgtaaactatcatttcgcattctttt 
 
cctctgtctgtctttcttagACCCATCATTTGTCCATGTGCACCTCATTCCTGACAGCGGTG 
 
AGAAAAACGATGACAAACTCTACTTTTTCTTTCGTGAAAAGTCTTCTGAAATGG 
 
GCCAGAGCCCGAAATCACAATCCCGCATCGGCCGCATCTGCCTGgtgagctcaaac 
 
tct 
Figure 5.3: TALEN design for inducing double-strand breaks at the endogenous 
zebrafish semaphorin3Fb gene at exon 8.  (A) A left and a right subunit of semaphorin3Fb 
TALE repeat aligned with its target DNA sequence in exon 8. The targeted nucleotides (as 
highlighted in yellow) of each RVD (as highlighted in blue) are expanded above or below. NI, 
NG, HD and NN are used for the recognition of A, T, C and G, respectively. The specific 
cleavage site of BslI restriction endonuclease is highlighted in red.  (B) The targeted DNA 
sequence of exon 8 with designed primers. A left and a right TALE repeat of DNA binding 
domain are highlighted in yellow. The specific cleavage site of MwoI restriction 
endonuclease is highlighted in red. A left and a right primer are highlighted in green. PCR 
product sizes (as illustrated in red arrow) after BslI digestion are 125 bp and 110 bp. 
Uppercase = exon; lowercase = intron.  
 
 
CATTTGTCCATGTGCACCTCATTCCTGACAGCGGTGAGAAAAACGATGACAAACTCTA 
 
GTAAACAGGTACACGTGGAGTAAGGACTGTCGCCACTCTTTTTGCTACTGTTTGAGAT 
 
Left subunit 
HD NI NG NG NG NN NG HD HD NI NG NN NG NN HD NI HD HD NG NN HD HD NI NG HD NG 
 
NG NG NG NG NG NN HD NG NI HD NG NN NG NG NG NN NI NN NI 
 
Right subunit 
Exon 8 
A 
B 
125 bp 
110 bp 
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5.2.2 Identification of mutations induced by TALENs in 
embryonic zebrafish cells 
The TALENs constructs of semaphorin3Fa and semaphorin3Fb were 
prepared and made as previously described (methods chapter 2 section 
2.2.3.9). RNA of the TALENs was then injected into the one-cell stage of 
mpx:GFP embryos. Once the injected fish were about 2-3 months old, these 
fish were crossed with mpx:GFP. Their progeny embryos were tested using 
the previously described mutation analysis method (methods chapter 2 
section 2.2.3.9) for screening of potential founder fish. The positive digestion 
results were then accurately analysed by sequencing using the same primers 
for PCR (semaphorin3Fa in Figure 5.4, semaphorin3Fb in Figure 5.5). The 
embryos of the potential founder with frameshift mutations were allowed to 
grow in the aquarium system. Once the offspring of the potential founder 
were 2-3 months old, the screening of these F1 fish was performed by fin 
clipping and mutation analysis. The genomic DNA was extracted and tested 
using the previously described mutation analysis method (methods chapter 2 
section 2.2.3.9). The positive digest arrays were then analysed by 
sequencing.  
The F1 generation of mutated fish of both semaphorin3Fa and 
semaphorin3Fb showed frameshift mutation at the somatic cell level. 
TALENs induced 1 bp deletion in semaphorin3Fa gene in exon 8, likewise, 
semaphorin3Fb gene had 1 bp deletion in exon 8 (Figure 5.6). 
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Figure 5.4: Screening of mutated semaphorin3Fa founder. (A) Gel showing MwoI 
digestion of PCR products amplified from genomic DNA of progeny embryos of 
semaphorin3Fa mutated fish. The uncleaved PCR products were shown as pointed by 
orange arrows. (B) The positive digestion results (with uncleaved product) were then 
accurately analysed by sequencing. Screenshot from FinchTV showing the sequence of this 
product. The overlapped peaks demonstrated nucleotide changes between WT and mutated 
sequence (as pointed by red arrows) starting from the cleavage site. 
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Figure 5.5: Screening of mutated semaphorin3Fb founder. (A) Gel showing BslI 
digestion of PCR products amplified from genomic DNA of progeny embryos of 
semaphorin3Fb mutated fish. The uncleaved PCR products were shown as pointed by 
orange arrows. (B) The positive digestion results (with uncleaved product) were then 
accurately analysed by sequencing. Screenshot from FinchTV showing the sequence of this 
product. The overlapped peaks demonstrated nucleotide changes between WT and mutated 
sequence (as pointed by red arrows) starting from the cleavage site. 
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TTATGGGAACAGACTCTGCCATCTTTCGCACGTTGGGCAAACACACGGCAATGAGGAC 
TTATGGGAACAGACTCTGCCATCTTTCGCAC~TTGGGCAAACACACGGCAATGAGGAC 
 
 
ATCATTTGTCCATGTGCACCTCATTCCTGACAGCGGTGAGAAAAACGATGACAAACTCA 
ATCATTTGTCCATGTGCACCTCATTCCTGACA~CGGTGAGAAAAACGATGACAAACTCA 
 
Figure 5.6: Target sequence and sequence of somatic mutation induced by TALENs in 
embryonic zebrafish cells at their intended target loci. For each pair of TALENs 
(semaphorin3Fa and semaphorin3Fb), the wild-type (WT) target sequence is shown at the 
top with the intended target sites of the TALE nucleases marked in yellow. Deletion is 
indicated by grey highlighted red dash.  
 
The protein sequence of each mutated gene was aligned with its WT 
sequence using NCBI/Blast. Both mutated genes induced by TALENs of 
semaphorin3Fa and semaphorin3Fb demonstrated a large number of stop 
codons compared to WT (Figure 5.7 and Figure 5.8). This showed that 
introduction of a 1 bp deletion at the cleavage sites of each mutated gene 
could potentially induce frameshift knockout mutations at the somatic cell 
level passing through the germline to create mutant fish. 
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Semaphorin3Fa WT protein sequence 
MDKVIMQGAGTLVLGTLLVSVFSAVSVHSSPLSSLPPASVPRVFLSFKELKSTGTAHHFAFL
LNSTDYRILRMDEDHDRMYVGSKDYILSLDLNDINKEPLIIHWPVAPQKRTECVLSGKDINGE
CGNFIRLIEPWNRTHLYVCGTGAYNPICTYVDRGQRAQGFLQDQMPRAGGRTSRAADPSA
SPEPYAPKEYIFRLEPGKVDSGKGKCPYDPKLNSVSALINGQLYAGVYIDFMGTDSAIFRTL
GKHTAMRTDQYNSRWLHDPTFVHAQLIPDSAEKNDDKLYFFFREKASEMGQTPMAQSRIG
RICLNDDGGHCCLVNKWSTFLKARLICSVTGSDGIETHFDELRDVYIQKTQDTKNPVIYGVF
SVSGSVFKGSAVCVYSMADVRMVFNGPFAHKEGPNYQWVAYQGKIPYPRPGTCPGGTFT
PNMKSTKDYPDEVINFMRTHPTMFNAVYPVHKRPLVVRTNVDYEFTTITVDQVAAADGNYE
VLFLGTDRGTVQKVIVLPRDDLQTEELVLEEVEVFRVPTSITTMKISPKRQQLYVSSAVGVTH
LALHRCDVYGEACADCCLARDPYCAWDGKSCSRYSANQKRRSRRQDVKYGNPIRQCRG
YNSNANKNTLETVQYGVEGSTAFLECQARSPHVSIKWHFQKENSDRRREIRSDGRVVRTE
QGLLLRSLQLSDSGVYQCTSTEKNFKHTLVKLQLVVLSAHTVNSIQTESGAPAAPPLQSSA
WTPSAEQYKDLLTILSQPEMGLINQYCQDYWQIGDDPMAHKKKDLKELQKDLRKPRNRRH
HQEQSSMAET* 
 
Semaphorin3Fa mutant protein sequence 
MDKVIMQGAGTLVLGTLLVSVFSAVSVHSSPLSSLPPASVPRVFLSFKELKSTGTAHHFAFL
LNSTDYRILRMDEDHDRMYVGSKDYILSLDLNDINKEPLIIHWPVAPQKRTECVLSGKDINGE
CGNFIRLIEPWNRTHLYVCGTGAYNPICTYVDRGQRAQGFLQDQMPRAGGRTSRAADPSA
SPEPYAPKEYIFRLEPGKVDSGKGKCPYDPKLNSVSALINGQLYAGVYIDFMGTDSAIFRTW
ANTRQ*GPTSITPAGSTIQHLSMLSSSLIVQKRMTTSCISSSVRRPLRWVRLPWLNLGLAEF
A*MMMEDTAVW*TSGAPS*RLGSSALSPALMASRRISMSSGTCTSRRLKTQRILSSTASFPC
PGLCLKAQQYVFIQWLMCAWSSMGLSLIKKAQTTNGLHTRAKSHTLAQEHVQEGRLPPT*S
LLKITQMR*STSCAHIPPCSMQFIQSTSAPWWYEPTWIMSSPPSLWTKWLQLMATMKFCS*
EQTGEQFRK*LSCPEMIYRLKSWFWRRWRSSEFQLQSLL*RFLQNDNSCMSVRRWASHIW
LCTDVMFTERPVPTAAWPETHTVPGTESPALATQQTKKGGVEGKT*SMETL*GNAEATTRM
PIRTHWRQCSME*REAQPFWSVRPDLLMCPSSGISRRRTATGEERSVLTGVWFARNRASS
CAPSSCLTAVFTSAPQLRRTSNTPLSNSSSWFSPPTQSTASRLKAAPRPPHPFSPAPGRPA
QNNTKTS*PSSANLRWASSTSTAKTTGR*GTTPWPTRRRTSRSSRRTCGSLEIGDTTRSRA
AWLRH 
 
Figure 5.7: Representative protein sequence alignment between semaphorin3Fa WT 
and semaphorin3Fa mutant. Semaphorin3Fa mutant revealed a large number of stop 
codons (shown as red highlighted star) compared to WT.  
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Semaphorin3Fb WT protein sequence 
MLLDSLWPVQVLLVLSVLTLVLGNEPQNAPRVFLSFKDLRSTGTAHYFSFLLNTSDYRILRM
DEDHDRMYVGSKDYILSLDLHDINREPLIIHWPVSPQRKTECVLSGKDTNGECGNFIRLIEP
WNRTHLYICGTGAYNPVCTYVNRGRKPMTAMHLQMPQTRGRASRAAEPETVFDETGLQE
YVFHLEPGKEDSGKGKCPYDPKLNSVSALINGELYAGVYIDFMGTDSAIFRTLGKNAVMRT
DQYNSRWLNDPSFVHVHLIPDSGEKNDDKLYFFFREKSSEMGQSPKSQSRIGRICLNDDG
GHCCLVNKWSTFLKARLICSVPGADGIETHFDELRDVYIQPTQDTKNPVIYGVFSVSGSVFK
GSAVCVYSMADIRMVFNGPFAHKEGPNYQWVAYTGKIPYPRPGTCPGGTFTPNMKSTKD
YPDEVINFMRNHPTMYNSVYPVHKRPLVVRTNVDYEFTTITVDQVTAADGNYEVLFLGTDR
GTVQKVIVLPSDDLQTEELVLEEVEVFKVPTSITTMKISSKRQQLYVASAVGVTHMALHRCD
VYGEACADCCLARDPYCAWDGKSCSRYSASQKRRSRRQDVKYGNPIRQCRGYNSNINKN
TLETVQYGVEGSSTFLECQARSPHAAIKWHLHRDNSDRRREVRSDGRVLKTDQGLLLRSL
QSSDSGIYICTATEKNFKHTLVKLQLLVLTNQAVNNILVDTGRPVVSPLQSSAWTPSAGQYK
DLLTILSQPEMGLINQYCQDYWQYGDPLTGVIKAKDLKELKEQKKPRNRRHHGDEEET* 
 
Semaphorin3Fb mutant protein sequence 
MLLDSLWPVQVLLVLSVLTLVLGNEPQNAPRVFLSFKDLRSTGTAHYFSFLLNTSDYRILRM
DEDHDRMYVGSKDYILSLDLHDINREPLIIHWPVSPQRKTECVLSGKDTNGECGNFIRLIEP
WNRTHLYICGTGAYNPVCTYVNRGRKPMTAMHLQMPQTRGRASRAAEPETVFDETGLQE
YVFHLEPGKEDSGKGKCPYDPKLNSVSALINGELYAGVYIDFMGTDSAIFRTLGKNAVMRT
DQYNSRWLNDPSFVHVHLIPDTVRKTMTNSTFSFVKSLLKWARARNHNPASAASA*TMTVV
TAAWSTSGAPS*KPVSSAQSQELTGLKRTSMSSEMCTYSPRRTLKTQSSTGSSLCPALYS
RARRSASTPWRTFGWCSMDLLPTKKVPITSGWPTLGKSPTPVREHVLVGLSPRT*SPLRTT
QTRSSTSCGIIPPCITPCIQCTSAPWWSGLTWTMSSQPSLWIRSQRPTETMRCSSWEQTE
EQCRR*SSYPVMTCRQRSLCWRKWRSLRSLLLSQQ*RFLQNGNNCMWPLRWE*RIWLCT
AVMSTARPVLTAVWPGTPIVHGTANPALDTQPRRRDAAVDKT*NTGTPYASAEDTIPTLIRT
HWRQCSMGWRAAAPFWSARPDHHTLPSSGTFTETTATGGEKSAVMAVC*RRIKVCFCAL
SSPQTPASTSARPQRRTSSTRWSNCSCSS*PIRPSTTFWWTRDVRSSLRSSPAPGPPVPG
NTKTC*PSSASPRWAS*TSTARTIGSMETL*PGSSRPKTSKSSRSRRNHEIADITGTRRRHE 
 
Figure 5.8: Representative protein sequence alignment between semaphorin3Fb WT 
and semaphorin3Fb mutant. Semaphorin3Fb mutant revealed a large number of stop 
codons (shown as red highlighted star) compared to WT.  
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5.2.3 Semaphorin3F mutation induced by TALENs showed 
the same phenotype as semaphorin3F whole fish 
knockdown. 
To investigate the inflammatory responses of neutrophils of semaphorin3F 
mutation induced by TALENs, the F1 generation mutants with heterozygous 
mutation of each gene were in-crossed. This resulted in predicted genotypes 
for the offspring of 50% heterozygous, 25% homozygous mutation 
(knockout), and 25% WT genotype. Tail transection was performed at 2 dpf. 
Green fluorescent neutrophil cells were assessed by counting at injured sites 
at 6 and 24 hours after injury. Embryos of mpx:GFP were used as a negative 
control. 
To retrospectively identify the genotype of each embryo after neutrophil 
counting, genomic DNA of each embryo was extracted and tested using the 
previously described mutation analysis (methods chapter 2 section 2.2.3.9). 
According to the digest array, WT revealed 2 bands caused by complete 
digestion, whereas homozygous mutation showed only 1 band caused by 
absolute modification of the cleavage site. Heterozygous mutation revealed 3 
bands because of partial digestion (Figure 5.9).  
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Figure 5.9: Digest array of a single embryo. (A) Gel showing MwoI digestion of PCR 
products amplified from genomic DNA of a single embryo of semaphorin3Fa mutated gene 
by TALENs. (B) Gel showing BslI digestion of PCR products amplified from genomic DNA of 
a single embryo of semaphorin3Fb mutated gene by TALENs. The uncleaved and cleaved 
PCR products are indicated.  
 
 
 
 
A 
B 
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During the recruitment phase, both semaphorin3Fa and semaphorin3Fb 
mutated embryos showed no significant difference in neutrophil numbers at 
the site of injury (semaphorin3Fa mean=26.9+0.38, semaphorin3Fb 
mean=26.2+0.34) compared to mpx:GFP control (mean=26.7+0.40) (n= 50 
performed as 4 independent experiments) (Figure 5.10A). Likewise, 
semaphorin3F mutated embryos with genotype identification revealed no 
significant changes in recruited neutrophil numbers (semaphorin3Fa WT 
mean=27.0+0.67, semaphorin3Fa het mean=27.0+0.54, semaphorin3Fa 
hom mean=26.1+0.88, semaphorin3Fb WT mean=26.3+0.90, 
semaphorin3Fb het mean=26.3+0.48, semaphorin3Fb hom 
mean=26.2+0.62) compared to control (mean=26.7+0.40) (n= 50 performed 
as 4 independent experiments) (Figure 5.10B).  
In contrast, at resolution phase, semaphorin3Fa and semaphorin3Fb 
mutated embryos showed significantly fewer neutrophil numbers at the injury 
site (semaphorin3Fa mean=9.6+0.31, semaphorin3Fb mean=9.6+0.37) 
compared to control (mean=11.1+0.34) (P<0.001, n= 50 performed as 4 
independent experiments) (Figure 5.11A).  
Subsequently, I compared the results with genotype identification. 
Semaphorin3Fa or semaphorin3Fb with WT genotype showed no significant 
difference in neutrophil numbers (semaphorin3Fa WT mean=10.7+0.52, 
semaphorin3Fb WT mean=11.1+0.71) compared to control 
(mean=11.1+0.34). Semaphorin3Fa or semaphorin3Fb with heterozygous 
mutation showed fewer neutrophil numbers at the site of injury 
(semaphorin3Fa het mean=9.8+0.47, semaphorin3Fb het mean=9.7+0.45). 
Semaphorin3Fa or semaphorin3Fb with homozygous mutation caused 
significantly decreased neutrophil numbers at the site of injury at 24 hpi 
(semaphorin3Fa hom mean=8.0+0.41, semaphorin3Fb hom mean=7.8+0.54) 
compared to control (mean=11.1+0.34) (P<0.0001, n= 50 performed as 4 
independent experiments) (Figure 5.11B). These findings give evidence that 
semaphorin3F mutant accelerates neutrophil resolution. 
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Figure 5.10: Semaphorin3F mutation induced by TALENs had no effect on neutrophil 
recruitment. Semaphorin3Fa or semaphorin3Fb mutated F1 fish were incrossed. Mpx:GFP 
was used as control. Tailfin transection was performed at 2dpf, and neutrophils counted at 6 
hpi. (A) Semaphorin3F WT, heterozygous mutation and homozygous mutation were shown 
as black, blue and red dots, respectively. (B) Identification of genotype with separate 
column. Data shown are mean + SEM. n= 50 performed as 4 independent experiments. 
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Figure 5.11: Semaphorin3F mutation induced by TALENs accelerated neutrophil 
resolution. Semaphorin3Fa or semaphorin3Fb mutated F1 fish were incrossed. Mpx:GFP 
was used as control. Tailfin transection was performed at 2dpf, and neutrophils counted at 
24 hpi. (A) Semaphorin3F WT, heterozygous mutation and homozygous mutation were 
shown as black, blue and red dots, respectively. (B) Identification of genotype with separate 
column. Data shown are mean + SEM. n= 50 performed as 4 independent experiments, 
*P<0.01, ***P<0.001. 
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To determine whether TALENs caused any effects on whole body neutrophil 
numbers, total neutrophils in each mutated embryos were counted. Both 
semaphorin3Fa and semaphorin3Fb mutated embryos showed no significant 
changes in the whole body neutrophil population compared to the controls 
(Figure 5.12). 
 
  
 
 
 
 
 
 
 
 
 
Figure 5.12: TALENs had no effect on the whole body neutrophil numbers. Whole body 
total neutrophil numbers were counted at 3dpf. n= 50 performed as 4 independent 
experiments. 
 
 
In summary, semaphorin3F mutation induced by TALENs did not affect 
neutrophil recruitment to the site of injury, but accelerated neutrophil 
resolution. Thus, semaphorin3F mutant lines replicated our observed 
morpholino phenotypes. Together, these data indicate that semaphorin3F 
plays an important role in orchestrating the persistence of neutrophils at the 
inflammatory site through the regulation of reverse migration from the wound 
site.  
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5.3 Discussion 
The zebrafish presents a powerful genetic model organism offering a diverse 
range of approaches to study human diseases. Several methods have been 
developed that enable the perturbation of a number of gene functions within 
the organism as a whole. In this chapter, I have created semaphorin3Fa and 
semaphorin3Fb mutant zebrafish lines using TALENs technology to 
investigate the role of semaphorin3F in the migratory behaviour of 
neutrophils during inflammation. Following the successful mutation of the 
semaphorin3F genes in zebrafish, the consequence on neutrophil 
recruitment and neutrophil resolution were determined, confirming the 
neutrophil phenotypes compared to the previous results of semaphorin3F 
knockdown induced by antisense morpholino injection.  
 
5.3.1 TALENs as a new tool for genome editing in zebrafish 
TALENs are one of the genome editing methods for altering specific gene 
sequences using artificially engineered nucleases. Site-specific double-
strand DNA breaks are induced at a locus of interest by these synthetic 
nucleases that increase the ability to knockout or alter the expression of that 
gene. Targeted gene function can be attenuated in zebrafish embryos by 
morpholino injections (Nasevicius and Ekker, 2000), but morpholinos 
frequently have off-target effects on zebrafish development, and may only 
interfere with gene expression transiently (Eisen and Smith, 2008). TALENs 
have been applied in a variety of organisms including yeast, flies, rat and 
plants (Li et al., 2011) (Liu et al., 2012) (Tesson et al., 2011) (Li et al., 2012). 
In addition to zinc finger nucleases (ZFNs), TALENs have been shown to 
provide an alternative genome editing method for introducing DNA mutation 
into zebrafish (Sander et al., 2011). However, TALENs offer a number of 
advantages over ZFNs. They are able to target larger gene sequences with 
higher specificities, and are easily constructed. Design tools such as 
accessible reagents and software, are freely available. TALENs can target a 
wide range of sequences by virtue of their more flexible RVD-based 
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recognition (Mussolino et al., 2011). TAL effector proteins are also readily 
stacked to recognise long sequences. In zebrafish, TALENs show a high 
success rate of active nuclease capacity, and high mutation rates leading to 
targeted gene inactivation (Moore et al., 2012). Moreover, TALENs have 
fewer off-target effects and lower toxicity than ZFNs (Mussolino et al., 2011). 
However, TALENs have the disadvantage that assembly of TAL effectors is 
complicated because of their large size and abundant repeat regions. Their 
weakness is thus the difficulty of delivery of their large and repeat-prone 
sequences.  
Although semaphorin3F knockdown demonstrates the significant phenotypes 
of neutrophilic inflammation, these findings need to be explicitly investigated. 
Gene knockdown using morpholinos requires optimisation of the injection 
dosage given the potential risk of off-target effects (Eisen and Smith, 2008). 
Thus, the effectiveness of the morpholino-based knockdown needs to be 
carefully considered. Therefore, I considered using TALENs as a tool to 
generate semaphorin3F mutation in zebrafish. 
Here, I have demonstrated that TALENs are effective at introducing double-
strand breaks resulting in mutations at the target sites. Up to 50% of 
embryos injected with RNA encoding semaphorin3Fa or semaphorin3Fb 
TALEN obtained multiple independently targeted mutations. Moreover, 
injection of semaphorin3F TALEN construct resulted in less than 30% 
mortality. The selected founders for both semaphorin3Fa and 
semaphorin3Fb were frameshift mutations, with 1bp deletions observed at 
the somatic cell level, known as indel, in that targeted gene. The mutated 
founders subsequently transmitted their mutation to 80% of their progeny 
indicating that TALENs have been successfully used to generate targeted 
mutations of semaphorin3Fa and semaphorin3Fb genes and, therefore, led 
to effective induction of heritable loss-of-function mutations in zebrafish. 
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5.3.2 Phenotype of neutrophil migration in the semaphorin3F 
mutant lines 
As shown in chapter 4, semaphorin3F knockdown causes no significant 
changes in recruited neutrophil numbers at the injury site compared to 
controls, but at the resolution phase, there are fewer neutrophil numbers at 
the site of inflammation. As a consequence, semaphorin3F knockdown 
accelerates resolution of inflammation. In order to confirm these findings, the 
numbers of neutrophils at recruitment and resolution phase at the site of 
injury in mutated zebrafish embryos generated by TALENs were assessed. 
Homozygous null fish revealed the same phenotype of semaphorin3F whole 
fish knockdown by morpholino. They facilitated inflammation resolution with a 
semaphorin3F-dependent reduction in neutrophil numbers at the site of 
injury. Although fish heterozygous for semaphorin3F displayed lower 
numbers of neutrophils at the site of inflammation, this did not reach 
statistical significance with the number of fish studied. This may be reflective 
of a partial phenotype in the heterozygous offspring. Further studies of other 
migratory behaviour of neutrophils including speed and meandering index of 
neutrophil apoptosis at the site of injury, and of movement of neutrophils 
away from the wound region will be carried out to elucidate this finding in the 
future.  
Taken together, these findings suggest that semaphorin3F mutant reduces 
the number of retained neutrophils at the wound site leading to acceleration 
of inflammation resolution. It also modulates the resolution rather than 
recruitment phase of inflammation. This phenomenon is similar to 
semaphorin3F knockdown induced by morpholinos. 
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5.3.3 Conclusions 
In conclusion, I have demonstrated that TALENs-induced mutations are 
sufficient to generate semaphorin3F gene mutation in zebrafish. Moreover, 
the TALENs-introduced mutant alleles are stably inherited by their progeny. 
Neutrophils in these semaphorin3F mutant lines display similar phenotypes 
to semaphorin3F knockdown confirming that semaphorin3F plays an 
important role in neutrophil migration during inflammation, especially in the 
resolution phase. Semaphorin3F is also a potential target for inflammatory 
disorders associated with persistence of neutrophils at the site of 
inflammation. 
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Chapter 6: Investigating potential mechanisms 
of semaphorin3F modulation of neutrophilic 
inflammation 
 
6.1 Introduction 
The previous results in chapters 3, 4 and 5 demonstrated that semaphorin3F 
expression could be modulated in response to hypoxia and pro-inflammatory 
mediators in human neutrophil culture. Semaphorin3F was markedly 
expressed in inflammatory tissues in murine acute lung injury models. In 
vivo, semaphorin3F whole fish overexpression delayed neutrophil 
recruitment and inflammation resolution, in contrast, semaphorin3F 
knockdown resulted in significantly faster neutrophil clearance from the injury 
site. Notably, semaphorin3F mutant transgenic lines induced by TALENs 
accelerated inflammation resolution, confirming the role of semaphorin3F in 
neutrophil migration during inflammation. These findings together led me to 
question the mechanisms by which neutrophil movement is regulated by 
semaphorin3F during inflammation.  
As previously mentioned, class 3 semaphorin binding to neuropilins requires 
a member of the plexin family in order to form a complex enabling the 
activation of downstream signal transduction cascades. In this complex, 
neuropilins function as the ligand-binding subunit, whereas plexins act as the 
signal-transducing subunit (Pueschel, 2002). Recently, neuropilin-2, as well 
as the plexin-A family have been identified as co-receptors of semaphorin3F 
(Negishi et al., 2005). I therefore hypothesised that co-expression of 
neuropilin-2 or plexin-As with semaphorin3F might modulate neutrophil 
responses to hypoxia or inflammation. To investigate this, I initially examined 
the protein expression of neuropilin-2, plexin A1, plexin A2 and plexin A3 in 
isolated human neutrophils in response to hypoxia and in the presence of 
pro-inflammatory cytokines (TNF-α and IL-1β). In addition, expression of 
neuropilin-1 and plexin D1 was investigated to confirm the specificity of 
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neuropilin-2 and plexin-As. Moreover, mRNA expression of neuropilin-1 and 
neuropilin-2 in murine bronchoalveolar lavage (BAL) neutrophils was 
quantified. 
Given the phenotype of delayed neutrophil recruitment and delayed 
neutrophil resolution in the context of semaphorin3F whole fish 
overexpression, I questioned a role for semaphorin3F in neutrophil 
chemotactic responses. Chemotaxis is the process by which an external-
signal gradient detected by cell-surface receptors is translated into the 
directed movement of the cell toward or away from the sources (Ridley et al., 
2003). Neutrophils migrate to inflammatory sites through this chemotaxis 
process. The directional movement of neutrophils requires the regulation of 
intracellular signalling pathways allowing neutrophils to detect a gradient of 
attractant, then polarize and migrate toward the highest concentration of the 
chemoattractant (Nuzzi et al., 2007). The source of chemoattractants 
includes bacterial products such as formylated peptides, e.g. N-formyl-
methionyl-leucyl-phenylalanine (fMLP), products of phospholipid metabolism 
such as leukotriene B4, components of the complement cascade (C5a) and 
chemokines such as IL-8, and they are detected by cell-surface receptors 
(Zachariae, 1993). In this chapter, I therefore investigated the chemotactic 
ability of isolated human neutrophils to a classical chemoattractants fMLP in 
the presence of semaphorin3F in vitro. 
Next, to gain specific insight into the mechanism of semaphorin3F regulating 
neutrophil migration to the injury site during inflammation, I sought to 
investigate the role of Phosphoinositide 3-Kinase (PI-3K) in neutrophil 
recruitment. It is well known that PI-3K is functionally important in neutrophil 
chemotaxis. Chemoattractants like fMLP or IL-8 can activate neutrophil 
receptors coupled to heterotrimeric G proteins (Puri et al., 2004). PI-3Ks in 
turn are a family of enzymes which have been identified to be downstream of 
the G-protein-coupled receptors in neutrophils that trigger signalling 
pathways to regulate neutrophil chemotaxis towards the inflamed tissue 
(Cicchetti et al., 2002). The major lipid products of the PI-3K are 
phosphatidylinositol-3-phosphate [PI(3)P],  phosphatidylinositol-3,4-
biphosphate [PI(3,4)P2] and phosphatidylinositol-3,4,5-triphosphate 
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[PI(3,4,5)P3]. [PI(3,4)P2] and [PI(3,4,5)P3] are involved in a wide variety of 
cellular processes, including cell survival, cell transformation, cell polarisation 
and re-arrangements of the actin cytoskeleton (Toker et al., 1997, Rameh et 
al., 1999). Furthermore, production of [PI(3,4,5)P3] was demonstrated in 
neutrophils stimulated with fMLP (Traynor-Kaplan et al., 1989).  
Once a chemoattractant binds to its cell surface receptor, it triggers a series 
of cytoplasmic events that result in the activation of the cytoskeletal 
machinery. As a result, neutrophils acquire a polarised morphology 
characterised by expansion of the leading-edge into a lamellipod involving 
localised actin assembly (Benard et al., 1999). Recent observation has 
shown that neutrophil polarisation is blocked by the PI-3K inhibitor 
wortmannin (Okada et al., 1994). Moreover, neutrophils from PI-3Kγ 
knockout mice are unable to produce PI(3,4,5)P3 upon stimulation resulting 
in a severe defect in chemotaxis and cell polarisation, and suggesting that 
PI-3K activity is important in cell polarity (Hirsch et al., 2000). In zebrafish, it 
has been shown that inhibition of PI-3Kγ disrupts neutrophil polarisation and 
directionality, and that zebrafish neutrophils migrate towards the wound site 
in a PI-3K-signalling-dependent manner (Yoo et al., 2010).  
To investigate the involvement of PI-3K signalling in polarity, the zebrafish 
transgenic line Tg(lyz:PHAkt-EGFP) was used, which expresses the 
Pleckstrin Homology (PH) domains of Akt/PKB (protein kinase B) fused to 
EGFP under the lyz promoter. This line expresses an in vivo sensor of 
PI(3,4,5)P3 to probe PI-3K subcellular localisation which is normally 
accumulated at the leading edge of neutrophils during chemotaxis   (Wang et 
al., 2014). In addition, translocation of PHAkt-EGFP to the plasma 
membrane can be visualised in real time, observing the activity of PI-3K to 
produce PI(3,4,5)P3. The loss of PHAkt-EGFP localisation indicates an 
inhibition of PI-3K signalling. This model provides the regulation of dynamics 
of neutrophil chemotaxis in vivo. In this chapter, Tg(lyz:PHAkt-EGFP) 
embryos were injected with semaphorin3F RNA, inducing whole fish 
semaphorin3F overexpression. Embryos were then injured at 3 dpf by tail 
transection, neutrophils were imaged, and the polarity index of each 
neutrophil was calculated. 
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Aims and hypotheses 
The aim of this chapter is to investigate the mechanisms by which 
semaphorin3F regulates neutrophil movement during inflammation. The 
expression of semaphorin3F co-receptors was examined in response to 
inflammatory mediators and by regional hypoxia. The chemotaxis of human 
neutrophils to the chemoattractant fMLP in the presence of semaphorin3F in 
vitro was also determined. Finally, PI-3K activity was investigated in the 
whole fish semaphorin3F overexpression model by dynamic study. 
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6.2 Results 
6.2.1 Neuropilin-2 and Plexin A3 expression were modulated 
by hypoxia and pro-inflammatory mediators. 
To investigate how hypoxia or pro-inflammatory mediators (TNF-α and IL-1β) 
regulate the expression of predicted receptors of semaphorin3F including 
neuropilin-1, neuropilin-2, plexin A1, plexin A2, plexin A3 and plexin D1, 
freshly isolated peripheral blood neutrophils from healthy volunteers were 
cultured in normoxic and hypoxic conditions for 4 hours. In addition, 
neutrophils were incubated in parallel in the presence or absence of TNF-α 
and IL-1β for 4 hours either in normoxia or hypoxia. Cells were lysed using 
hypotonic sonication lysis buffer, the lysates were then separated by SDA-
PAGE with 8% resolving gels, and p38-MAPK was used as a loading control. 
Neuropilin-1 has an approximate molecular weight of 103 kDa, neuropilin-2 
105 kDa, plexin A1 211 kDa, plexin A2 212 kDa, plexin A3 207 kDa, and 
plexin D1 212 kDa. Human neutrophils constitutively expressed all six of 
these co-receptor proteins. The expression of neuropilin-1 was unchanged in 
all conditions (Figure 6.1 & 6.2A), in contrast, neuropilin-2 expression was 
significantly downregulated in response to hypoxia compared to normoxia. 
Expression of neuropilin-2 was upregulated compared to unstimulated 
neutrophils when aged neutrophils were incubated with TNF-α or IL-1β 
(Figure 6.1 & 6.2B) (densitometry performed relative to p38, *P<0.05, n=3 
performed as 3 independent experiments). 
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Figure 6.1: Hypoxia and pro-inflammatory mediators (TNF-α or IL-1β) can modulate 
the expression of neuropilin 2 and plexin A3. Western blot analysis of semaphorin3F, 
neuropilin-1, neuropilin-2, Plexin A1, plexin A2, plexin A3 and plexin D1 protein in human 
neutrophils. Human peripheral blood neutrophils (PMNs) were lysed at time 0 or following 4 
hours +/- TNF-α or IL-1β culture in normoxia (N) or hypoxia (H), with p38-MAPK used as a 
loading control.  
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Figure 6.2: Hypoxia and pro-inflammatory mediators (TNF-α or IL-1β) can modulate 
the expression of neuropilin 2. (A) Densitometry performed relative to p38 of neuropilin 1 
or (B) of neuropilin 2 at time 0 or following 4 hours in normoxia and hypoxia in the presence 
or absence of TNF-α or IL-1β (n=3), P values were calculated using one-way ANOVA 
*P<0.05, **P<0.01. 
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Plexin A1 expression demonstrated no significant change between normoxia 
and hypoxia both in the presence or absence of pro-inflammatory mediators 
(Figure 6.1 & 6.3A). Likewise, hypoxic conditions did not markedly affect the 
expression of plexin A2 in human neutrophils (Figure 6.1 & 6.3B). By 
contrast, plexin A3 expression was significantly downregulated in response 
to hypoxia compared to normoxia, but this hypoxic suppression of plexin A3 
was partially rescued by co-incubation of neutrophils with TNF-α and IL-1β 
(Figure 6.1 & 6.3C). Plexin D1 was significantly unchanged by hypoxic 
conditions or TNF-α and IL-1β (Figure 6.1 & 6.3D). 
In summary, neuropilin-2 and plexin A3 expression were altered in hypoxia 
and in the presence of TNF-α or IL-1β. These studies revealed that hypoxia 
and pro-inflammatory mediators could modulate the expression of these two 
receptors. 
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Figure 6.3: Hypoxia and pro-inflammatory mediators (TNF-α or IL-1β) could modulate 
the expression of plexin A3. (A) Densitometry performed relative to p38 of plexin A1 or (B) 
of plexin A2 or (C) plexin A3 or (D) plexin D1 at time 0 or following 4 hours in normoxia and 
hypoxia in the presence or absence of TNF-α or IL-1β (n=3), P values were calculated using 
one-way ANOVA *P<0.05, **P<0.01, ***P<0.0001. 
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6.2.2 Neuropilin-1 and Neuropilin-2 expression in acute 
models of neutrophilic inflammation 
To further investigate the expression of neuropilin-1 and -2 in neutrophilic 
inflammation in vivo, an acute model of lung injury in mice was performed. 
LPS was directly instilled intratracheally inducing acute lung injury. Six hours 
after LPS, mice were recovered in environmental normoxia or hypoxia. Mice 
were sacrificed at 24 hours, lung sections were stained with neuropilin-1 or 
neuropilin-2 isotypecontrol and neuropilin-1 or neuropilin-2 antibody, 
respectively (data reproduced with permission from Dr.Sarah Walmsley). 
Both neuropilin-1 and neuropilin-2 were co-localised to neutrophils (shown as 
deep brown cells). Neuropilin-1 expression was not obviously different 
between normoxia and hypoxia. Moreover, neuropilin-1 isotype was quite 
dirty with non-specific background (Figure 6.4), whereas neuropilin-2 
appeared to be more highly induced in hypoxic acute models of neutrophilic 
inflammation. High number of neutrophils was co-detected with neuropilin-2 
(Figure 6.5) (data with permission from Dr.Sarah Walmsley). 
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Figure 6.4: Neuropilin-1 expression was unchanged in acute models of neutrophilic 
inflammation.  An acute lung injury was induced by intratracheal LPS installtion. Six hours 
after LPS, mice were recovered in environmental normoxia or hypoxia. Mice were sacrificed, 
lung sections were stained with neuropilin-1 isotype and neuropilin-1 antibody (deep purple 
staining) (data with permission from Dr.Sarah Walmsley). 
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Figure 6.5: Neuropilin-2 expression appeared to be more highly induced in hypoxic 
acute models of neutrophilic inflammation.  An acute lung injury was induced by 
intratracheal LPS installtion. Six hours after LPS, mice were recovered in environmental 
normoxia or hypoxia. Mice were sacrificed, lung sections were stained neuropilin-2 isotype 
and neuropilin-2 antibody (deep purple staining) (data with permission from Dr.Sarah 
Walmsley). 
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6.2.3 Neuropilin-2 mRNA expression was upregulated in 
murine bronchoalveolar lavage (BAL) neutrophils. 
To further investigate the expression of neuropilin-1 and neuropilin-2 in 
response to inflammation in vivo, neuropilin-1 and neuropilin-2 mRNA in 
murine bronchoalveolar lavage (BAL) neutrophils were quantified. Acute lung 
injury in mice was induced by intratracheal LPS installtion. Then, 6, 24 and 
48 hours after LPS, mice were recovered in environmental hypoxia. Mice 
were sacrificed, BAL cells were collected, and cDNA was then extracted. The 
cDNA samples of each condition were applied to TaqMan® gene expression 
assays. Beta-actin (ACTB) was selected as the endogenous control as it is 
highly expressed and expression is not altered by hypoxia (data with 
permission from Dr.Sarah Walmsley). 
Consistent with the previous finding of lung section staining, the mRNA 
expression of neuropilin-1 was unchanged in BAL neutrophils at 6, 24 and 48 
hours after LPS compared to peripheral blood neutrophils (T0). This finding 
was also consistent with the previous result of neuropilin-1 protein 
expression in human neutrophils (data normalized to beta-actin expression, 
n=4) (Figure 6.6A).  
In contrast, the expression of neuropilin-2 mRNA was significantly 
upregulated in BAL neutrophils at 6, 24 and 48 hours after LPS compared to 
peripheral blood neutrophils (T0) (data normalized to beta-actin expression, 
*P<0.05, ***P<0.001, n=4) (Figure 6.6B). These results demonstrated that 
neuropilin-2 was markedly induced in neutrophilic inflammation at an mRNA 
level (data with permission from Dr.Sarah Walmsley). 
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Figure 6.6: Neuropilin-2 mRNA expression was upregulated in murine 
bronchoalveolar lavage (BAL) neutrophils. Fold change in expression of (A) neuropilin-1 
or (B) neuropilin-2 following acute lung injury with LPS. Mice were recovered for 6, 24 and 
48 hours in hypoxia. BAL neutrophils were then collect, and cDNA was extracted. TaqMan 
analysis of cDNA was performed with data normalized to beta-actin (ACTB) expression. 
Data show mean and SEM of fold change compared to peripheral blood neutrophils (T0), 
n=4, analysed by ANOVA, *P<0.05, ***P<0.0001 (data with permission from Dr.Sarah 
Walmsley). 
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6.2.4 Semaphorin3F inhibited neutrophil chemotaxis to the 
chemoattractant fMLP. 
To dissect the mechanism by which semaphorin3F regulates neutrophil 
movement, we planned a parallel experiment in human peripheral blood 
neutrophils. We first sought to characterise neutrophil chemotactic responses 
in the presence of exogenous semaphorin3F. To address this question, 
freshly isolated peripheral blood neutrophils from healthy volunteers were 
treated with recombinant semaphorin3F, and the chemotactic behaviour of 
neutrophils to fMLP was determined by chemotaxis assay using modified 
Boyden chambers (Boyden, 1962). Neutrophils were placed in the presence 
of semaphorin3F (10 nM or 100 nM) (Atwal et al., 2003) into the upper 
chamber, while fMLP (10 nM or 100 nM) was put into the lower chamber. 
Neutrophils were allowed to migrate through the pores of membrane from the 
upper into the lower chamber. After incubation for 1 hour at 37o C, the 
number of neutrophils that had migrated to the lower chamber was counted 
using a haemocytometer.  In addition, to test whether semaphorin3F is itself 
a chemoattractant, neutrophils were placed into the upper chamber without 
semaphorin3F, and the chemotactic effect of semaphorin3F in the lower 
chamber was evaluated. Migratory behaviours of neutrophils to media and 
fMLP were used as controls. Moreover, fMLP or semaphorin3F 
chemokinesis randomly directed or non-directional neutrophil migration, was 
used as negative control (data with permission from Dr.Sarah Walmsley). 
Incubation of human neutrophils with semaphorin3F demonstrated 
significantly fewer neutrophils migrated toward the chemoattractant fMLP in 
the lower chamber compared to neutrophils without semaphorin3F (*P<0.05, 
**P<0.001, ***P<0.0001, n=3). The number of neutrophils migrated to 
semaphorin3F was unchanged compared to media, fMLP chemokinesis and 
semaphorin3F chemokinesis negative control, but was significantly fewer 
than fMLP positive controls (***P<0.0001, n=3) (Figure 6.7). These results 
indicated that semaphorin3F inhibited neutrophil chemotaxis to fMLP. 
Semaphorin3F itself was unable to induce neutrophil chemotaxis (data with 
permission from Dr.Sarah Walmsley). 
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Figure 6.7: Semaphorin3F inhibited neutrophil chemotaxis to a chemoattractant fMLP. 
A graph to show the percentage of neutrophils undergoing chemotaxis demonstrating 
modulation of chemoattraction to fMLP by semaphorin3F. Isolated peripheral blood 
neutrophils from healthy volunteers were treated with recombinant semaphorin3F, and the 
chemotactic behaviour of neutrophils to fMLP was determined by chemotaxis assay using 
Boyden chambers (Boyden, 1962). Neutrophils were placed in the presence or absence of 
semaphorin3F (10 nM or 100 nM) in the upper chamber, while fMLP (10 nM or 100 nM) was 
put into the lower chamber. Neutrophils were allowed to migrate through the pores of 
membrane from the upper into the lower chamber. After incubation for 1 hour at 37
o
 C, the 
number of neutrophils that had migrated to the lower chamber was counted using a 
haemocytometer. Semaphorin3F inhibited neutrophil chemotaxis to fMLP. Semaphorin3F 
itself was not a chemoattractant. Data show mean and SEM, n=3, analysed by ANOVA, 
*P<0.05, **P<0.001, ***P<0.0001 (data with permission from Dr.Sarah Walmsley). 
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6.2.5 Semaphorin3F overexpression had no effect on PI-3K 
activity and neutrophil polarisation. 
On the basis of previous findings showing semaphorin3F inhibited neutrophil 
chemotaxis, I subsequently extended my study into PI-3K signalling and 
neutrophil polarisation. In order to investigate the effect of semaphorin3F on 
neutrophil migration towards the wound site and on dynamic PI-3K-
signalling, the zebrafish transgenic line Tg(lyz:PHAkt-EGFP) (obtained 
through collaboration with Dr.Xingang Wang and Professor Philip Ingham 
(IMCB, Singapore)) was used. Semaphorin3Fa or semaphorin3Fb RNA was 
injected into 1-cell stage embryos of lyz/PHAkt lineage to induce 
semaphorin3F whole fish overexpression. Tail transection was performed at 
3 dpf, and embryos were then mounted in agarose. Neutrophils in the region 
between the site of injury and the posterior blood island were individually 
imaged on an UltraVIEWVoX spinning disk confocal imaging system with an 
inverted Olympus IX81 microscope at 60x magnification. Non-injected 
lyz/PHAkt embryos were used as controls.  
To quantify the polarity index from the images, the difference in EGFP 
intensity at the leading edge of the cell compared to the trailing edge and 
compared to the fluorescence within the cell was analysed using ImageJ. 
The word ‘polarity’ in this analysis means localised accumulation of PHAkt-
EGFP with PI(3,4,5)P3 at the leading edge. In this, using the straight-line 
tool, a transecting line was drawn through each cell from the trailing edge 
towards the leading edge. A plot profile was generated to measure the 
fluorescence intensity per pixel along the length of the line. Using Microsoft 
Excel, the mean intensity values for each parameter (more detail in section 
2.2.3.10) were entered into the equation: 
 
Polarity index = (log10 a / b) x [(a + b) / c] 
where a = trailing edge of cell; b = leading edge of cell; c = whole cell 
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Neutrophils with semaphorin3Fa or semaphorin3Fb overexpression 
displayed PHAkt-EGFP localisation at the cell membrane, and had a defined 
leading edge. This localisation was equivalent to the PHAkt-EGFP signal 
observed in non-injected controls. Plot profile of the fluorescence intensity 
from the trailing edge towards the leading edge of semaphorin3Fa or 
semaphorin3Fb overexpression as well as the control demonstrated a similar 
pattern (Figure 6.8). Using the polarity index equation, neutrophils of 
semaphorin3F overexpression showed no significant difference in polarity 
index (semaphorin3Fa mean = 0.0412 + 0.013, semaphorin3Fb mean = 
0.0416 + 0.0097) compared to control (mean = 0.0428 + 0.0118) (n=9, 1 
independent experiment) (Figure 6.9).  
Interestingly, although the polarity index of all conditions was not altered, 
neutrophil shape was obviously different. Neutrophils of control fish displayed 
stretched body with pseudopodia, whereas most neutrophils of 
semaphorin3Fa or semaphorin3Fb overexpressing fish were round or oval 
(Figure 6.10).  
Subsequently, I quantified neutrophil roundness using the ‘analyse’ function 
of imageJ (Yoo et al., 2012). In this, a freehand line was drawn around each 
cell, and the roundness of each neutrophil was quantified by ‘measure’ of the 
analyse function.  
                                   
                                  Roundness = 4 x [Area] /   x [Major axis] 2 
 
    The value is between 0 and 1, which 0 is a line segment, and 1 is actually a circle. 
 
Semaphorin3Fa or semaphorin3Fb overexpression was associated with 
rounder neutrophils than the non-injected controls (semaphorin3Fa mean = 
0.743 + 0.043, semaphorin3Fb mean = 0.762 + 0.061, control mean = 0.446 
+ 0.039) (***P<0.0001, n=9, 1 independent experiment) (Figure 6.10). These 
results suggested that semaphorin3F overexpression had no effect on PI-3K 
activity and neutrophil polarisation, but might affect neutrophil shape during 
inflammation. 
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Figure 6.8: Semaphorin3F whole fish overexpression showed no significant difference 
in neutrophil polarity index in Tg(lyz:PHAkt-EGFP) embryos. Semaphorin3Fa or 
semaphorin3Fb RNA (50ng/μl) was injected into 1-cell stage Tg(lyz:PHAkt-EGFP) embryos. 
In addition, lyz:PHAkt-EGFP embryos without injection were used as control. Tailfin 
transection was performed at 3 dpf, and embryos were imaged as described previously. A 
representative recruited neutrophil of (A) control or (B) semaphorin3Fa overexpression or 
(C) semaphorin3Fb overexpression with straight-line tool as illustrated in yellow line is 
matched to a representative intensity plot.  
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Figure 6.9: Semaphorin3F whole fish overexpression showed no significant difference 
in neutrophil polarity index in Tg(lyz:PHAkt-EGFP) embryos. Semaphorin3Fa or 
semaphorin3Fb RNA (50ng/μl) was injected into 1-cell stage Tg(lyz:PHAkt-EGFP) embryos. 
In addition, lyz:PHAkt-EGFP embryos without injection were used as control. Tailfin 
transection was performed at 3 dpf, and embryos were imaged as described previously. 
Polarity index of each neutrophil was calculated. Data shown are mean + SEM. n= 9 
performed as 1 independent experiment.  
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Figure 6.10: Semaphorin3F whole fish overexpression induced a more round 
morphology of recruited neutrophils in Tg(lyz:PHAkt-EGFP) embryos. Semaphorin3Fa 
or semaphorin3Fb RNA (50ng/μl) was injected into 1-cell stage Tg(lyz:PHAkt-EGFP) 
embryos. In addition, lyz:PHAkt-EGFP embryos without injection were used as control. 
Tailfin transection was performed at 3 dpf, and embryos were imaged as described 
previously. Neutrophil roundness of each neutrophil was calculated. Data shown are mean + 
SEM. n= 9 performed as 1 independent experiment, ***P<0.0001.  
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6.3 Discussion 
Whilst a role for semaphorin3F in tumour progression has begun to emerge, 
the function of semaphorin3F in the immune system remains largely 
unknown. Here I explored for the first time the role of semaphorin3F in 
neutrophilic inflammation. In this chapter, I have investigated the mechanism 
of semaphorin3F regulation of neutrophil migration. Characterisation of 
semaphorin3F receptors, neutrophil chemotactic responses, and PI-3K-
triggered polarisation are then determined. 
 
6.3.1 Receptors of semaphorin3F in regulating neutrophil 
migration during inflammation 
Neuropilin-1 and neuropilin-2 are receptors for axon guidance factors 
belonging to the class 3 semaphorins. Most of these semaphorins bind to 
one or to both of the neuropilin family exhibiting different binding-specificities 
(Kolodkin et al., 1997). Neuropilin-1 was initially identified as a 
semaphorin3A receptor (He and Tessier-Lavigne, 1997), whereas neuropilin-
2 was originally characterised as a receptor for semaphorin3C and 
semaphorin3F (Kolodkin et al., 1997). In addition, neuropilin-2 is a receptor 
of VEGF165, and binds semaphorin3F and VEGF with similar affinities in a 
competitive manner (Geretti et al., 2007). 
Interestingly, experiments with hypoxia have revealed conflicting results 
regarding neuropilin-2 expression in different cell types. Hypoxia leads to 
decreased expression of neuropilin-2 in glioblastoma and melanoma cells at 
both transcriptional and translational level (Coma et al., 2011), whereas 
neuropilin-2 expression is maintained in human umbilical vein endothelial 
cells (HUVECs) (Bae et al., 2008) and in human pulmonary microvascular 
endothelial cells (Blythe et al., 2012) under hypoxic conditions, and is in 
contrast downregulated in murine hepatoma cells in response to hypoxia 
(Raskopf et al., 2012). However, in inflammatory tissues such as rheumatoid 
synovium, neuropilin-2 is markedly increased (Fassold et al., 2009), as it is in 
chronic bladder inflammation (Saban et al., 2010). In this study, I observe 
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that neuropilin-2 protein is downregulated in response to hypoxia in 
peripheral blood neutrophils, but this can be rescued by co-stimulation with 
TNF-α or IL-1β. Moreover, neuropilin-2 mRNA and protein are significantly 
upregulated in murine BAL and tissue recruited neutrophils respectively, 
suggesting that neuropilin-2 is regulated by additional factors released in the 
inflammatory microenvironment.  In contrast, neuropilin-1 expression is 
unchanged both at mRNA and protein level.  
Neuropilins have short intracellular domains and are thus through to act as 
independent signalling receptors. Several studies demonstrate that the class 
3 semaphorin signals are transduced by plexins, with neuropilins functioning 
as high-affinity binding receptors (Takahashi et al., 1999). Current studies in 
neurons suggest that neuropilin-2/plexin A3 complexes mediate responses to 
semaphorin3F (Cheng et al., 2001) (Yaron et al., 2005). Other research 
groups have shown that plexin A3 and semaphorin3F have a similar 
expression pattern. For instance, a significant decreased expression of 
plexin A3 and semaphorin3F was observed in human ovarian cancer cells 
(Capparuccia and Tamagnone, 2009), in human breast neoplasia (Staton et 
al., 2011) and in endometrial carcinomas (Nguyen et al., 2011). Here, I found 
that only plexin A3 expression is decreased in response to hypoxia, but 
upregulated in response to inflammatory cytokines, displaying the same 
pattern as the expression of semaphorin3F, and of neuropilin-2 as well. By 
contrast, other class A plexins, plexin A1and plexin A2, and another control 
plexin, plexin D1, are not altered in all conditions. This led me to postulate 
that neuropilin-2 and plexin A3 may represent the critical receptors for 
semaphorin3F in inflammatory neutrophils. 
Given that semaphorin3F affects neutrophil migration during inflammation, I 
hypothesise that semaphorin3F triggers signalling through neuropilin-2/plexin 
A3 complexes regulating neutrophil motility. To support this, other groups 
have shown the ability of this combination to regulate cell migration. Specific 
binding of semaphorin3F and its ligand, neuropilin-2, can inhibit VEGF-A and 
VEGF-C-induced endothelial cell migration (Favier et al., 2006). Tumour 
studies also suggest that semaphorin3F directly inhibits cancer cell migration 
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by reducing the level of integrin αvβ3, a key mediator of cell motility, through 
a neuropilin-2 dependent pathway (Wu et al., 2011).  
Furthermore, semaphorin3F mediates sympathetic neuron migration during 
development in mice (Waimey et al., 2008), and oligodendrocyte precursor 
cell migration (Xiang et al., 2012) through plexin A3. Although no direct 
evidence has been shown that semaphorin3F acts via binding of neuropilin-2 
and plexin A3 in modulating cell migration in the immune system, their similar 
expression pattern and their increased expression depending on 
inflammatory stimuli convince us that thisis very probable. 
 
6.3.2 Semaphorin3F regulated chemotactic signalling 
pathway 
In vivo, neutrophils navigate effectively through tissue microenvironments 
towards a chemoattractant source (Ridley et al., 2003). Here, we provided an 
in vitro experiment using Boyden chambers to investigate the chemotactic 
behaviour of neutrophils to fMLP in the presence of exogenous 
semaphorin3F. We found that semaphorin3F inhibits neutrophil chemotaxis 
to fMLP. Moreover, semaphorin3F itself is not chemoattractive. Conversely, 
other class 3 semaphorins have been reported to act as chemoattractants, 
for instance, semaphorin3A is a chemoattractant for cortical apical dendrites 
during neuron development (Polleux et al., 2000). The inhibition of neutrophil 
chemotaxis by semaphorin3F led me to further investigate the cellular 
mechanisms behind this response. 
During chemotaxis, directional migration of neutrophils requires cell 
polarisation, resulting in formation of a leading edge characterised by actin-
rich lamella and a tail-like uropod (Ciccahetti et al., 2002). Studies on the 
mechanism of chemotaxis have shown that PI-3K activity regulates the 
establishment of cell polarity (Stephens et al., 2002). PI3Kγ have been 
identified to be downstream of the βγ complex of G-protein-coupled 
receptors (GPCRs), which is released after stimulation by chemoattractants 
(Gerard and Gerard, 1994). Gβγ proteins activate their downstream 
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effectors, including PI3Kγ, guanosine triphosphatases of the Rho family (Rho 
GTPases), protein kinase C, cytosolic phospholipase A2 (cPLA2), and 
cytosolic tyrosine kinases. Inactivation of Gβγ proteins or inhibition of those 
downstream effectors causes defects of neutrophil motility in response to 
chemoattractants (Weiner et al., 2000). Studies of PI3Kγ signalling have 
reported that inhibition of PI3Kγ activities results in impairment of leading 
edge formation and suppression of neutrophil chemotaxis (Hirsch et al., 
2000). Furthermore, localised accumulation of PI(3,4,5,)P3, a major lipid 
product of PI3K, is a key event directing the activation of signalling 
components required for cell polarity and chemotaxis (Orlando and Guo, 
2009). In this study, lyz/PHAkt zebrafish embryos were used to determine 
the localisation of PHAkt-EGFP observed in neutrophils during recruitment to 
the wound site. Akt binds directly to PI(3,4,5,)P3 at the membrane through its 
PH domain. Trafficking of PHAkt-EGFP to the neutrophil membrane is thus 
dependent on the amount of PI(3,4,5,)P3 which also refers to PI-3K activity. 
Although semaphorin3F inhibits neutrophil chemotaxis in vitro, it shows no 
significant effect on PI-3K activity. The localised accumulation of PHAkt-
EGFP at the membrane between fish with semaphorin3F overexpression 
and control fish is similar. They all also have a defined leading edge, and 
reveal the same polarity suggesting that semaphorin3F does not affect 
signalling either directly on or upstream of PI-3K involve in neutrophil 
polarisation. I hypothesise that semaphorin3F might be implicated in 
activities of other Gβγ downstream effectors such as Rho GTPases, protein 
kinase C, or cytosolic tyrosine kinases that could be further elucidated in the 
future. Moreover, besides PI-3K, the establishment of PI(3,4,5)P3 gradients in 
neutrophils is regulated by the phosphatase with tensin homology (PTEN) 
and the Src homology2-containing inositol phosphatase (SHIP). PTEN 
dephosphorylates PI(3,4,5)P3 into PI(4,5)P2, thereby switching off PI3-K/Akt 
signalling (Cantley and Neel, 1999). SHIP hydrolyses the 5’ phosphatase of 
the inositol ring from PI(3,4,5)P3 to PI(3,4)P2 (. Both enzymes are important 
regulators of phosphoinositide pools and also thought to be important in 
establishing polarity in signalling (Leslie et al., 2008). 
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Interestingly, the observed neutrophil shape of semaphorin3F 
overexpression is obviously different from the control. Neutrophils of the 
control display stretched bodies with pseudopodia, whereas most neutrophils 
of semaphorin3F overexpressing fish are round or oval. One possible 
explanation is the activity of small GTPases of the Rho subfamily which have 
been reported to act as active regulators of cell shape change and also 
motility (Hall and Nobes, 2000). Besides being downstream effector of Gβγ 
proteins, Rho GTPases are also downstream targets of PI-3K that are 
activated by PI(3,4,5,)P3 accumulation (Benard et al., 1999). The spatially 
distinct activation of different members of the small GTPases of the Rho 
subfamily reveals specific functional responses within the cytoskeleton. For 
instance, RhoA plays a role in the regulation of cell shape and polarity 
through actin polymerisation and actomyosin contractility (Wheeler and 
Ridley, 2004). Activated Rac triggers extension of lamellipodia containing 
arborized actin polymers, and stimulation of actin polymerisation, whereas 
Cdc42 activation induces fine finger-like protrusions formed by actin 
filaments called filopodia, and also activates Rac (Nobes and Hall, 1995). 
Notably, studies using differentiated HL60 (dHL-60) cells, a neutrophil-like 
cell line, have shown that fMLP induces polarisation and cell migration by 
triggering ‘frontness’ and ‘backness’ of the cells. The frontness is 
characterised by a protruding pseudopod composed of actively polymerising 
F-actin mediated by a trimeric G protein, which has positive feedback loops 
to PI(3,4,5,)P3 and Rac (Weiner et al., 2002). In contrast, the backness is 
characterised by a rounded shape induced by contracting actomyosin 
complexes, which are stimulated by RhoA, Rho-dependent kinase and 
myosin II (Xu et al., 2003). In polarised cells, Rac-dependent frontness 
constrains backness to the trailing edge, whereas RhoA-dependent 
backness confines frontness to pseudopods. Furthermore, frontness and 
backness have an ability to inhibit one another (Wong et al., 2006). 
Consistently, studies of epithelia shape demonstrate that a balance of RhoA- 
and Rac-activities is critical for control of cell shape. RhoA mutant cells 
display longer and less apically constricted cells than control, whereas Rac1 
deficient cells are shorter and more apically restricted (Chauhan et al., 2011). 
This led me to hypothesis that semaphorin3F might excessively stimulate the 
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RhoA-activity or inhibit the Rac-activity. Thus, neutrophils of semaphorin3F 
overexpression form rounded shape during chemotaxis, and as a 
consequence, the migratory ability of neutrophils is inhibited compared to 
controls.  
 
6.3.3 Conclusions 
In conclusion, I have identified the probable receptors of semaphorin3F in 
regulating neutrophilic inflammation, namely neuropilin-2 and plexin A3. 
Furthermore, the mechanism of semaphorin3F modulation of neutrophil 
chemotaxis was investigated. I demonstrated that semaphorin3F inhibits 
neutrophil chemotaxis to chemoattractants. However, semaphorin3F does 
not affect the chemotaxis-downstream PI-3K activity controlling cell 
polarisation. Semaphorin3F appears to be implicated in neutrophil shape 
change during directed migration, which may be affected by members of Rho 
GTPases families. 
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Chapter 7: Final discussion and future work 
In response to injury or infection, neutrophils migrate to the site of infection or 
to eliminate potentially injurious stimuli. A critical active process following the 
elimination of invading pathogens is resolution of inflammation. This requires 
removal of neutrophils from inflamed sites, since they themselves can 
release their own injurious contents. Inflammation resolution therefore 
contributes to the prevention of propagation of host tissue damage caused 
by release of oxidants and proteinases from persistent neutrophilic activity 
that leads to pathology of many chronic inflammatory diseases. In recent 
years, much research has focussed on the regulation of neutrophilic 
inflammation, especially mechanisms involved in resolution of inflammation. 
Semaphorins, originally identified as axon guidance factors functioning in the 
nervous system, have recently emerged as regulators of the immune system. 
These semaphorins play critical roles in various phases of immune 
responses such as B-or T-cell activation, T-cell differentiation, T-cell-
macrophage interaction, and in the functional activity of macrophages 
(Takamatsu et al., 2010) (Casazza et al., 2013). At inflamed sites, 
neutrophils are functionally regulated by hypoxia-inducible transcription 
factors (HIFs) and their hydroxylation by the prolyl hydroxylase (PHDs) 
(Thompson et al., 2013). Interestingly, our group has found that 
semaphorin3F is significantly induced in PHD3-deficient neutrophils following 
hypoxic stimulation (Walmsley et al., 2011). This led me to question whether 
semaphorin3F is involved in regulating neutrophil functions in inflammation. 
To address this, investigation of semaphorin3F expression in human 
neutrophils and in vivo experiments were carried out. Most of experiments in 
this study were performed in the zebrafish because it is an ideal alternative 
model for the study of vertebrate innate immune responses in vivo, 
especially neutrophil behaviour during inflammation (Renshaw et al., 2006). 
This model effectively enables the visualisation and tracking of neutrophils in 
real-time to investigate the role of semaphorin3F in parallel with experiments 
in human cells and in mouse models. Moreover, genome editing techniques 
for altering specific gene sequences such as morpholino-based knockdown 
and Transcription Activator-Like Effector Nucleases (TALENs)-induced 
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mutation, are reliable and easily applied to the zebrafish models. However, 
for microinjections, it’s difficult to quantify how much the injected message is 
diluted or degraded by cell division, and how reproducible this effect is 
between different microinjections. At least, phenotypic changes e.g. in 
neutrophil counts at recruitment and resolution phase or shape of injected 
embryos (such as curly tail of morpholino-injected embryos). 
 
7.1 Is semaphorin3F involved in neutrophil function in 
inflammation? 
As previously mentioned, the hypoxic PHD3-deficient neutrophils have 
increased levels of semaphorin3F transcript (Walmsley et al., 2011). This 
evidence persuaded me of a correlation between neutrophil function and 
semaphorin3F expression during inflammation.  Although semaphorin3F has 
only been reported to be involved in nervous system and tumour 
progression, other class 3 semaphorins, such as semaphorin3A affect cells 
of the myeloid lineage, especially macrophages. Semaphorin3A/neuropilin-1 
signalling enhances tumour-associated macrophage recruitment to hypoxic 
tumour areas. However, semaphorin3A can interact with macrophages in the 
absence of neuropilin-1. This action of semaphorin3A can antogonise VEGF-
induced attraction (Casazza et al., 2013). Thus, it is interesting to further 
investigate the expression of semaphorin3F in neutrophils in various 
conditions. As suggested by the PHD3 study, semaphorin3F expression is 
altered by inflammatory culture conditions, both at transcriptional and 
translational levels in human neutrophils. In response to hypoxia, 
semaphorin3F exhibits the opposite expression to VEGF, a known HIF target 
gene and regulator of neutrophil function (Taichman et al., 1997) (Gong and 
Koh, 2010). Semaphorin3F mRNA expression in iflammed neutrophils is 
significantly upregulated compared to peripheral blood neutrophils. The 
hypoxia-downregulation of semaphorin3F in peripheral blood neutrophils is 
also in contrast to the significant induction of semaphroin3F in inflammation 
and suggests that semaphorin3F is strongly regulated by the activity of 
additional factors released in the inflammatory microenvironment. All findings 
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support that semaphorin3F expression in inflamed neutrophils is obviously 
different to that in peripheral blood neutrophils. Although it’s difficult to 
interpret the results of zebrafish linking to those of human according to 
unknown cellular sources of semaphorin3F in zebrafish, semaphorin3F is 
thought to play a crucial role in regulating neutrophil function during 
inflammation. The effect of exogenous semaphorin3F on neutrophil 
chemotaxis, and the consistent convincing upregulation of semaphorin3F in 
inflamed tissues in mouse lung section and in zebrafish support my 
hypothesis. Furthermore, I found that semaphorin3F receptor components, 
neuropilin-2 and plexin A3, have a similar expression profile, raising the 
possibility that semaphorin3F may act in an autocrine fashion on neutrophils 
during inflammation.  
 
7.2 Novel role of semaphorin3F in neutrophil migration 
during inflammation 
Semaphorin3F has been recently found to be involved in regulating cell 
migration of a variety of cell types, including neural cells, endothelial cells, 
and tumour cells (Gammill et al., 2007) (Coma et al., 2011) (Xiang et al., 
2012). Here, I demonstrate for the first time the role of semaphorin3F in 
regulating neutrophil migration in inflammation. As shown by overexpression 
and by knockdown both by morpholino suppression and TALENs-generated 
mutation, semaphorin3F affects not only neutrophil migration to the site of 
injury, but also the reverse migration from the inflamed site. This suggested 
that semaphorin3F affects neutrophil chemotaxis, the key process governing 
neutrophil migration during inflammation. Chemotactic cells are 
characterised by three abilities, namely direction sensing, polarisation, and 
motility (Swaney et al., 2010). I found that semaphorin3F has effects only on 
speed, not direction of neutrophils suggesting that neutrophil directional 
sensing is not affected by semaphorin3F, but that cell motility is impaired. 
Consistent with this, I found that the polarisation of neutrophils, as indicated 
by the localisation of PI-3K to the leading edge during migration, is not 
affected by semaphorin3F. By contrast, neutrophil shape is obviously 
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different when semaphorin3F is overexpressed. Neutrophils of the control 
fish displayed stretched bodies with pseudopodia, whereas when 
semaphorin3F was overexpressed, most neutrophils were round or oval. Cell 
motility occurs through random extension of pseudopodia driven through the 
cytoskeleton (Chung et al., 2000). Therefore, the finding that semaphorin3F-
affected neutrophil shape and motility raises the possibility that 
semaphorin3F may be associated with cytoskeleton directly or via related 
signalling pathways.  
This is consistent with a plethora of studies of the effects of class 3 
semaphorins on neuron growth cones, most particularly of semaphorin3A, 
that demonstrate their ability to disassemble the actin cytoskeleton (Fan et 
al., 1993) (Mann et al., 2007). More recently, semaphorin3F has been shown 
to have similar effects on the actin cytoskeleton of endothelial and tumour 
cells (Nasarre et al., 2003) (Bielenberg and Klangsbrun, 2007). 
Studies of tumour cell migration have demonstrated that semaphorin3F 
inhibits cell migration by inactivating RhoA, followed by inactivation of Rho 
kinase. As a result, F-actin cytoskeleton depolymerisation is stimulated. 
Moreover, semaphorin3F inactivates small GTPase Rac1, so that 
lamellipodia formation at the cell leading edge is disrupted. The migration 
and contractility of this cell are then inhibited (Shimizu et al., 2008). 
Therefore, it is possible that semaphorin3F affects RhoA-activity or Rac-
activity in neutrophils. As a consequence, semaphorin3F can regulate 
migratory behaviour of neutrophils during inflammation. 
 
7.3 Is semaphorin3F expression associated with resolution of 
inflammation? 
The clearance of neutrophils from inflamed sites is necessary for successful 
resolution of inflammation. Besides neutrophil apoptosis at the site of 
inflammation, neutrophil reverse migration away from the wound is an 
alternative important mechanism of neutrophil clearance. The work 
presented here has demonstrated that semaphorin3F does not affect rates of 
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neutrophil apoptosis at the site of injury, whereas it has considerable 
influence on neutrophil reverse migration. Although semaphorin3F 
overexpression affected both recruitment and resolution, the loss of function 
experiments specifically affected the clearance of neutrophils from the injury 
site, accelerating reverse migration. Coupled with the fact that semaphorin3F 
overexpression resulted in persistence of neutrophils at the site of 
inflammation, and that semaphorin3F expression in human neutrophils 
appears to be modulated antagonistically by hypoxia and inflammatory 
cytokines, this is consistent with the idea that modulation of semaphorin3F 
signalling during inflammation may govern the persistence of neutrophils at 
the injury site. One possibility is that as neutrophils arrive at the injury site, 
their movement is slowed by upregulation of semaphorin3F, causing them to 
‘pause’ where the inflammation is greatest. However, increased hypoxia may 
have the opposite effect, downregulating semaphorin3F expression and 
initiating resolution. Unfortunately, according to limited availability of the 
reverse migration assay, speed and meandering index of neutrophils during 
the resolution phase could not be quantified. Volocity® sorfware of this assay 
can only calculate the numbers of neutrophils reverse migrating from the site 
of injury into a defined distal region. For further study of the effects of 
semaphorin3F on migratory behaviour of neutrophils in that phase, additional 
experiments have to be investigated. 
Moreover, the use of zebrafish to study the effect of semaphorin3F in 
regulating neutrophil migration is possibly limited. Most of neutrophils have 
been reported to migrate away from sites of inflammation through the tissues 
rather than true “reverse migration” and return to the blood vessels 
(Robertson et al., 2014). This is distinct from mammalian systems, in which 
neutrophils have a return migration to the vasculature (Woodfin et al., 2011). 
Therefore, despite our finding that semaphorin3F is involved in both 
zebrafish and mammal, it is possible that some details of the molecular 
mechanisms or signalling pathways regulating this process in zebrafish may 
be different from those in mammalian systems. Thus, the effect of 
semaphorin3F on neutrophil reverse migration has to be further investigated 
in mammalian models of inflammation. 
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7.4 Is semaphorin3F a possible therapeutic target in chronic 
inflammatory diseases? 
Unresolved neutrophilic inflammation often leads to a wide variety of 
inflammatory diseases. Persistently activated neutrophils release excessively 
cytotoxic molecules such as proteinases, and reactive oxygen species 
(ROS). Uncontrolled or impaired neutrophil activation can also leads to 
persisting tissue damage from these cytotoxic molecules. An ideal drug to 
treat inflammatory diseases should be able to reduce inflammatory 
responses or activate resolution of inflammation. Currently, most of the anti-
inflammatory therapies target key inflammatory responses controlling 
infiltration of neutrophils into the site of inflammation, such as use of 
chemokine receptor CXCR2 inhibitors reducing neutrophil recruitment during 
acute and chronic inflammatory responses (Goncavalves and Appelberg, 
2002) (Donnelly and Barnes, 2011), or use of laser therapy inhibiting 
inflammatory mediator (TNF-α, IL-1β and IL-6) expression during 
inflammation (Alves et al., 2013). However, these do not effectively reduce 
permanent inflammation, because different microenvironments composed of 
tissue-specific cell types can themselves activate inflammatory responses. 
For instance, some cell types such as fibroblasts play an important role in the 
switch from acute resolving to chronic persistent inflammation. Fibroblasts 
can provide survival and retention signals for neutrophils, leading to their 
persistent accumulation within inflamed sites (Buckley et al., 2001). More 
recently, attention has turned to inflammatory disease treatments that target 
the resolution phase and anti-inflammatory mechanisms that lead to the 
return of homeostasis. Particular emphasis has been placed on drugs that 
might accelerate resolution by enhancing neutrophil apoptosis (Burgon et al., 
2014). Treatment promoting neutrophil clearance from the site of injury by 
neutrophil reverse migration may also become an alternative solution for 
chronic inflammatory diseases (Robertson et al., 2014).  
Semaphorin3F has been shown to affect neutrophil migration during 
inflammation. Loss of semaphorin3F can accelerate inflammation resolution 
by enhancing neutrophil reverse migration from the inflamed site. 
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Semaphorin3F therefore would be a potential therapeutic target for 
inflammatory diseases caused by persistent neutrophilia. However, 
semaphorin3F has also been reported to be a tumour suppressor 
(Bielenberg et al., 2004) (Kusy et al., 2005) (Nasarra et al., 2005) (Futamura 
et al., 2007) (Guttmann-Raviv et al., 2007). Use of semaphorin3F 
antagonists as drugs for inflammatory conditions therefore must be carefully 
considered in light of its potential effect on tumour progression. 
 
7.5 Future work 
Further work determining in vivo whether neuropilin-2 and plexin A3 are 
important receptor components of semaphorin3F, expression of plexin A3 in 
lung sections of acute neutrophilic inflammation, as well as in murine 
bronchoalveolar lavage neutrophils should be performed. Moreover, 
TALENs-generated neuropilin-2 or plexin A3 mutation in zebrafish may 
enable dissection of the mechanism of semaphorin3F regulating neutrophil 
migration. In this study, one could demonstrate only the action of exogenous 
semaphorin3F in modulating neutrophil persistence at the site of 
inflammation as contrasted to whole fish in which overexpression or 
knockdown/knockout of semaphroin3F was generated. To specifically define 
the function of neutrophil-derived semaphorin3F, neutrophil-specific 
semaphorin3F overexpression or knockdown zebrafish lines are an 
alternative future approach. Nonetheless, the molecular mechanisms or 
signalling pathways regulating neutrophil reverse migration in zebrafish may 
be different from those in mammalian systems. Thus, the effect of 
semaphorin3F on neutrophil reverse migration has to be further investigated 
in mammalian models of inflammation.  
As thought that semaphorin3F plays a role in neutrophil function at inflamed 
tissues, semaphorin3F expression in chronic inflammatory tissues such as 
samples of COPD patients would be important for the further work. It will also 
be important to discover those mechanisms involved in neutrophil 
chemotaxis which are affected by semaphorin3F, perhaps factors involved in 
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RhoA- and Rac-activity or the cytoskeleton such as RhoA kinase (ROCK), 
cofilin, STAT3, actin, myosin, or microtubule, to determine whether 
semaphorin3F is associated with or affects their functions. Class 3 
semaphorins have been suggested to modulate cell adhesion, notably 
through effects on integrins and their trafficking (Zhou et al., 2008), but also 
on other adhesion systems, for example cadherins (Nasarre et al., 2005), all 
of which are likely to have a role in neutrophil migration. Discovering which of 
these mechanisms is critical to the effects we see, should provide further 
insight into the mechanisms regulating neutrophil migration. This research is 
currently underway. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
205 
 
7.6 Thesis summary 
To summarise, in this thesis I have discovered a novel role of semaphorin3F 
in regulating neutrophil migration during inflammation. The expression of 
semaphorin3F, and also its receptors neuropilin-2 and plexin A3, in 
neutrophils has been characterised. In vivo investigation of the role of 
semaphorin3F in neutrophil behaviour in inflammation was performed in 
transgenic zebrafish embryos accompanied with use of genomic editing 
techniques, including TALENs. I found that semaphorin3F affects the 
migratory behaviour of neutrophils and leads to changes in the recruitment 
and resolution phases of inflammation. Semaphorin3F overexpression 
reduces neutrophil motility causing retention of neutrophils at the inflamed 
site, whereas loss of semaphorin3F promotes inflammation resolution by 
accelerating neutrophil movement away from the site of injury. I further 
determined the mechanism of semaphorin3F involvement in neutrophil 
migration. I demonstrated that semaphorin3F inhibits chemotactic response 
of neutrophils to chemoattractants, but it does not affect PI-3K activity which 
generates polarisation during chemotaxis. Notably, distinct changes in 
neutrophil shape between semaphorin3F overexpression and the controls 
were observed. This may be affected by involvement of semaphorin3F in 
cytoskeletal signalling pathways that must be further elucidated in the future. 
Coupled with the fact that semaphorin3F knockdown/knockout shows no 
considerable effect on neutrophil recruitment, and that semaphorin3F 
expression in human neutrophils appears to be modulated antagonistically 
by hypoxia and inflammatory cytokines released at the inflammatory site, 
these suggest that semaphorin3F may not be induced until neutrophils reach 
the site of inflammation. As neutrophils arrive at the injury site, their 
movement is slowed by upregulation of semaphorin3F caused by cytokines, 
causing them to stop where the inflammation is greatest. Once the 
pathogens are destroyed, increased hypoxia may have the opposite effect, 
downregulating semaphorin3F expression and initiating resolution, resulting 
in neutrophil reverse migration (Figure 7.1). This work will hopefully extend 
the study of neutrophilic inflammation, and provide a new concept of drug 
discovery for inflammatory diseases.    
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Figure 7.1: Semaphorin3F regulates neutrophil migration during inflammation. Once 
an injury occurs, neutrophils are recruited from the circulation to the site of inflammation by 
alarm signal from hypoxia and pro-inflammatory cytokines though chemotaxis. At the 
beginning of recruitment phase, semaphorin3F is thought to be downregulated. As 
neutrophils arrive at the site of injury, released cytokines upregulate semaphorin3F 
expression, causing neutrophil movement to slow or stop where the inflammation is greatest. 
Once the pathogens are destroyed, increased hypoxia downregulates semaphorin3F 
expression and initiate resolution, resulting in neutrophil reverse migration. 
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Appendix 1 
 
Primary antibodies 
Name Producer 
species 
Species 
reactivity 
Isotype Dilution Source 
Anti-semaphorin3F Rabbit Human, 
Mouse, Rat 
Polyclonal 1:200 #ab39956 
Abcam 
Anti-neuropilin1 Rabbit Human, 
Mouse, Rat 
IgG 1:500 #ab81321 
Abcam 
Anti-neuropilin2 Rabbit Human, 
Mouse, Rat 
Polyclonal 1:200 #ab135456 
Abcam 
Anti-plexin A1 Rabbit Human, 
Mouse, Rat 
Polyclonal 1:500 #ab23391 
Abcam 
Anti-plexin A2 Mouse Human, 
Mouse, Rat 
IgG2b 1:500 #ab88130 
Abcam 
Anti-plexin A3 Rabbit Human, 
Mouse 
Polyclonal 1:500 #ab41564 
Abcam 
Anti-plexin D1 Rabbit Human, 
Mouse, Rat 
Polyclonal 1:500 #ab96313 
Abcam 
Anti-p38 MAPK Rabbit Human, 
Mouse, 
Rat, 
Monkey, 
Guinea pig 
Polyclonal 1:1000 #9212 
Cell Signaling 
Technology 
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Secondary antibodies 
Name Producer 
species 
Species 
reactivity 
Isotype Dilution Source 
Anti-Rabbit 
Immunoglobulins/HRP 
Goat Rabbit Polyclonal 1:2000 #P0448 
Dako 
Anti-Mouse 
Immunoglobulins/HRP 
Rabbit Mouse Polyclonal 1:2000 #P0260 
Dako 
 
 
Cytokines 
Name Concentration Source 
Recombinant Human TNF-alpha 10 ng/ml #210-TA-100 
R&D Systems 
Recombinant Human IL-1 beta 10 ng/ml #201-LB-025 
R&D Systems 
 
 
Plasmid constructs 
Name Information Source 
Full length Zebrafish 
semaphorin3Fa in pCR4 
vector 
Insert size: 2.6 kb 
Antisense cut with PmeI 
Transcription with T7 
From Prof.Cecilia B. Moens  
(University of Washington) 
Full length Zebrafish 
semaphorin3Fb in pCR4 
vector 
Insert size: 2.2 kb 
Antisense cut with NotI 
Transcription with T3 
From Prof.Cecilia B. Moens 
(University of Washington) 
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Morpholino oligonucleotides 
 
Name Sequence Type Source 
Zebrafish  
semaphorin3Fa 
5'-TATCCATAAAACCCACAAGAGATTT-3’ Translation 
blocker 
Yu and 
Moens, 
2005 
Zebrafish  
semaphorin3Fb 
5’-CATAGACTGTCCAAGAGCATGGTGC-3’ Translation 
blocker 
Tanaka et 
al., 2007 
Zebrafish  
semaphorin3Fb 
5'-TATGAAGCGATACTCACGTTTGTGT-‘3 Splice 
blocker 
Dr.Stephen 
Renshaw 
Control  5’-CCTCTTACCTCAGTTACAATTTATA-3’ - Gene Tools 
 
Primer for morpholino test 
Name Sequence 
Sema3fb-splice blocker (F) 5’-CATGTATGTGGGCAGCAAAG-3’ 
Sema3fb-splice blocker (R) 5’-CATAGGCTTGCGTCCTCTGT-3’ 
Ef1α (F) 5’-CTTCTCAGGCTGACTGTGC-3’ 
Ef1α (R) 5’-CCGCTAGCATTACCCTCC-3’ 
 
 
Primer for TALEN 
Name Sequence 
TAL_R2 5’-GGCGACGAGGTGGTCGTTGG-3’ 
SeqTALEN_5-1 5’-CATCGCGCAATGCACTGAC-3’ 
Sema3Fa MwoI (F) 5’-ATGGATGGGCTCATTTTGTC-3’ 
Sema3Fa MwoI (R) 5’-GTAGTATGCCACGGTTCAAA-3’ 
Sema3Fb Bsll (F) 5’-TCTCCCTGCATTGTCTTGC-3’ 
Sema3Fb Bsll (R) 5’-TTTGAGCTCACCAGGCAGAT-3’ 
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Appendix 2 
Resolving gels 
To make 1 gels for 1.5 mm gel plates:    3    ml 40% Acrylamide 
   3.8  ml 1.5 M Tris pH 8.8 
   8 ml dH2O 
  75 μl 20% SDS 
 150 μl 20% APS 
    6 μl  TEMED 
Stacking gels   
To make 1 gels for 1.5 mm gel plates:  620   μl 40% Acrylamide 
  1260 μl 1.5 M Tris pH 6.8 
    3 ml dH2O 
  25 μl 20% SDS 
  50 μl 20% APS 
    5 μl  TEMED 
20% Ammonium persulfate (APS) 
To make 1 ml of 20% APS stock: 0.2 g APS 
 1 ml dH2O  
This can be stored in aliquots at -20C for up to 1 month, but do not freeze-thaw. 
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Hypotonic sonication lysis buffer 
To make 100 ml: 10 ml  1 M Tris pH 7.8 
 55.84 mg 1 M EDTA 
 74.56 mg KCl 
  7.71  mg DTT 
 18.39 mg Sodium orthovanadate 
 48.15 mg Tetramisole 
 dH2O up to 100 ml 
Immediately before use the following were added: 
Complete mini EDTA-free protease inhibitor cocktail tablets 
(1 tablet in 1 ml water) 
Phenylmethanesulfonyl fluoride (PMSF)                       1:100                         
 
 
1:20 
 
 
2x SDS lysis buffer 
To make 10 ml: 308.5 mg DTT 
    2 ml 20% SDS 
    2 ml Glycerol 
    2 ml 1 M Tris-HCl pH 6.8 
 100 μl Bromophenol blue 
 200 μl Protease inhibitor cocktail 
 dH2O up to 10 ml 
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Running buffer 
To make 1 L of 10x stock: 190 g Glycine 
  30.3 g Tris base 
 50 ml 20% SDS 
 dH2O up to 1 L 
Transfer buffer 
To make 1 L of 10x stock: 145 g  Glycine 
   29 g Tris base 
  dH2O up to 1 L 
To make 1 L of 1x stock: 100 ml 10x Transfer buffer 
  200 ml Methanol 
  700 ml dH2O 
This should be made immediately before use. 
 
Tris-buffered saline (TBS) 
To make 1 L of 10x stock: 97.3 g NaCl 
  100 ml 1 M Tris-HCl pH 8.0 
  dH2O up to 1 L 
 
Tris-buffered saline + 0.1% tween 20 (TBS-Tween) 
To make 1 L of 10x stock: 97.3 g  NaCl 
  100 ml 1 M Tris-HCl pH 8.0 
      5 ml Tween-20 
  dH2O up to 1 L  
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  Blocking buffer 
To make 100 ml:   5 g Skim milk powder 
  100 ml 1x TBS 
 
E3 medium 
To make 1 L of 60x stock:   5 mM  NaCl 
    0.17 mM  KCl 
    0.33 mM  CaCl2 
    0.33 mM  MgSO4 
  dH2O up to 1 L 
To make 1 L of 1x stock: 16.6 ml  60x E3 stock 
  1% methylene blue 
  dH2O up to 1 L 
In all cases, the 60x E3 stock was autoclaved before dilution and use in in vivo 
inflammation assays, to avoid contamination.  
  
Hybridisation wash buffer (HybWash) 
To make 50 ml:   25 ml 50% formamide 
    12.5 ml 20x SSC 
  460 μl Citric acid 
    50 μl Tween 20 
 
 Pre-hybridisation buffer (PreHyb) 
 As HypWash, with  50 μg/ml Heparin 
  500 μg/ml tRNA 
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Probe-hybridisation buffer (ProbeHyb) 
As PreHyb, with 1:200 dilution of probe in formamide 
 
20x Saline sodium citrate buffer (SSC)  
To make 200 ml: 35.06 g NaCl 
  17.64 g Sodium citrate 
  dH2O up to 200 ml 
  pH 7.0 using citric acid 
 
Blocking solution 
PBT, with 2% Sheep serum 
  2 mg/ml BSA 
 
Staining wash 
To make 50 ml:    5 ml 100 mM Tris-HCl pH 9.5 
    2.5 ml 50 mM MgCl2 
    5 ml 100 mM NaCl 
  dH2O up to 50 ml 
 
Staining solution 
As staining wash, with 100 mg/ml  NBT 
   50 mg/ml  BCIP 
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Appendix 3 
Transgenic line Abbreviation Application Reference 
Tg(mpx:GFP)i114 mpx:GFP Recruitment, 
Resolution, 
Total neutrophil 
number assays 
 
TUNEL assays 
 
In situ hybridisation 
Renshaw et al., 
2006 
Tg(mpx:Gal4;UAS:Kaede)i222 mpx/Kaede Reverse migration 
assays 
Elks et al.,  
2011 
Tg(fms:GAL4;UNM) fms:UNM Recruitment, 
Resolution assays 
Gray et al., 
2011 
Tg(lyz:PHAkt-EGFP) lyz/PHAkt PI-3K assays Wang et al., 
2014 
 
 
 
